<!DOCTYPE html SYSTEM "about:legacy-compat"><html lang="en" class="win-std-desktop-val"><head>
<META http-equiv="Content-Type" content="text/html">
<title>Source View: https://classic.clinicaltrials.gov/ct2/show/NCT03530683?term=NCT03530683&amp;draw=2&amp;rank=1</title><meta name="robots" content="noindex,nofollow"><meta name="SortSite-IgnoreRule-Page" content="AccHtmlLinkTextReused,AccAdvancedReadingLevel,Section508-m-3,BugHtmlColgroup,BugIeCssMinMaxWidthHeight,ErrSpellingError,SeoBingTitleLength,SeoPage150k,UseGov5.1,UseGov9.2.3,UseGov10.11,UseGov11.7,UseGov14.3,UseGov17.4,UseGunningFog,W3cTitleTooLong"><link rel="icon" href="https://www-powermapper-com.azureedge.net/favicon.ico"><link rel="stylesheet" href="../Report/report-min-20200618.css"><script type="text/javascript" src="../Report/report-min-20210409.js"></script><!--[if lte IE 8]>
            <script>
                document.createElement('header');
                document.createElement('aside');
            </script>
            <![endif]--></head><body class="source"><a class="accessible" href="#content">Skip to Content</a><header><h1>
                        HTML Document
                    </h1><table><tr><th>
                        URL:
                    </th><td><a rel="nofollow" target="_top" href="https://classic.clinicaltrials.gov/ct2/show/NCT03530683?term=NCT03530683&amp;draw=2&amp;rank=1">https://classic.clinicaltrials.gov/ct2/show/NCT03530683?term=NCT03530683&amp;draw=2&amp;rank=1</a></td></tr><tr><th>
                        HTTP Status:
                    </th><td>200 OK</td></tr><tr><th>
                        MIME Type:
                    </th><td>text/html </td></tr><tr><th>
                        Last Modified:
                    </th><td>Mon, 01 Jan 1601 00:00:00 GMT</td></tr><tr><th>
                        Download Time:
                    </th><td>1 seconds
                            </td></tr><tr><th>
                        Cookies:
                    </th><td> Psid=vihzm6CL8w0BLDLJSyz3FQ7V  CTOpts=Qihzm6CL8w0BLDLJSyUgzw </td></tr><tr><th>
                        Size:
                    </th><td>136 KB
                        </td></tr><tr><th>
                                Depth:
                            </th><td>4 clicks from home page
                            </td></tr><tr><th>
                                Charset:
                            </th><td>utf-8</td></tr><tr><th>
                                Forms:
                            </th><td>1 forms containing 3 controls
                            </td></tr><tr><th>
                        HTTP Headers:
                    </th><td><button class="chevron toggleChevron" data-toggleid="HttpHeaders"><img width="20" height="20" alt="View Headers" id="chevHttpHeaders" src="../Report/chevron-down.svg"></button>&nbsp;<span>9&nbsp;headers</span><div class="links" id="expand-HttpHeaders">Connection: close<br>Date: Wed, 27 Sep 2023 21:56:40 GMT<br>Server: Apache<br>Set-Cookie: CTOpts=Qihzm6CL8w0BLDLJSyUgzw-R98Fz3R4HhCGB; Expires=Wed, 27-Sep-2023 22:16:40 GMT; Path=/; Secure; HttpOnly<br>Strict-Transport-Security: max-age=31536000; includeSubDomains; preload<br>Transfer-Encoding: chunked<br>X-Frame-Options: SAMEORIGIN<br>X-UA-Compatible: IE=Edge<br>X-XSS-Protection: 1; mode=block<br></div></td></tr><tr><th>
                        Links In:
                    </th><td><button class="chevron toggleChevron" data-toggleid="LinksIn"><img width="20" height="20" alt="View Links" id="chevLinksIn" src="../Report/chevron-down.svg"></button>&nbsp;<span>1&nbsp;pages</span><div class="links" id="expand-LinksIn"><a class="viewsource" rel="nofollow" target="_top" href="https://content.montefioreeinstein.org/cancer/research/blood-institute/bci-research/translational-clinical-trials" data-pageid="6639" data-line="0" data-col="0">https://content.montefioreeinstein.org/cancer/research/blood-institute/bci-research/translational-clinical-trials</a><br></div></td></tr><tr><td>&nbsp;</td><td>&nbsp;</td></tr><tr class="middle"><th><img alt="OK" width="20" height="20" src="../Report/bench-better.svg">
                                Issues:
                            </th><td>
                                No issues found
                            </td></tr></table></header><main id="content" class="pre"><p><code>1</code><code>          </code></p><p><code>2</code><code>          </code></p><p><code>3</code><code>          </code></p><p><code>4</code><code>          </code></p><p><code>5</code><code>          </code></p><p><code>6</code><code>          </code></p><p><code>7</code><code>          </code></p><p><code>8</code><code>          </code></p><p><code>9</code><code>          </code></p><p><code>10</code><code>          </code></p><p><code>11</code><code>          </code></p><p><code>12</code><code>          </code></p><p><code>13</code><code>          </code></p><p><code>14</code><code>          </code></p><p><code>15</code><code>          </code></p><p><code>16</code><code>          </code></p><p><code>17</code><code>          </code></p><p><code>18</code><code>          </code></p><p><code>19</code><code>          </code></p><p><code>20</code><code>  </code></p><p><code>21</code><code>          </code></p><p><code>22</code><code>          </code></p><p><code>23</code><code>          </code></p><p><code>24</code><code>          </code></p><p><code>25</code><code>          </code></p><p><code>26</code><code>          </code></p><p><code>27</code><code>          </code></p><p><code>28</code><code>          </code></p><p><code>29</code><code>          </code></p><p><code>30</code><code>          </code></p><p><code>31</code><code>          </code></p><p><code>32</code><code>          </code></p><p><code>33</code><code>          </code></p><p><code>34</code><code>          </code></p><p><code>35</code><code>          </code></p><p><code>36</code><code>          </code></p><p><code>37</code><code>          </code></p><p><code>38</code><code>          </code></p><p><code>39</code><code>          </code></p><p><code>40</code><code>          </code></p><p><code>41</code><code>          </code></p><p><code>42</code><code>          </code></p><p><code>43</code><code>          </code></p><p><code>44</code><code>          </code></p><p><code>45</code><code>          </code></p><p><code>46</code><code>          </code></p><p><code>47</code><code>          </code></p><p><code>48</code><code>          </code></p><p><code>49</code><code>          </code></p><p><code>50</code><code>          </code></p><p><code>51</code><code>          </code></p><p><code>52</code><code>          </code></p><p><code>53</code><code>          </code></p><p><code>54</code><code>          </code></p><p><code>55</code><code>          </code></p><p><code>56</code><code>          </code></p><p><code>57</code><code>          </code></p><p><code>58</code><code>          </code></p><p><code>59</code><code>          </code></p><p><code>60</code><code>          </code></p><p><code>61</code><code>          </code></p><p><code>62</code><code>          </code></p><p><code>63</code><code>          </code></p><p><code>64</code><code>          </code></p><p><code>65</code><code>          </code></p><p><code>66</code><code>          </code></p><p><code>67</code><code>          </code></p><p><code>68</code><code>          </code></p><p><code>69</code><code>          </code></p><p><code>70</code><code>          </code></p><p><code>71</code><code>          </code></p><p><code>72</code><code>          </code></p><p><code>73</code><code>          </code></p><p><code>74</code><code>&lt;!DOCTYPE html&gt;</code></p><p><code>75</code><code>&lt;html xmlns="https://www.w3.org/1999/xhtml" lang='en'&gt;</code></p><p><code>76</code><code>&lt;head&gt;  </code></p><p><code>77</code><code>  &lt;meta http-equiv="X-UA-Compatible" content="IE=edge" /&gt;</code></p><p><code>78</code><code>  &lt;meta name="viewport" content="width=device-width, initial-scale=1"&gt;</code></p><p><code>79</code><code>  &lt;meta http-equiv="content-type" content="text/html; charset=UTF-8" /&gt;</code></p><p><code>80</code><code>    &lt;meta name="robots" content="noindex,nofollow"/&gt;</code></p><p><code>81</code><code>    &lt;meta name="referrer" content="origin-when-cross-origin"/&gt;</code></p><p><code>82</code><code>  &lt;title&gt;A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma - Full Text View - ClinicalTrials.gov&lt;/title&gt;</code></p><p><code>83</code><code>    &lt;link href="/ct2/show/NCT03530683" rel="canonical"/&gt;</code></p><p><code>84</code><code>    </code></p><p><code>85</code><code>  &lt;!-- Twitter Card data --&gt;</code></p><p><code>86</code><code>  &lt;meta name="twitter:card" content="summary"&gt;</code></p><p><code>87</code><code>  &lt;meta name="twitter:image" content="https://clinicaltrials.gov/ct2/html/images/ct.gov-nlm-nih-square-logo.png?v1"&gt;</code></p><p><code>88</code><code>          </code></p><p><code>89</code><code>  &lt;!-- Open Graph data --&gt;</code></p><p><code>90</code><code>  &lt;meta property="og:type" content="article" /&gt;</code></p><p><code>91</code><code>  &lt;meta property="og:title" content="A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma - Full Text View - ClinicalTrials.gov"&gt;</code></p><p><code>92</code><code>  &lt;meta property="og:image" content="https://clinicaltrials.gov/ct2/html/images/ct.gov-nlm-nih-square-logo.png?v1"&gt;</code></p><p><code>93</code><code>    &lt;meta property="og:description" content="A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma - Full Text View."&gt;</code></p><p><code>94</code><code>  &lt;meta property="og:url" content="https://clinicaltrials.gov/ct2/show/NCT03530683"&gt;</code></p><p><code>95</code><code>    </code></p><p><code>96</code><code>  &lt;link rel="shortcut icon" href="/ct2/html/images/favicon.ico" /&gt;</code></p><p><code>97</code><code>  &lt;link rel='apple-touch-icon-precomposed' href='/ct2/html/images/apple-touch-icon-144x144.png' sizes='144x144'&gt;</code></p><p><code>98</code><code>  &lt;link rel='apple-touch-icon-precomposed' href='/ct2/html/images/apple-touch-icon-114x114.png' sizes='114x114'&gt;</code></p><p><code>99</code><code>  &lt;link rel='apple-touch-icon-precomposed' href='/ct2/html/images/apple-touch-icon-72x72.png'   sizes='72x72'&gt;</code></p><p><code>100</code><code>  &lt;link rel='apple-touch-icon-precomposed' href='/ct2/html/images/apple-touch-icon-precomposed.png' &gt;</code></p><p><code>101</code><code>  &lt;link rel='apple-touch-icon-precomposed' href='/ct2/html/images/apple-touch-icon.png' &gt;</code></p><p><code>102</code><code>          </code></p><p><code>103</code><code>  &lt;link rel="stylesheet" type="text/css" href="/ct2/html/jquery/css/superfish.css?v=48" media="screen" /&gt;</code></p><p><code>104</code><code>  &lt;link rel="stylesheet" type="text/css" href="/ct2/html/jquery/css/superfish-vertical.css?v=48" media="screen" /&gt;</code></p><p><code>105</code><code>  &lt;link rel="stylesheet" type="text/css" href="/ct2/html/css/glossary.css?v=48" /&gt;</code></p><p><code>106</code><code>  &lt;link rel="stylesheet" type="text/css" href="/ct2/html/css/base.css?v=48" /&gt;</code></p><p><code>107</code><code>  &lt;link rel="stylesheet" type="text/css" href="/ct2/html/css/print.css?v=48" media="print" /&gt;</code></p><p><code>108</code><code>  &lt;link rel="stylesheet" href="/ct2/html/css/w3-ct.css?v=48" type="text/css" /&gt;</code></p><p><code>109</code><code>  &lt;!--[if lt IE 9]&gt;</code></p><p><code>110</code><code>	&lt;link rel="stylesheet" href="/ct2/html/css/w3-ct-oldIE.css?v=48" type="text/css" /&gt;</code></p><p><code>111</code><code>  &lt;![endif]--&gt;</code></p><p><code>112</code><code>   	</code></p><p><code>113</code><code>  &lt;link rel="preconnect" href="https://use.fontawesome.com"&gt;</code></p><p><code>114</code><code>  &lt;link rel="preconnect" href="https://www.ncbi.nlm.nih.gov"&gt;</code></p><p><code>115</code><code>  </code></p><p><code>116</code><code>  &lt;script src="https://use.fontawesome.com/20a31629ec.js"&gt;&lt;/script&gt;</code></p><p><code>117</code><code>&lt;!--[if lte IE 7]&gt;</code></p><p><code>118</code><code>       &lt;link href="/ct2/html/css/target-IE7-and-below.css" rel="stylesheet" type="text/css"&gt;</code></p><p><code>119</code><code>&lt;![endif]--&gt;</code></p><p><code>120</code><code>          </code></p><p><code>121</code><code>&lt;style type="text/css"&gt;</code></p><p><code>122</code><code>  h2 </code></p><p><code>123</code><code>  {</code></p><p><code>124</code><code>      background-color: #EAEAEA;</code></p><p><code>125</code><code>  }</code></p><p><code>126</code><code>&lt;/style&gt;</code></p><p><code>127</code><code>&lt;link href="/ct2/html/css/trial-record.css?v=48" rel="stylesheet" type="text/css" /&gt;</code></p><p><code>128</code><code>          </code></p><p><code>129</code><code>	&lt;script type="text/javascript" src="/ct2/html/jquery/js/jquery.min.js?v=48"&gt;&lt;/script&gt;&lt;noscript&gt;&lt;/noscript&gt;</code></p><p><code>130</code><code>&lt;script type="text/javascript" async src="/ct2/html/jquery/js/superclick.min.js?v=48"&gt;&lt;/script&gt;&lt;noscript&gt;&lt;/noscript&gt;</code></p><p><code>131</code><code>&lt;script type="text/javascript" async src="/ct2/html/js/ct.js?v=48"&gt;&lt;/script&gt;&lt;noscript&gt;&lt;/noscript&gt;</code></p><p><code>132</code><code>&lt;script type="text/javascript" async src="/ct2/html/js/ctmenu.js?v=48"&gt;&lt;/script&gt;&lt;noscript&gt;&lt;/noscript&gt;</code></p><p><code>133</code><code>&lt;script&gt;</code></p><p><code>134</code><code>var theURL = "/ct2/show/NCT03530683?term=NCT03530683&amp;draw=2&amp;rank=1"+window.location.hash;</code></p><p><code>135</code><code>history.replaceState(null,null,theURL);</code></p><p><code>136</code><code>&lt;/script&gt;</code></p><p><code>137</code><code>          </code></p><p><code>138</code><code>  &lt;meta name="ncbi_sid" content="4ec6157c5146f356_130e19SID"/&gt;</code></p><p><code>139</code><code>  &lt;meta name="ncbi_app" content="ctgov"/&gt;</code></p><p><code>140</code><code>  &lt;meta name="ncbi_db" content="ctgov"/&gt;</code></p><p><code>141</code><code>  &lt;meta name="ncbi_pdid" content="show_study"/&gt;</code></p><p><code>142</code><code>  &lt;meta name="ncbi_pcid" content="NCT03530683"/&gt;</code></p><p><code>143</code><code>  &lt;meta name="ncbi_ctreqid" content="R9A05mW3"/&gt;</code></p><p><code>144</code><code>  &lt;meta name="ncbi_ctsessid" content="S9A05FLV"/&gt;</code></p><p><code>145</code><code>  &lt;meta name="ncbi_ctipid" content="IjatRiK3"/&gt;</code></p><p><code>146</code><code>  &lt;meta name="ncbi_cthost" content="w11"/&gt;</code></p><p><code>147</code><code>  &lt;meta name="ncbi_ctterm" content="NCT03530683"/&gt;</code></p><p><code>148</code><code>  &lt;meta name="ncbi_ctrank" content="1"/&gt;</code></p><p><code>149</code><code>&lt;/head&gt;</code></p><p><code>150</code><code>          </code></p><p><code>151</code><code>          </code></p><p><code>152</code><code>&lt;body&gt; </code></p><p><code>153</code><code>&lt;script type="text/javascript"&gt;</code></p><p><code>154</code><code>    jQuery.getScript("https://www.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {</code></p><p><code>155</code><code>      galert(['#alert_banner', 'body &amp;gt; *:nth-child(1)'])});</code></p><p><code>156</code><code>&lt;/script&gt;</code></p><p><code>157</code><code>          </code></p><p><code>158</code><code>&lt;div id="alert_banner"&gt;&lt;/div&gt;</code></p><p><code>159</code><code>          </code></p><p><code>160</code><code>          </code></p><p><code>161</code><code>          </code></p><p><code>162</code><code>&lt;!-- eff6fb / aa0000; f9dede/black; ac2020/white --&gt;</code></p><p><code>163</code><code>&lt;!--</code></p><p><code>164</code><code>&lt;div style="display:flex; flex-direction:row; justify-content:center; background-color:#f9dede; margin-top:0px; padding: 10px 0 10px 0;"&gt;</code></p><p><code>165</code><code>    &lt;div style="text-align:center; color:black; font-size:18px; font-weight:700;"&gt;</code></p><p><code>166</code><code>        Maintenance test banner&lt;/br&gt;</code></p><p><code>167</code><code>        Line # 2</code></p><p><code>168</code><code>    &lt;/div&gt;</code></p><p><code>169</code><code>&lt;/div&gt;</code></p><p><code>170</code><code>--&gt;</code></p><p><code>171</code><code>          </code></p><p><code>172</code><code>&lt;div style="width:100%; height:8px; background-color:#ffbe2e;"&gt;&lt;/div&gt;</code></p><p><code>173</code><code>&lt;div id="longAlert" style="width:100%; background-color:#faf3d1; padding: 10px 0px; "&gt;</code></p><p><code>174</code><code>    &lt;div style="max-width: 1200px; margin: 0px auto; display:flex; align-items: center; font-size:14px; font-weight:700; padding:0px 8px;"&gt;</code></p><p><code>175</code><code>        &lt;div style="margin-right:1rem; display:flex; justify-content: center;"&gt;&lt;img src="/ct2/html/images/icon-disclaimer.png" width="24" height="24"/&gt;&lt;/div&gt;</code></p><p><code>176</code><code>        </code></p><p><code>177</code><code>                        &lt;div&gt;</code></p><p><code>178</code><code>            This is the classic website, which will be retired eventually. Please visit the modernized &lt;a href="https://www.clinicaltrials.gov" title="Follow link"&gt;ClinicalTrials.gov&lt;/a&gt; instead.</code></p><p><code>179</code><code>                    &lt;/div&gt;</code></p><p><code>180</code><code>    &lt;/div&gt;</code></p><p><code>181</code><code>&lt;/div&gt;</code></p><p><code>182</code><code>&lt;div style="width:100%; height:8px; background-color:#ffbe2e; margin-bottom:-8px;"&gt;&lt;/div&gt;</code></p><p><code>183</code><code>&lt;!--</code></p><p><code>184</code><code>&lt;div id="shortAlrt" style="display:block;margin-left:auto;margin-right:auto;border-bottom: 1px solid #aeb0b5;"&gt;</code></p><p><code>185</code><code>&amp;nbsp;</code></p><p><code>186</code><code>&lt;/div&gt;</code></p><p><code>187</code><code>--&gt;</code></p><p><code>188</code><code>          </code></p><p><code>189</code><code>          </code></p><p><code>190</code><code>          </code></p><p><code>191</code><code>          </code></p><p><code>192</code><code>&lt;!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--&gt;</code></p><p><code>193</code><code>&lt;script type='text/javascript'&gt;</code></p><p><code>194</code><code>/*</code></p><p><code>195</code><code>(function(){var g=function(e,h,f,g){</code></p><p><code>196</code><code>this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b&lt;e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null};</code></p><p><code>197</code><code>this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "};</code></p><p><code>198</code><code>this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&amp;&amp;(e=Math.random()&gt;=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0};</code></p><p><code>199</code><code>this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g+ "&amp;t=" + (new Date()).getTime();document.body&amp;&amp;document.body.appendChild(a)}};</code></p><p><code>200</code><code>this.start=function(){var a=this;window.addEventListener?window.addEventListener("load",function(){a.go()},!1):window.attachEvent&amp;&amp;window.attachEvent("onload",function(){a.go()})}};</code></p><p><code>201</code><code>try{(new g(100,"r","QSI_S_ZN_7WHWRcRMBs9xWYd","https://zn7whwrcrmbs9xwyd-nlmenterprise.siteintercept.qualtrics.com/WRSiteInterceptEngine/?Q_ZID=ZN_7WHWRcRMBs9xWYd")).start()}catch(i){}})();</code></p><p><code>202</code><code>*/</code></p><p><code>203</code><code>/*</code></p><p><code>204</code><code>$(window).on('error', function(e){</code></p><p><code>205</code><code>	// this will prevent error propagation from qualtrics</code></p><p><code>206</code><code>	// window.addEventListener('error', (e) =&gt; { e.preventDefault(); });</code></p><p><code>207</code><code>	// window.onerror = function(message, source, lineno, colno, error){ event.preventDefault(); });</code></p><p><code>208</code><code>	console.log('eondow.error', event.message)</code></p><p><code>209</code><code>	e.preventDefault();		// stop reporting (and maybe execution) of failed script</code></p><p><code>210</code><code>})</code></p><p><code>211</code><code>*/</code></p><p><code>212</code><code>(function () {</code></p><p><code>213</code><code>    var g = function (e, h, f, g) {</code></p><p><code>214</code><code>        this.get = function (a) {</code></p><p><code>215</code><code>            for (var a = a + "=", c = document.cookie.split(";"), b = 0, e = c.length; b &lt; e; b++) {</code></p><p><code>216</code><code>                for (var d = c[b]; " " == d.charAt(0); ) d = d.substring(1, d.length);</code></p><p><code>217</code><code>                if (0 == d.indexOf(a)) return d.substring(a.length, d.length);</code></p><p><code>218</code><code>            }</code></p><p><code>219</code><code>            return null;</code></p><p><code>220</code><code>        };</code></p><p><code>221</code><code>        this.set = function (a, c) {</code></p><p><code>222</code><code>            var b = "",</code></p><p><code>223</code><code>                b = new Date();</code></p><p><code>224</code><code>            b.setTime(b.getTime() + 6048e5);</code></p><p><code>225</code><code>            b = "; expires=" + b.toGMTString();</code></p><p><code>226</code><code>            document.cookie = a + "=" + c + b + "; path=/; ";</code></p><p><code>227</code><code>        };</code></p><p><code>228</code><code>        this.check = function () {</code></p><p><code>229</code><code>            var a = this.get(f);</code></p><p><code>230</code><code>            if (a) a = a.split(":");</code></p><p><code>231</code><code>            else if (100 != e) "v" == h &amp;&amp; (e = Math.random() &gt;= e / 100 ? 0 : 100), (a = [h, e, 0]), this.set(f, a.join(":"));</code></p><p><code>232</code><code>            else return !0;</code></p><p><code>233</code><code>            var c = a[1];</code></p><p><code>234</code><code>            if (100 == c) return !0;</code></p><p><code>235</code><code>            switch (a[0]) {</code></p><p><code>236</code><code>                case "v":</code></p><p><code>237</code><code>                    return !1;</code></p><p><code>238</code><code>                case "r":</code></p><p><code>239</code><code>                    return (c = a[2] % Math.floor(100 / c)), a[2]++, this.set(f, a.join(":")), !c;</code></p><p><code>240</code><code>            }</code></p><p><code>241</code><code>            return !0;</code></p><p><code>242</code><code>        };</code></p><p><code>243</code><code>        this.go = function () {</code></p><p><code>244</code><code>			try {</code></p><p><code>245</code><code>				if (this.check()) {</code></p><p><code>246</code><code>					var a = document.createElement("script");</code></p><p><code>247</code><code>					a.type = "text/javascript";</code></p><p><code>248</code><code>					a.src = g + "&amp;t=" + new Date().getTime();</code></p><p><code>249</code><code>					document.body &amp;&amp; document.body.appendChild(a);</code></p><p><code>250</code><code>				}</code></p><p><code>251</code><code>			}</code></p><p><code>252</code><code>			catch(ex) {}</code></p><p><code>253</code><code>        };</code></p><p><code>254</code><code>        this.start = function () {</code></p><p><code>255</code><code>            var a = this;</code></p><p><code>256</code><code>            window.addEventListener</code></p><p><code>257</code><code>                ? window.addEventListener(</code></p><p><code>258</code><code>                      "load",</code></p><p><code>259</code><code>                      function () {</code></p><p><code>260</code><code>                          a.go();</code></p><p><code>261</code><code>                      },</code></p><p><code>262</code><code>                      !1</code></p><p><code>263</code><code>                  )</code></p><p><code>264</code><code>                : window.attachEvent &amp;&amp;</code></p><p><code>265</code><code>                  window.attachEvent("onload", function () {</code></p><p><code>266</code><code>                      a.go();</code></p><p><code>267</code><code>                  });</code></p><p><code>268</code><code>        };</code></p><p><code>269</code><code>    };</code></p><p><code>270</code><code>    try {</code></p><p><code>271</code><code>        new g(100, "r", "QSI_S_ZN_7WHWRcRMBs9xWYd", "https://zn7whwrcrmbs9xwyd-nlmenterprise.siteintercept.qualtrics.com/WRSiteInterceptEngine/?Q_ZID=ZN_7WHWRcRMBs9xWYd").start();</code></p><p><code>272</code><code>    } catch (i) {}</code></p><p><code>273</code><code>})();</code></p><p><code>274</code><code>&lt;/script&gt;</code></p><p><code>275</code><code>&lt;div id='ZN_7WHWRcRMBs9xWYd'&gt;&lt;!--DO NOT REMOVE-CONTENTS PLACED HERE--&gt;&lt;/div&gt;</code></p><p><code>276</code><code>&lt;!--END WEBSITE FEEDBACK SNIPPET--&gt;</code></p><p><code>277</code><code>          </code></p><p><code>278</code><code>          </code></p><p><code>279</code><code>&lt;div id="glossary" class="glossary"</code></p><p><code>280</code><code>    aria-describedby="glossary-result" aria-hidden="true"&gt;</code></p><p><code>281</code><code>  &lt;button</code></p><p><code>282</code><code>      title="Close glossary"</code></p><p><code>283</code><code>      class="js-glossary-close button button--close js-glossary-toggle usa-button-unstyled"</code></p><p><code>284</code><code>    &gt;&lt;span class="usa-sr-only"&gt;Hide glossary&lt;/span&gt;</code></p><p><code>285</code><code>    &lt;i class="fa fa-times" aria-hidden="true"&gt;&lt;/i&gt;</code></p><p><code>286</code><code>  &lt;/button&gt;</code></p><p><code>287</code><code>  &lt;h4 class="glossary-heading"&gt;Glossary&lt;/h4&gt;</code></p><p><code>288</code><code>  &lt;p&gt;</code></p><p><code>289</code><code>  Study record managers: refer to the &lt;a href="https://classic.clinicaltrials.gov/ct2/manage-recs/resources#DataElement"&gt;&lt;span style="text-decoration:underline"&gt;Data Element Definitions&lt;/span&gt;&lt;/a&gt; if submitting registration or results information.</code></p><p><code>290</code><code>    &lt;/p&gt;</code></p><p><code>291</code><code>  &lt;p&gt;</code></p><p><code>292</code><code>  &lt;label for="glossary-search" class="label"&gt;Search for terms&lt;/label&gt;</code></p><p><code>293</code><code>  &lt;/p&gt;</code></p><p><code>294</code><code>  &lt;span class="clearable-input"&gt;</code></p><p><code>295</code><code>    &lt;input id="glossary-search" class="glossary__search js-glossary-search" type="search"&gt;</code></p><p><code>296</code><code>  &lt;/span&gt;</code></p><p><code>297</code><code>  &lt;div class="glossary__content" id="glossary-result"&gt;</code></p><p><code>298</code><code>    &lt;ul class="js-glossary-list"&gt;&lt;/ul&gt;</code></p><p><code>299</code><code>  &lt;/div&gt;</code></p><p><code>300</code><code>&lt;/div&gt;</code></p><p><code>301</code><code>          </code></p><p><code>302</code><code>          </code></p><p><code>303</code><code>          </code></p><p><code>304</code><code>          </code></p><p><code>305</code><code>&lt;script type="text/javascript" src="/ct2/html/js/working.js"&gt;&lt;/script&gt;&lt;noscript&gt;&lt;/noscript&gt;</code></p><p><code>306</code><code>&lt;div id="workingDim" class="ct-dim"&gt;</code></p><p><code>307</code><code>  &lt;div id="workingIndicator" class="ct-workingBox" style="text-align:center;vertical-align:middle;"&gt;</code></p><p><code>308</code><code>    &lt;img alt="Working&amp;#8230;" src="/ct2/html/images/working.gif" height="50" &gt;</code></p><p><code>309</code><code>  &lt;/div&gt;</code></p><p><code>310</code><code>&lt;/div&gt;</code></p><p><code>311</code><code>          </code></p><p><code>312</code><code>&lt;div id="wrapper"&gt; </code></p><p><code>313</code><code>&lt;div class="ct-inner_wrapper"&gt;   			&lt;a href="/ct2/home" style='float:left;border-bottom-width:0;min-width:200px;width:29%;'&gt;&lt;img src='/ct2/html/images/ct.gov-nlm-nih-logo.png' alt='ClinicalTrials.gov'/&gt;&lt;/a&gt;</code></p><p><code>314</code><code>          </code></p><p><code>315</code><code>				&lt;div id="hamburger" class="w3-hide-medium w3-hide-large" style="float:right;border-width:0;display:block;margin-left:1em;padding:4px;"</code></p><p><code>316</code><code>			title="Show menus"&gt;</code></p><p><code>317</code><code>			&lt;img src="/ct2/html/images/hamburgerMenuIcon.png" alt="ClinicalTrials.gov Menu" style="max-width:30px;cursor:pointer;" </code></p><p><code>318</code><code>			 onclick="$('#global-nav-popupMenu').toggle();"/&gt;</code></p><p><code>319</code><code>		&lt;/div&gt;</code></p><p><code>320</code><code>		&lt;div id="global-nav-popupMenu" class="w3-hide-medium w3-hide-large w3-modal w3-center" </code></p><p><code>321</code><code>			 style="display:none;" onclick="$('#global-nav-popupMenu').hide();"&gt; 			&lt;div id="global-nav-popupMenu-content" class="w3-modal-content"&gt;</code></p><p><code>322</code><code>				&lt;div class="w3-container"&gt;</code></p><p><code>323</code><code>				    &lt;span onclick="$('#global-nav-popupMenu').hide();"</code></p><p><code>324</code><code>				      class="w3-closebtn"&gt;&amp;times;&lt;/span&gt;</code></p><p><code>325</code><code>					&lt;ul class="sf-menu sf-vertical"&gt;</code></p><p><code>326</code><code>									&lt;li class="first"&gt;&lt;a href="/ct2/search/index"&gt;Find Studies&lt;img src="/ct2/html/images/pulldown.png" alt="Find Studies Menu"&gt;&lt;/a&gt;</code></p><p><code>327</code><code>			&lt;ul&gt;</code></p><p><code>328</code><code>                      &lt;li                  &gt;&lt;a                  href="/ct2/home"&gt;New Search&lt;/a&gt;&lt;/li&gt;</code></p><p><code>329</code><code>                      &lt;li                  &gt;&lt;a         href="/ct2/search/advanced"&gt;Advanced Search&lt;/a&gt;&lt;/li&gt;</code></p><p><code>330</code><code>                      &lt;li                  &gt;&lt;a     href="/ct2/search/browse?brwse=cond_cat"&gt;See Studies by Topic&lt;/a&gt;&lt;/li&gt;</code></p><p><code>331</code><code>                      &lt;li                  &gt;&lt;a             href="/ct2/search/map"&gt;See Studies on Map&lt;/a&gt;&lt;/li&gt;</code></p><p><code>332</code><code>                      &lt;li class="new-group"&gt;&lt;a           href="/ct2/help/how-find/index"&gt;How to Search&lt;/a&gt;&lt;/li&gt;</code></p><p><code>333</code><code>                      &lt;li                  &gt;&lt;a href="/ct2/help/how-use-search-results"&gt;How to Use Search Results&lt;/a&gt;&lt;/li&gt;</code></p><p><code>334</code><code>                      &lt;li                  &gt;&lt;a        href="/ct2/help/how-find/find-study-results"&gt;How to Find Results of Studies&lt;/a&gt;&lt;/li&gt;</code></p><p><code>335</code><code>                      &lt;li                  &gt;&lt;a          href="/ct2/help/how-read-study"&gt;How to Read a Study Record&lt;/a&gt;&lt;/li&gt;</code></p><p><code>336</code><code>			&lt;/ul&gt;</code></p><p><code>337</code><code>			&lt;/li&gt;</code></p><p><code>338</code><code>			&lt;li&gt;&lt;a href="/ct2/about-studies"&gt;About Studies&lt;img src="/ct2/html/images/pulldown.png" alt="About Studies Menu"&gt;&lt;/a&gt;</code></p><p><code>339</code><code>			&lt;ul&gt;</code></p><p><code>340</code><code>                      &lt;li&gt;&lt;a href="/ct2/about-studies/learn"&gt;Learn About Studies&lt;/a&gt;&lt;/li&gt;</code></p><p><code>341</code><code>                      &lt;li&gt;&lt;a  href="/ct2/about-studies/other-sites"&gt;Other Sites About Studies&lt;/a&gt;&lt;/li&gt;</code></p><p><code>342</code><code>                      &lt;li&gt;&lt;a         href="/ct2/about-studies/glossary"&gt;Glossary of Common Site Terms&lt;/a&gt;&lt;/li&gt;</code></p><p><code>343</code><code>			&lt;/ul&gt;</code></p><p><code>344</code><code>			&lt;/li&gt;</code></p><p><code>345</code><code>			&lt;li&gt;&lt;a href="/ct2/manage-recs"&gt;Submit Studies&lt;img src="/ct2/html/images/pulldown.png" alt="Submit Studies Menu"&gt;&lt;/a&gt;</code></p><p><code>346</code><code>			&lt;ul&gt;</code></p><p><code>347</code><code>                      &lt;li&gt;&lt;a                          href="/ct2/manage-recs/submit-study"&gt;Submit Studies to ClinicalTrials.gov PRS&lt;/a&gt;&lt;/li&gt;</code></p><p><code>348</code><code>                      &lt;li&gt;&lt;a                          href="/ct2/manage-recs/background"&gt;Why Should I Register and Submit Results?&lt;/a&gt;&lt;/li&gt;</code></p><p><code>349</code><code>                      &lt;li&gt;&lt;a                                href="/ct2/manage-recs/fdaaa"&gt;FDAAA 801 and the Final Rule&lt;/a&gt;&lt;/li&gt;</code></p><p><code>350</code><code>                      &lt;li class="new-group"&gt;&lt;a    href="/ct2/manage-recs/how-apply"&gt;How to Apply for a PRS Account&lt;/a&gt;&lt;/li&gt;</code></p><p><code>351</code><code>                      &lt;li&gt;&lt;a                        href="/ct2/manage-recs/how-register"&gt;How to Register Your Study&lt;/a&gt;&lt;/li&gt;</code></p><p><code>352</code><code>                      &lt;li&gt;&lt;a                         href="/ct2/manage-recs/how-edit"&gt;How to Edit Your Study Record&lt;/a&gt;&lt;/li&gt;</code></p><p><code>353</code><code>                      &lt;li&gt;&lt;a                   href="/ct2/manage-recs/how-report"&gt;How to Submit Your Results&lt;/a&gt;&lt;/li&gt;</code></p><p><code>354</code><code>                      &lt;li class="new-group"&gt;&lt;a       href="/ct2/manage-recs/faq"&gt;Frequently Asked Questions&lt;/a&gt;&lt;/li&gt;</code></p><p><code>355</code><code>                      &lt;li                  &gt;&lt;a href="/ct2/manage-recs/resources"&gt;Support Materials&lt;/a&gt;&lt;/li&gt;</code></p><p><code>356</code><code>                      &lt;li                  &gt;&lt;a      href="/ct2/manage-recs/present"&gt;Training Materials&lt;/a&gt;&lt;/li&gt;</code></p><p><code>357</code><code>			&lt;/ul&gt;</code></p><p><code>358</code><code>			&lt;/li&gt;</code></p><p><code>359</code><code>			&lt;li&gt;&lt;a href="/ct2/resources"&gt;Resources&lt;img src="/ct2/html/images/pulldown.png" alt="Resources Menu"&gt;&lt;/a&gt;</code></p><p><code>360</code><code>			&lt;ul&gt;</code></p><p><code>361</code><code>                      &lt;li                  &gt;&lt;a    href="/ct2/resources/pubs"&gt;Selected Publications&lt;/a&gt;&lt;/li&gt;</code></p><p><code>362</code><code>                      &lt;li                  &gt;&lt;a       href="/ct2/resources/alert"&gt;Clinical Alerts and Advisories&lt;/a&gt;&lt;/li&gt;</code></p><p><code>363</code><code>                      &lt;li                  &gt;&lt;a     href="/ct2/resources/rss"&gt;RSS Feeds&lt;/a&gt;&lt;/li&gt;</code></p><p><code>364</code><code>                      &lt;li class="new-group"&gt;&lt;a href="/ct2/resources/trends"&gt;Trends, Charts, and Maps&lt;/a&gt;&lt;/li&gt;</code></p><p><code>365</code><code>                      &lt;li                  &gt;&lt;a   href="/ct2/resources/download"&gt;Downloading Content for Analysis&lt;/a&gt;&lt;/li&gt;</code></p><p><code>366</code><code>			&lt;/ul&gt;</code></p><p><code>367</code><code>			&lt;/li&gt;</code></p><p><code>368</code><code>			&lt;li class="last"&gt;&lt;a href="/ct2/about-site"&gt;About Site&lt;img src="/ct2/html/images/pulldown.png" alt="About Site Menu"&gt;&lt;/a&gt;</code></p><p><code>369</code><code>			&lt;ul&gt;</code></p><p><code>370</code><code>                      &lt;li class="new-group"&gt;&lt;a href="/ct2/about-site/new"&gt;What's New&lt;/a&gt;&lt;/li&gt;</code></p><p><code>371</code><code>                      &lt;li                  &gt;&lt;a    href="/ct2/about-site/background"&gt;ClinicalTrials.gov Background&lt;/a&gt;&lt;/li&gt;</code></p><p><code>372</code><code>                      &lt;li                  &gt;&lt;a    href="/ct2/about-site/results"&gt;About the Results Database&lt;/a&gt;&lt;/li&gt;</code></p><p><code>373</code><code>                      &lt;li                  &gt;&lt;a    href="/ct2/about-site/history"&gt;History, Policies, and Laws&lt;/a&gt;&lt;/li&gt;</code></p><p><code>374</code><code>                      &lt;li                  &gt;&lt;a    href="/ct2/about-site/modernization"&gt;ClinicalTrials.gov Modernization&lt;/a&gt;&lt;/li&gt;</code></p><p><code>375</code><code>                      &lt;li                  &gt;&lt;a   href="/ct2/about-site/for-media"&gt;Media/Press Resources&lt;/a&gt;&lt;/li&gt;</code></p><p><code>376</code><code>                      &lt;li class="new-group"&gt;&lt;a          href="/ct2/about-site/link-to"&gt;Linking to This Site&lt;/a&gt;&lt;/li&gt;</code></p><p><code>377</code><code>                      &lt;li                  &gt;&lt;a           href="/ct2/about-site/terms-conditions"&gt;Terms and Conditions&lt;/a&gt;&lt;/li&gt;</code></p><p><code>378</code><code>                      &lt;li                  &gt;&lt;a      href="/ct2/about-site/disclaimer"&gt;Disclaimer&lt;/a&gt;&lt;/li&gt;</code></p><p><code>379</code><code>			&lt;/ul&gt;</code></p><p><code>380</code><code>			&lt;/li&gt;</code></p><p><code>381</code><code>			&lt;li&gt;&lt;a title="Login to the ClinicalTrials.gov Protocol Registration and Results System (PRS)"</code></p><p><code>382</code><code>				href="/ct2/manage-recs/register"&gt;&lt;span style="border-bottom:1px solid;padding-bottom:1px;padding-right:0;"&gt;PRS Login&lt;/span&gt;&lt;/a&gt;</code></p><p><code>383</code><code>			&lt;/li&gt;</code></p><p><code>384</code><code>								&lt;/ul&gt;</code></p><p><code>385</code><code>				&lt;/div&gt;</code></p><p><code>386</code><code>    		&lt;/div&gt;</code></p><p><code>387</code><code>  		&lt;/div&gt;		</code></p><p><code>388</code><code>		</code></p><p><code>389</code><code>&lt;div </code></p><p><code>390</code><code>style="float:right;margin-top:1.5%;" </code></p><p><code>391</code><code>class="w3-hide-small"&gt;</code></p><p><code>392</code><code>	&lt;ul class="sf-menu sf-vertical"&gt;</code></p><p><code>393</code><code>				&lt;li class="first"&gt;&lt;a href="/ct2/search/index"&gt;Find Studies&lt;img src="/ct2/html/images/pulldown.png" alt="Find Studies Menu"&gt;&lt;/a&gt;</code></p><p><code>394</code><code>			&lt;ul&gt;</code></p><p><code>395</code><code>                      &lt;li                  &gt;&lt;a                  href="/ct2/home"&gt;New Search&lt;/a&gt;&lt;/li&gt;</code></p><p><code>396</code><code>                      &lt;li                  &gt;&lt;a         href="/ct2/search/advanced"&gt;Advanced Search&lt;/a&gt;&lt;/li&gt;</code></p><p><code>397</code><code>                      &lt;li                  &gt;&lt;a     href="/ct2/search/browse?brwse=cond_cat"&gt;See Studies by Topic&lt;/a&gt;&lt;/li&gt;</code></p><p><code>398</code><code>                      &lt;li                  &gt;&lt;a             href="/ct2/search/map"&gt;See Studies on Map&lt;/a&gt;&lt;/li&gt;</code></p><p><code>399</code><code>                      &lt;li class="new-group"&gt;&lt;a           href="/ct2/help/how-find/index"&gt;How to Search&lt;/a&gt;&lt;/li&gt;</code></p><p><code>400</code><code>                      &lt;li                  &gt;&lt;a href="/ct2/help/how-use-search-results"&gt;How to Use Search Results&lt;/a&gt;&lt;/li&gt;</code></p><p><code>401</code><code>                      &lt;li                  &gt;&lt;a        href="/ct2/help/how-find/find-study-results"&gt;How to Find Results of Studies&lt;/a&gt;&lt;/li&gt;</code></p><p><code>402</code><code>                      &lt;li                  &gt;&lt;a          href="/ct2/help/how-read-study"&gt;How to Read a Study Record&lt;/a&gt;&lt;/li&gt;</code></p><p><code>403</code><code>			&lt;/ul&gt;</code></p><p><code>404</code><code>			&lt;/li&gt;</code></p><p><code>405</code><code>			&lt;li&gt;&lt;a href="/ct2/about-studies"&gt;About Studies&lt;img src="/ct2/html/images/pulldown.png" alt="About Studies Menu"&gt;&lt;/a&gt;</code></p><p><code>406</code><code>			&lt;ul&gt;</code></p><p><code>407</code><code>                      &lt;li&gt;&lt;a href="/ct2/about-studies/learn"&gt;Learn About Studies&lt;/a&gt;&lt;/li&gt;</code></p><p><code>408</code><code>                      &lt;li&gt;&lt;a  href="/ct2/about-studies/other-sites"&gt;Other Sites About Studies&lt;/a&gt;&lt;/li&gt;</code></p><p><code>409</code><code>                      &lt;li&gt;&lt;a         href="/ct2/about-studies/glossary"&gt;Glossary of Common Site Terms&lt;/a&gt;&lt;/li&gt;</code></p><p><code>410</code><code>			&lt;/ul&gt;</code></p><p><code>411</code><code>			&lt;/li&gt;</code></p><p><code>412</code><code>			&lt;li&gt;&lt;a href="/ct2/manage-recs"&gt;Submit Studies&lt;img src="/ct2/html/images/pulldown.png" alt="Submit Studies Menu"&gt;&lt;/a&gt;</code></p><p><code>413</code><code>			&lt;ul&gt;</code></p><p><code>414</code><code>                      &lt;li&gt;&lt;a                          href="/ct2/manage-recs/submit-study"&gt;Submit Studies to ClinicalTrials.gov PRS&lt;/a&gt;&lt;/li&gt;</code></p><p><code>415</code><code>                      &lt;li&gt;&lt;a                          href="/ct2/manage-recs/background"&gt;Why Should I Register and Submit Results?&lt;/a&gt;&lt;/li&gt;</code></p><p><code>416</code><code>                      &lt;li&gt;&lt;a                                href="/ct2/manage-recs/fdaaa"&gt;FDAAA 801 and the Final Rule&lt;/a&gt;&lt;/li&gt;</code></p><p><code>417</code><code>                      &lt;li class="new-group"&gt;&lt;a    href="/ct2/manage-recs/how-apply"&gt;How to Apply for a PRS Account&lt;/a&gt;&lt;/li&gt;</code></p><p><code>418</code><code>                      &lt;li&gt;&lt;a                        href="/ct2/manage-recs/how-register"&gt;How to Register Your Study&lt;/a&gt;&lt;/li&gt;</code></p><p><code>419</code><code>                      &lt;li&gt;&lt;a                         href="/ct2/manage-recs/how-edit"&gt;How to Edit Your Study Record&lt;/a&gt;&lt;/li&gt;</code></p><p><code>420</code><code>                      &lt;li&gt;&lt;a                   href="/ct2/manage-recs/how-report"&gt;How to Submit Your Results&lt;/a&gt;&lt;/li&gt;</code></p><p><code>421</code><code>                      &lt;li class="new-group"&gt;&lt;a       href="/ct2/manage-recs/faq"&gt;Frequently Asked Questions&lt;/a&gt;&lt;/li&gt;</code></p><p><code>422</code><code>                      &lt;li                  &gt;&lt;a href="/ct2/manage-recs/resources"&gt;Support Materials&lt;/a&gt;&lt;/li&gt;</code></p><p><code>423</code><code>                      &lt;li                  &gt;&lt;a      href="/ct2/manage-recs/present"&gt;Training Materials&lt;/a&gt;&lt;/li&gt;</code></p><p><code>424</code><code>			&lt;/ul&gt;</code></p><p><code>425</code><code>			&lt;/li&gt;</code></p><p><code>426</code><code>			&lt;li&gt;&lt;a href="/ct2/resources"&gt;Resources&lt;img src="/ct2/html/images/pulldown.png" alt="Resources Menu"&gt;&lt;/a&gt;</code></p><p><code>427</code><code>			&lt;ul&gt;</code></p><p><code>428</code><code>                      &lt;li                  &gt;&lt;a    href="/ct2/resources/pubs"&gt;Selected Publications&lt;/a&gt;&lt;/li&gt;</code></p><p><code>429</code><code>                      &lt;li                  &gt;&lt;a       href="/ct2/resources/alert"&gt;Clinical Alerts and Advisories&lt;/a&gt;&lt;/li&gt;</code></p><p><code>430</code><code>                      &lt;li                  &gt;&lt;a     href="/ct2/resources/rss"&gt;RSS Feeds&lt;/a&gt;&lt;/li&gt;</code></p><p><code>431</code><code>                      &lt;li class="new-group"&gt;&lt;a href="/ct2/resources/trends"&gt;Trends, Charts, and Maps&lt;/a&gt;&lt;/li&gt;</code></p><p><code>432</code><code>                      &lt;li                  &gt;&lt;a   href="/ct2/resources/download"&gt;Downloading Content for Analysis&lt;/a&gt;&lt;/li&gt;</code></p><p><code>433</code><code>			&lt;/ul&gt;</code></p><p><code>434</code><code>			&lt;/li&gt;</code></p><p><code>435</code><code>			&lt;li class="last"&gt;&lt;a href="/ct2/about-site"&gt;About Site&lt;img src="/ct2/html/images/pulldown.png" alt="About Site Menu"&gt;&lt;/a&gt;</code></p><p><code>436</code><code>			&lt;ul&gt;</code></p><p><code>437</code><code>                      &lt;li class="new-group"&gt;&lt;a href="/ct2/about-site/new"&gt;What's New&lt;/a&gt;&lt;/li&gt;</code></p><p><code>438</code><code>                      &lt;li                  &gt;&lt;a    href="/ct2/about-site/background"&gt;ClinicalTrials.gov Background&lt;/a&gt;&lt;/li&gt;</code></p><p><code>439</code><code>                      &lt;li                  &gt;&lt;a    href="/ct2/about-site/results"&gt;About the Results Database&lt;/a&gt;&lt;/li&gt;</code></p><p><code>440</code><code>                      &lt;li                  &gt;&lt;a    href="/ct2/about-site/history"&gt;History, Policies, and Laws&lt;/a&gt;&lt;/li&gt;</code></p><p><code>441</code><code>                      &lt;li                  &gt;&lt;a    href="/ct2/about-site/modernization"&gt;ClinicalTrials.gov Modernization&lt;/a&gt;&lt;/li&gt;</code></p><p><code>442</code><code>                      &lt;li                  &gt;&lt;a   href="/ct2/about-site/for-media"&gt;Media/Press Resources&lt;/a&gt;&lt;/li&gt;</code></p><p><code>443</code><code>                      &lt;li class="new-group"&gt;&lt;a          href="/ct2/about-site/link-to"&gt;Linking to This Site&lt;/a&gt;&lt;/li&gt;</code></p><p><code>444</code><code>                      &lt;li                  &gt;&lt;a           href="/ct2/about-site/terms-conditions"&gt;Terms and Conditions&lt;/a&gt;&lt;/li&gt;</code></p><p><code>445</code><code>                      &lt;li                  &gt;&lt;a      href="/ct2/about-site/disclaimer"&gt;Disclaimer&lt;/a&gt;&lt;/li&gt;</code></p><p><code>446</code><code>			&lt;/ul&gt;</code></p><p><code>447</code><code>			&lt;/li&gt;</code></p><p><code>448</code><code>			&lt;li&gt;&lt;a title="Login to the ClinicalTrials.gov Protocol Registration and Results System (PRS)"</code></p><p><code>449</code><code>				href="/ct2/manage-recs/register"&gt;&lt;span style="border-bottom:1px solid;padding-bottom:1px;padding-right:0;"&gt;PRS Login&lt;/span&gt;&lt;/a&gt;</code></p><p><code>450</code><code>			&lt;/li&gt;</code></p><p><code>451</code><code>				&lt;/ul&gt;</code></p><p><code>452</code><code>    &lt;div style="clear:both;"&gt;&lt;/div&gt;</code></p><p><code>453</code><code>&lt;/div&gt;</code></p><p><code>454</code><code>&lt;div style="clear:both;"&gt;&lt;/div&gt;</code></p><p><code>455</code><code>          </code></p><p><code>456</code><code>&lt;/div&gt; </code></p><p><code>457</code><code>&lt;div class="ct-outer_breadcrumb w3-container"&gt;</code></p><p><code>458</code><code>	&lt;div id="breadcrumb"&gt;</code></p><p><code>459</code><code>    &lt;ul class="ct-horz-list w3-left"&gt;</code></p><p><code>460</code><code>			&lt;li&gt;&lt;a href="/ct2/home"&gt;Home&lt;/a&gt;&lt;/li&gt;</code></p><p><code>461</code><code>												&lt;li&gt;&lt;a href="/ct2/results?term=NCT03530683&amp;amp;draw=2&amp;amp;rank=1"&gt;Search Results&lt;/a&gt;&lt;/li&gt;</code></p><p><code>462</code><code>										&lt;li&gt;Study Record Detail&lt;/li&gt;</code></p><p><code>463</code><code>    &lt;/ul&gt;</code></p><p><code>464</code><code>    &lt;div id="savedStudies" class="w3-right"&gt;</code></p><p><code>465</code><code>  	&lt;div id="cart" style="cursor:pointer;" onclick="location.href=('/ct2/results'+cartToURL()); showWorking();"&gt;</code></p><p><code>466</code><code>  	&lt;button class="ct-savedStudiesEnabled" id="open-cart-link" type="button" </code></p><p><code>467</code><code>  		onclick="location.href=('/ct2/results'+cartToURL()); showWorking();"</code></p><p><code>468</code><code>  		title="Show previously saved studies."&gt;Saved Studies&lt;/button&gt;</code></p><p><code>469</code><code>  	&lt;/div&gt;</code></p><p><code>470</code><code>&lt;/div&gt;</code></p><p><code>471</code><code>&lt;script type="text/javascript" src="/ct2/html/js/cart.js?v=48"&gt;&lt;/script&gt;&lt;noscript&gt;&lt;/noscript&gt;</code></p><p><code>472</code><code>          </code></p><p><code>473</code><code>		&lt;script type="text/javascript"&gt;</code></p><p><code>474</code><code>	$(document).ready(function(){</code></p><p><code>475</code><code>		$("input#saved").prop( 'checked', (inCart("NCT03530683")&gt;=0));</code></p><p><code>476</code><code>	});</code></p><p><code>477</code><code>&lt;/script&gt;</code></p><p><code>478</code><code>		&lt;div class="w3-right" style="margin-right: 1em;"&gt;</code></p><p><code>479</code><code>			&lt;label for="saved" title="Add or Remove this study in the Saved Studies list"&gt;&lt;input type="checkbox" id="saved" name="NCT03530683" onchange="updateCart('NCT03530683');" style="margin-left:1em;"&gt; Save this study &lt;/label&gt;</code></p><p><code>480</code><code>		&lt;/div&gt;</code></p><p><code>481</code><code>		&lt;div id="maxSavedStudies-popup" class="w3-modal" style="cursor:pointer;border:2px groove" onclick="$('#maxSavedStudies-popup').hide();"&gt;</code></p><p><code>482</code><code>	&lt;div id="maxSavedStudies-popup-content" class="w3-modal-content"&gt;</code></p><p><code>483</code><code>		&lt;div class="w3-display-container" style="border:1px solid #ccc;background-color:#eee;"&gt;</code></p><p><code>484</code><code>			&lt;form&gt;</code></p><p><code>485</code><code>			&lt;div class="w3-center" style="font-size:large;font-weight:bold;padding:3ex 1.5em;"&gt;</code></p><p><code>486</code><code>				&lt;img src="/ct2/html/images/warning.png" alt="Maximum Saved Studies Reached" style="max-width:1.0rem;cursor:pointer;"/&gt;</code></p><p><code>487</code><code>			    &lt;b&gt;Warning&lt;/b&gt;</code></p><p><code>488</code><code>				&lt;div style="margin-top:1ex;margin-bottom:0.5ex;"&gt;You have reached the maximum number of saved studies (100).&lt;/div&gt;</code></p><p><code>489</code><code>				&lt;div&gt;Please remove one or more studies before adding more.&lt;/div&gt;</code></p><p><code>490</code><code>			&lt;/div&gt;</code></p><p><code>491</code><code>		</code></p><p><code>492</code><code>			&lt;div class="w3-center" style="padding-bottom:1.5ex"&gt;</code></p><p><code>493</code><code>			  &lt;input class="ct-searchButton" type="button" style="opacity:1.0;font-weight:bold;font-size:inherit;padding:1.1ex 1em;" onclick="$('#maxSavedStudies-popup').hide();" value="Close" title="Close this dialog"/&gt;</code></p><p><code>494</code><code>			&lt;/div&gt;</code></p><p><code>495</code><code>			&lt;/form&gt;</code></p><p><code>496</code><code>		&lt;/div&gt;</code></p><p><code>497</code><code>	&lt;/div&gt;</code></p><p><code>498</code><code>&lt;/div&gt;</code></p><p><code>499</code><code>          </code></p><p><code>500</code><code>	&lt;/div&gt;</code></p><p><code>501</code><code>&lt;/div&gt;</code></p><p><code>502</code><code>          </code></p><p><code>503</code><code>&lt;div style="clear:both;"&gt;&lt;/div&gt;</code></p><p><code>504</code><code>          </code></p><p><code>505</code><code>&lt;div id="main-content" tabindex='-1'&gt;</code></p><p><code>506</code><code>	</code></p><p><code>507</code><code>	</code></p><p><code>508</code><code>		&lt;div class="tr-indent2"&gt;</code></p><p><code>509</code><code>        	&lt;div id="search-results" class="tr-search-results"&gt;</code></p><p><code>510</code><code>					&lt;div class="tr-results-summary"&gt;</code></p><p><code>511</code><code>				Trial record &lt;strong&gt;1 of 1&lt;/strong&gt; for:</code></p><p><code>512</code><code>		        &amp;nbsp;&amp;nbsp;  NCT03530683	        &lt;/div&gt;</code></p><p><code>513</code><code>	            &lt;div class="tr-results-nav"&gt;</code></p><p><code>514</code><code>         &lt;span class="grayed_fore_color"&gt;Previous Study&lt;/span&gt;         | &lt;a href="/ct2/results?term=NCT03530683&amp;amp;draw=2&amp;amp;rank=1" class="tr-return-link" &gt;Return to List&lt;/a&gt; |</code></p><p><code>515</code><code>         &lt;span class="grayed_fore_color"&gt;Next Study&lt;/span&gt; 		&lt;/div&gt;</code></p><p><code>516</code><code>	&lt;/div&gt;</code></p><p><code>517</code><code>	&lt;h1 class="tr-h1 ct-sans-serif"&gt;A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma&lt;/h1&gt;</code></p><p><code>518</code><code>          </code></p><p><code>519</code><code>  &lt;div class="w3-row"&gt;</code></p><p><code>520</code><code>    &lt;div class="w3-col m6"&gt;       &lt;div class="usa-alert usa-alert-warning" style="clear:both;margin:2ex 2em;"&gt;</code></p><p><code>521</code><code>        &lt;table&gt;</code></p><p><code>522</code><code>          &lt;tr&gt;</code></p><p><code>523</code><code>            &lt;td style="width:5%"&gt;</code></p><p><code>524</code><code>              &lt;img src="/ct2/html/images/warning.png" style="width:1.3em;" alt=""/&gt;</code></p><p><code>525</code><code>            &lt;/td&gt;</code></p><p><code>526</code><code>            &lt;td style="padding-right:2em;"&gt;</code></p><p><code>527</code><code>              The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.</code></p><p><code>528</code><code>                              &lt;a href="/ct2/about-studies/learn#Considerations"&gt;Know the risks and potential benefits&lt;/a&gt; of clinical studies and talk to your health care provider before participating.</code></p><p><code>529</code><code>                            Read our &lt;a href="/ct2/about-site/disclaimer"&gt;disclaimer&lt;/a&gt; for details.</code></p><p><code>530</code><code>            &lt;/td&gt;</code></p><p><code>531</code><code>          &lt;/tr&gt;</code></p><p><code>532</code><code>        &lt;/table&gt;</code></p><p><code>533</code><code>      &lt;/div&gt;      &lt;/div&gt; </code></p><p><code>534</code><code>&lt;!--</code></p><p><code>535</code><code>    &lt;div style="float:right;margin-right:4em"&gt;ClinicalTrials.gov Identifier: NCT03530683&lt;/div&gt;</code></p><p><code>536</code><code>--&gt;</code></p><p><code>537</code><code>    &lt;div class="w3-col m1"&gt;&amp;nbsp;&lt;/div&gt; </code></p><p><code>538</code><code>    &lt;div class="w3-col m5"&gt;       &lt;table style="width:95%"&gt;</code></p><p><code>539</code><code>        &lt;tr&gt;</code></p><p><code>540</code><code>          &lt;td&gt;ClinicalTrials.gov Identifier: NCT03530683&lt;/td&gt;</code></p><p><code>541</code><code>        &lt;/tr&gt;</code></p><p><code>542</code><code>        &lt;tr&gt;</code></p><p><code>543</code><code>          &lt;td&gt;</code></p><p><code>544</code><code>                          </code></p><p><code>545</code><code>                          </code></p><p><code>546</code><code>                                  &lt;div class="tr-status tr-recruiting-colors"&gt;</code></p><p><code>547</code><code>                                            &lt;span style="display:inline;" class="term" data-term="Recruitment Status" title="Show definition"&gt;Recruitment Status &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Recruitment Status" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; : </code></p><p><code>548</code><code>                                        Recruiting</code></p><p><code>549</code><code>                                                                  </code></p><p><code>550</code><code>                                              </code></p><p><code>551</code><code>            &lt;div style="font-size:inherit"&gt;</code></p><p><code>552</code><code>            &lt;span style="display:inline;" class="term" data-term="First Posted" title="Show definition"&gt;First Posted &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="First Posted" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; : May 21, 2018&lt;/div&gt;</code></p><p><code>553</code><code>                        &lt;div style="font-size:inherit"&gt;</code></p><p><code>554</code><code>            &lt;span style="display:inline;" class="term" data-term="Last Update Posted" title="Show definition"&gt;Last Update Posted &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Last Update Posted" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; : September 1, 2023&lt;/div&gt;</code></p><p><code>555</code><code>          </code></p><p><code>556</code><code>                          &lt;div style="margin-top:1ex; font-size:14px"&gt;</code></p><p><code>557</code><code>                &lt;span style="color:black;"&gt;See &lt;/span&gt;&lt;a href="#contacts"&gt;</code></p><p><code>558</code><code>                &lt;span class="ct-header2" style="font-size:inherit;"&gt; Contacts and Locations&lt;/span&gt;&lt;/a&gt;</code></p><p><code>559</code><code>              &lt;/div&gt;</code></p><p><code>560</code><code>            </code></p><p><code>561</code><code>                                    &lt;/div&gt;</code></p><p><code>562</code><code>          &lt;/td&gt;</code></p><p><code>563</code><code>        &lt;/tr&gt;</code></p><p><code>564</code><code>      &lt;/table&gt;</code></p><p><code>565</code><code>          </code></p><p><code>566</code><code>      &lt;!-- CTGDEV-1242 --&gt;</code></p><p><code>567</code><code>      &lt;div style="width:95%; margin-top:10px; padding: 0px 3px;"&gt;</code></p><p><code>568</code><code>        &lt;div style="padding: 15px 15px; background-color: #eff6fb; border: 5px #aacdec; border-style: solid none none none;"&gt;</code></p><p><code>569</code><code>        </code></p><p><code>570</code><code>          &lt;a href="https://clinicaltrials.gov/study/NCT03530683" target="_blank"&gt;View this study on the modernized ClinicalTrials.gov&lt;/a&gt;</code></p><p><code>571</code><code>                            &lt;/div&gt;</code></p><p><code>572</code><code>      &lt;/div&gt;</code></p><p><code>573</code><code>    &lt;/div&gt;    &lt;!-- div.w3-col.m5 --&gt;</code></p><p><code>574</code><code>  &lt;/div&gt;</code></p><p><code>575</code><code>          </code></p><p><code>576</code><code>  &lt;!-- CTGDEV-1242 --&gt;</code></p><p><code>577</code><code>  &lt;!--</code></p><p><code>578</code><code>  &lt;div style="float: right; width:41.66666%; margin-top:1rem; margin-left: 3rem; margin-bottom: 1rem;"&gt;</code></p><p><code>579</code><code>    &lt;div style="width:95%; background-color: #eff6fb; "&gt;</code></p><p><code>580</code><code>      &lt;div style="width:100%; height:.5rem; background-color: #aacdec;"&gt;&lt;/div&gt;</code></p><p><code>581</code><code>      &lt;div style="padding: 15px 15px;"&gt;</code></p><p><code>582</code><code>        &lt;a href="https://beta.clinicaltrials.gov/study/NCT03530683" target="_blank"&gt;View Record on Beta&lt;/a&gt;</code></p><p><code>583</code><code>      &lt;/div&gt;</code></p><p><code>584</code><code>    &lt;/div&gt;</code></p><p><code>585</code><code>  &lt;/div&gt;</code></p><p><code>586</code><code>  --&gt;</code></p><p><code>587</code><code>          </code></p><p><code>588</code><code>          </code></p><p><code>589</code><code>                &lt;div class="tr-info-title"&gt;Sponsor:&lt;/div&gt;</code></p><p><code>590</code><code>                &lt;div class="tr-info-text" id="sponsor"&gt; Pfizer &lt;/div&gt;</code></p><p><code>591</code><code>          </code></p><p><code>592</code><code>                              &lt;div class="tr-info-title"&gt;Information provided by (Responsible Party):&lt;/div&gt;</code></p><p><code>593</code><code>                &lt;div class="tr-info-text" id="responsibleparty"&gt;Pfizer&lt;/div&gt;</code></p><p><code>594</code><code>              	&lt;/div&gt;</code></p><p><code>595</code><code>&lt;br&gt;</code></p><p><code>596</code><code>          </code></p><p><code>597</code><code>    </code></p><p><code>598</code><code>&lt;div id="tabs"&gt;</code></p><p><code>599</code><code>    &lt;ul id="tab-links"&gt;</code></p><p><code>600</code><code>		&lt;li id="full-text"  class="current"&gt;Study Details     &lt;/li&gt;</code></p><p><code>601</code><code>		&lt;li id="tabular"   &gt;&lt;a href="/ct2/show/record/NCT03530683?term=NCT03530683&amp;amp;draw=2&amp;amp;rank=1" &gt;Tabular View&lt;/a&gt;&lt;/li&gt;</code></p><p><code>602</code><code>  					&lt;li id="results"   &gt;&lt;a href="/ct2/show/results/NCT03530683?term=NCT03530683&amp;amp;draw=2&amp;amp;rank=1"&gt;No Results Posted&lt;/a&gt;&lt;/li&gt;</code></p><p><code>603</code><code>						&lt;li id="disclaimer"&gt;&lt;a title="Disclaimer - opens new window"  href="/ct2/about-site/disclaimer" onclick="openNewWindow('/ct2/about-site/disclaimer'); return false"</code></p><p><code>604</code><code>&gt;Disclaimer&lt;/a&gt;&lt;/li&gt;</code></p><p><code>605</code><code>		&lt;li id="howtoread"&gt;&lt;a title="How to Read a Study Record - opens new window"  href="/ct2/help/how-read-study" onclick="openNewWindow('/ct2/help/how-read-study'); return false"</code></p><p><code>606</code><code>&gt;How to Read a Study Record&lt;/a&gt;&lt;/li&gt;</code></p><p><code>607</code><code>    &lt;/ul&gt;</code></p><p><code>608</code><code>&lt;/div&gt;  &lt;!--</code></p><p><code>609</code><code>&lt;div style="background-color:#f6f6f6;margin-top:5.0ex;padding-bottom:1.5ex;"&gt; &lt;/div&gt;</code></p><p><code>610</code><code>--&gt;</code></p><p><code>611</code><code>		</code></p><p><code>612</code><code>	&lt;div id="tab-body"&gt;</code></p><p><code>613</code><code>		&lt;div class="tr-indent2" style="background-color:white;"&gt;</code></p><p><code>614</code><code>						  </code></p><p><code>615</code><code>&lt;!-- purpose_section --&gt;</code></p><p><code>616</code><code>&lt;div class="tr-indent1" style="margin-top:1ex"&gt;</code></p><p><code>617</code><code>          </code></p><p><code>618</code><code>&lt;div class="tr-subsection"&gt;</code></p><p><code>619</code><code>	&lt;div class="ct-header2"&gt;&lt;a id="studydesc"&gt;&lt;/a&gt;Study Description&lt;/div&gt;</code></p><p><code>620</code><code>	&lt;div class="tr-underline"&gt;&lt;/div&gt;</code></p><p><code>621</code><code>	&lt;div class="tr-dropdown" style="padding-right:10em"&gt;</code></p><p><code>622</code><code>Go&amp;nbsp;to&amp;nbsp;</code></p><p><code>623</code><code>&lt;button class="tr-dropbtn" style="font-weight:bold; font-size:14px"&gt;</code></p><p><code>624</code><code>&lt;img src="/ct2/html/images/pulldown.png" alt="sections"&gt;</code></p><p><code>625</code><code>&lt;/button&gt;</code></p><p><code>626</code><code>          </code></p><p><code>627</code><code>  &lt;div class="tr-dropdown-content"&gt;</code></p><p><code>628</code><code>	&lt;a href="#wrapper"&gt;Top of Page&lt;/a&gt;</code></p><p><code>629</code><code>    &lt;a href="#studydesc"&gt;Study Description&lt;/a&gt;</code></p><p><code>630</code><code>    &lt;a href="#studydesign"&gt;Study Design&lt;/a&gt;</code></p><p><code>631</code><code>          </code></p><p><code>632</code><code>    &lt;!-- arms and groups table --&gt;</code></p><p><code>633</code><code>        &lt;a href="#armgroup"&gt;Arms and Interventions&lt;/a&gt;</code></p><p><code>634</code><code>    </code></p><p><code>635</code><code>        &lt;a href="#outcomemeasures"&gt;Outcome Measures&lt;/a&gt;</code></p><p><code>636</code><code>        &lt;a href="#eligibility"&gt;Eligibility Criteria&lt;/a&gt;</code></p><p><code>637</code><code>    &lt;a href="#contactlocation"&gt;Contacts and Locations&lt;/a&gt;</code></p><p><code>638</code><code>    &lt;a href="#moreinfo"&gt;More Information&lt;/a&gt;</code></p><p><code>639</code><code>  &lt;/div&gt;</code></p><p><code>640</code><code>&lt;/div&gt;</code></p><p><code>641</code><code>&lt;/div&gt;</code></p><p><code>642</code><code>          </code></p><p><code>643</code><code>&lt;div class="tr-indent2" style="margin-top:2ex"&gt;</code></p><p><code>644</code><code>          </code></p><p><code>645</code><code>  &lt;div class="ct-body3"&gt;Brief Summary:&lt;/div&gt;</code></p><p><code>646</code><code>  &lt;div class="ct-body3 tr-indent2"&gt;&lt;p style="margin-top:1ex; margin-bottom:1ex;"&gt;The purpose of this clinical trial is to learn how the experimental medicine maplirpacept (PF-07901801) affects people with various types of blood cancers:&lt;/p&gt;</code></p><p><code>647</code><code>  &lt;ul style="margin-top:1ex; margin-bottom:1ex;"&gt;</code></p><p><code>648</code><code>    &lt;li style="margin-top:0.7ex;"&gt;relapsed or refractory (R/R) lymphoma&lt;/li&gt;</code></p><p><code>649</code><code>    &lt;li style="margin-top:0.7ex;"&gt;multiple myeloma&lt;/li&gt;</code></p><p><code>650</code><code>    &lt;li style="margin-top:0.7ex;"&gt;newly diagnosed acute myeloid leukemia (AML).&lt;/li&gt;</code></p><p><code>651</code><code>  &lt;/ul&gt;</code></p><p><code>652</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;This trial will be conducted in the outpatient setting in 2 parts, phase 1a and phase 1b. You may only participate in one part of the study.&lt;/p&gt;</code></p><p><code>653</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;During phase 1a of this study, we will explore how much maplirpacept (PF-07901801), when used by itself, can be safely used.&lt;/p&gt;</code></p><p><code>654</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;If you have lymphoma, the study medicine maplirpacept (PF-07901801) will be given by infusion through a vein once a week or once every 2 weeks or every 3 weeks as determined by your doctor. Following your first dose, you will be expected to come back twice more the first week. From week 2, you will have weekly visits for blood tests, questions about your medications, any side effects, or illnesses you may have experienced and your cancer response. After you have completed 21 days (for every week dosing) or 42 days (for every 2- or 3-weeks dosing), your doctor will discuss whether you should stop study treatment or continue.&lt;/p&gt;</code></p><p><code>655</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;If you continue, you will be expected to come back weekly for blood tests, vital signs, a brief physical exam, asked about any side effects or illnesses you may have experienced and medications you may be taking. The dosing schedule you are assigned to will continue until your disease has worsened, significant side effects occur or other reasons that lead you and your doctor to decide treatment may be stopped.&lt;/p&gt;</code></p><p><code>656</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;To be eligible for the first part of the study you must be 18 years or older, your disease has worsened after receiving other medicines approved for blood cancer, no other treatment options exist for you, a sample of your tissue for exploratory research which can be taken from tissue already obtained or if necessary, a new sample of your tissue will be taken so your disease may be seen and measured on routine tests/scans. If you have had radiation therapy or received any anticancer medication within 14 days before the planned start of study treatment your doctor will let you know if you are eligible to participate in the study. If you have had major surgery within 30 days before the planned start of study treatment you may not be eligible to participate.&lt;/p&gt;</code></p><p><code>657</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;The phase 1a part of the study may last up to 51/2 years. How long you participate in this study depends on side effects you may have to the study drug. It also depends on how your cancer responds to the study drug. Therefore, you may remain in the study as long as you and your study doctor think you may benefit. However, you are free to stop taking part in this study at any time and for any reason.&lt;/p&gt;</code></p><p><code>658</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;During phase 1b part of this study, we will explore how much maplirpacept (PF-07901801), when used with other anticancer medicine(s), can be safe and reduce cancer growth. In the phase 1b part of this study, you will receive maplirpacept (PF-07901801) and other anticancer medicine(s). Which medicine combination you will receive depends on the types of cancer under treatment. Your treatment experiences will be examined to determine if maplirpacept (PF-07901801) when given with other anticancer medicine(s), is safe and can reduce cancer growth.&lt;/p&gt;</code></p><p><code>659</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;To be eligible for the second part of the study you may have newly diagnosed Acute Myelocytic Leukemia with or without a genetic mutation or you have Multiple Myeloma or Diffuse Large B Cell Lymphoma, and your disease has worsened.&lt;/p&gt;</code></p><p><code>660</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;The Phase 1b part of this study may last as long as you and your study doctor think you may benefit which could be up to approximately 31/2 years. How long you participate in this study depends on side effects you may have to the study drug. It also depends on how your cancer responds to the study drug. Therefore, you may remain in the study as long as you and your study doctor think you may benefit. However, you are free to stop taking part in this study at any time and for any reason.&lt;/p&gt;&lt;/div&gt;&lt;br/&gt;</code></p><p><code>661</code><code>          </code></p><p><code>662</code><code>    &lt;!-- condition, intervention, phase summary table --&gt;</code></p><p><code>663</code><code>  &lt;table class="ct-data_table tr-data_table" border="1" style="margin:auto;width:80%;"&gt;</code></p><p><code>664</code><code>    &lt;tr style="text-align:left;"&gt;</code></p><p><code>665</code><code>            &lt;th class="ct-header3 tr-pale_banner_color"&gt;</code></p><p><code>666</code><code>&lt;span style="display:inline;" class="term" data-term="Condition/disease" title="Show definition"&gt;Condition or disease &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Condition/disease" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt;       &lt;/th&gt;</code></p><p><code>667</code><code>                  &lt;th class="ct-header3 tr-pale_banner_color"&gt;</code></p><p><code>668</code><code>&lt;span style="display:inline;" class="term" data-term="Intervention/treatment" title="Show definition"&gt;Intervention/treatment &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Intervention/treatment" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt;       &lt;/th&gt;</code></p><p><code>669</code><code>                  &lt;th class="ct-header3 tr-pale_banner_color"&gt;</code></p><p><code>670</code><code>&lt;span style="display:inline;" class="term" data-term="Phase" title="Show definition"&gt;Phase &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Phase" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt;       &lt;/th&gt;</code></p><p><code>671</code><code>          &lt;/tr&gt;</code></p><p><code>672</code><code>    &lt;tr style="text-align:left;vertical-align:top;"&gt;</code></p><p><code>673</code><code>            &lt;td class="ct-body3"&gt;</code></p><p><code>674</code><code>                &lt;span style="display:block;margin-bottom:1ex;"&gt;Lymphoma&lt;/span&gt;</code></p><p><code>675</code><code>                &lt;span style="display:block;margin-bottom:1ex;"&gt;Multiple Myeloma&lt;/span&gt;</code></p><p><code>676</code><code>                &lt;span style="display:block;margin-bottom:1ex;"&gt;Acute Myeloid Leukemia&lt;/span&gt;</code></p><p><code>677</code><code>                &lt;span style="display:block;margin-bottom:1ex;"&gt;Diffuse Large B-Cell Lymphoma&lt;/span&gt;</code></p><p><code>678</code><code>              &lt;/td&gt;</code></p><p><code>679</code><code>                  &lt;td class="ct-body3"&gt;</code></p><p><code>680</code><code>                &lt;span style="display:block;margin-bottom:1ex;"&gt;Drug: Maplirpacept (PF-07901801)&lt;/span&gt;</code></p><p><code>681</code><code>                &lt;span style="display:block;margin-bottom:1ex;"&gt;Drug: Azacitidine&lt;/span&gt;</code></p><p><code>682</code><code>                &lt;span style="display:block;margin-bottom:1ex;"&gt;Drug: Venetoclax&lt;/span&gt;</code></p><p><code>683</code><code>                &lt;span style="display:block;margin-bottom:1ex;"&gt;Drug: Carfilzomib&lt;/span&gt;</code></p><p><code>684</code><code>                &lt;span style="display:block;margin-bottom:1ex;"&gt;Drug: Dexamethasone&lt;/span&gt;</code></p><p><code>685</code><code>                &lt;span style="display:block;margin-bottom:1ex;"&gt;Drug: Anti-CD20 Targeting agent&lt;/span&gt;</code></p><p><code>686</code><code>                &lt;span style="display:block;margin-bottom:1ex;"&gt;Drug: Isatuximab&lt;/span&gt;</code></p><p><code>687</code><code>              &lt;/td&gt;</code></p><p><code>688</code><code>                  &lt;td class="ct-body3" style="white-space:nowrap;"&gt;</code></p><p><code>689</code><code>                &lt;span style="display:block;margin-bottom:1ex;"&gt;Phase 1&lt;/span&gt;</code></p><p><code>690</code><code>              &lt;/td&gt;</code></p><p><code>691</code><code>          &lt;/tr&gt;</code></p><p><code>692</code><code>  &lt;/table&gt;</code></p><p><code>693</code><code>  &lt;br/&gt;</code></p><p><code>694</code><code>  </code></p><p><code>695</code><code>  </code></p><p><code>696</code><code>      &lt;a id="desc"&gt;&lt;/a&gt;</code></p><p><code>697</code><code>          </code></p><p><code>698</code><code>    </code></p><p><code>699</code><code>    &lt;!-- detailed description --&gt;</code></p><p><code>700</code><code>    &lt;div id="COLLAPSE-DetailedDesc" class="COLLAPSE"  style="margin-bottom:2ex;"&gt;</code></p><p><code>701</code><code>      &lt;div class="ct-body3"&gt;&lt;a id="detaileddesc"&gt;&lt;/a&gt;Detailed Description:&lt;/div&gt;</code></p><p><code>702</code><code>      &lt;div class="ct-body3 tr-indent2"&gt;&lt;p style="margin-top:1ex; margin-bottom:1ex;"&gt;This is a trial of maplirpacept (PF-07901801) in subjects with relapsed or refractory lymphoma or multiple myeloma (MM) and subjects with newly diagnosed acute myeloid leukemia (AML).&lt;/p&gt;</code></p><p><code>703</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;This trial will be conducted in 2 phases: Phase 1a (Dose-Escalation Phase for Single-Agent maplirpacept (PF-07901801) and Phase 1b maplirpacept (PF-07901801) Combinations and Single-Agent.&lt;/p&gt;</code></p><p><code>704</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;In the Dose-Escalation Phase for Single-Agent maplirpacept (PF-07901801), subjects with relapsed or refractory lymphoma will be enrolled in sequential dose cohorts.&lt;/p&gt;</code></p><p><code>705</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;In the Combination and Single-Agent Treatment part, subjects will be included in 1 of 14 cohorts: (Cohort A1 and A2) subjects with newly diagnosed TP53-mutated AML will be treated with maplirpacept (PF-07901801) + azacitidine; (Cohort B1 and B2) elderly subjects or subjects unfit for intensive induction chemotherapies with newly diagnosed TP53-wildtype AML will be treated with maplirpacept (PF-07901801) + azacitidine and venetoclax; (Cohort C1, C2, and C3) subjects with relapsed or refractory MM will be treated with maplirpacept (PF-07901801) + carfilzomib and dexamethasone;(Cohort D1 and D2) subjects in relapsed or refractory CD20+ diffuse large B-cell lymphoma will be treated with maplirpacept (PF-07901801) + an anti-CD20 targeting agent; (Cohort E1 and E2) subjects with relapsed refractory MM will be treated with single-agent maplirpacept (PF-07901801); and (Cohorts F1, F2 and F3) with relapsing or refractory MM will be treated with increasing doses of maplirpacept (PF-07901801) + isatuximab, carfilzomib and dexamethasone.&lt;/p&gt;&lt;/div&gt;</code></p><p><code>706</code><code>    &lt;/div&gt;</code></p><p><code>707</code><code>&lt;/div&gt; </code></p><p><code>708</code><code>&lt;div class="tr-subsection"&gt;</code></p><p><code>709</code><code>  &lt;div class="ct-header2"&gt;&lt;a id="studydesign"&gt;&lt;/a&gt;Study Design&lt;/div&gt;</code></p><p><code>710</code><code>  &lt;div class="tr-underline"&gt;&lt;/div&gt;</code></p><p><code>711</code><code>  &lt;div class="tr-dropdown" style="padding-right:10em"&gt;</code></p><p><code>712</code><code>Go&amp;nbsp;to&amp;nbsp;</code></p><p><code>713</code><code>&lt;button class="tr-dropbtn" style="font-weight:bold; font-size:14px"&gt;</code></p><p><code>714</code><code>&lt;img src="/ct2/html/images/pulldown.png" alt="sections"&gt;</code></p><p><code>715</code><code>&lt;/button&gt;</code></p><p><code>716</code><code>          </code></p><p><code>717</code><code>  &lt;div class="tr-dropdown-content"&gt;</code></p><p><code>718</code><code>	&lt;a href="#wrapper"&gt;Top of Page&lt;/a&gt;</code></p><p><code>719</code><code>    &lt;a href="#studydesc"&gt;Study Description&lt;/a&gt;</code></p><p><code>720</code><code>    &lt;a href="#studydesign"&gt;Study Design&lt;/a&gt;</code></p><p><code>721</code><code>          </code></p><p><code>722</code><code>    &lt;!-- arms and groups table --&gt;</code></p><p><code>723</code><code>        &lt;a href="#armgroup"&gt;Arms and Interventions&lt;/a&gt;</code></p><p><code>724</code><code>    </code></p><p><code>725</code><code>        &lt;a href="#outcomemeasures"&gt;Outcome Measures&lt;/a&gt;</code></p><p><code>726</code><code>        &lt;a href="#eligibility"&gt;Eligibility Criteria&lt;/a&gt;</code></p><p><code>727</code><code>    &lt;a href="#contactlocation"&gt;Contacts and Locations&lt;/a&gt;</code></p><p><code>728</code><code>    &lt;a href="#moreinfo"&gt;More Information&lt;/a&gt;</code></p><p><code>729</code><code>  &lt;/div&gt;</code></p><p><code>730</code><code>&lt;/div&gt;</code></p><p><code>731</code><code>&lt;/div&gt;</code></p><p><code>732</code><code>          </code></p><p><code>733</code><code>  &lt;p&gt;</code></p><p><code>734</code><code>  &lt;table class="ct-layout_table tr-tableStyle tr-studyInfo" style="margin-bottom:2ex;"&gt;</code></p><p><code>735</code><code>   &lt;caption&gt;Layout table for study information&lt;/caption&gt;</code></p><p><code>736</code><code>   &lt;thead&gt;</code></p><p><code>737</code><code>    &lt;tr&gt;</code></p><p><code>738</code><code>      &lt;th id="studyInfoColTitle"&gt;&lt;/th&gt;</code></p><p><code>739</code><code>      &lt;th id="studyInfoColData"&gt;&lt;/th&gt;</code></p><p><code>740</code><code>    &lt;/tr&gt;</code></p><p><code>741</code><code>    &lt;/thead&gt;</code></p><p><code>742</code><code>    &lt;tbody&gt;</code></p><p><code>743</code><code>        &lt;tr&gt;</code></p><p><code>744</code><code>      &lt;td headers="studyInfoColTitle"&gt;</code></p><p><code>745</code><code>&lt;span style="display:inline;" class="term" data-term="Study Type" title="Show definition"&gt;Study Type &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Study Type" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; :&lt;/td&gt;</code></p><p><code>746</code><code>      &lt;td headers="studyInfoColData" style="padding-left:1em"&gt;</code></p><p><code>747</code><code>        Interventional</code></p><p><code>748</code><code>                &amp;nbsp;(Clinical Trial)</code></p><p><code>749</code><code>                </code></p><p><code>750</code><code>        </code></p><p><code>751</code><code>      &lt;/td&gt;</code></p><p><code>752</code><code>    &lt;/tr&gt;</code></p><p><code>753</code><code>                    &lt;tr&gt;</code></p><p><code>754</code><code>      &lt;td headers="studyInfoColTitle"&gt;Estimated</code></p><p><code>755</code><code>&lt;span style="display:inline;" class="term" data-term="Enrollment" title="Show definition"&gt;Enrollment &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Enrollment" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; :&lt;/td&gt;</code></p><p><code>756</code><code>      &lt;td headers="studyInfoColData" style="padding-left:1em"&gt;476 participants&lt;/td&gt;</code></p><p><code>757</code><code>    &lt;/tr&gt;</code></p><p><code>758</code><code>                &lt;tr&gt;</code></p><p><code>759</code><code>            &lt;td headers="studyInfoColTitle"&gt;Allocation:&lt;/td&gt;</code></p><p><code>760</code><code>            &lt;td headers="studyInfoColData" style="padding-left:1em"&gt;Non-Randomized&lt;/td&gt;</code></p><p><code>761</code><code>    &lt;/tr&gt;</code></p><p><code>762</code><code>        &lt;tr&gt;</code></p><p><code>763</code><code>            &lt;td headers="studyInfoColTitle"&gt;Intervention Model:&lt;/td&gt;</code></p><p><code>764</code><code>            &lt;td headers="studyInfoColData" style="padding-left:1em"&gt;Sequential Assignment&lt;/td&gt;</code></p><p><code>765</code><code>    &lt;/tr&gt;</code></p><p><code>766</code><code>        &lt;tr&gt;</code></p><p><code>767</code><code>            &lt;td headers="studyInfoColTitle"&gt;Masking:&lt;/td&gt;</code></p><p><code>768</code><code>            &lt;td headers="studyInfoColData" style="padding-left:1em"&gt; None (Open Label)&lt;/td&gt;</code></p><p><code>769</code><code>    &lt;/tr&gt;</code></p><p><code>770</code><code>        &lt;tr&gt;</code></p><p><code>771</code><code>            &lt;td headers="studyInfoColTitle"&gt;Primary Purpose:&lt;/td&gt;</code></p><p><code>772</code><code>            &lt;td headers="studyInfoColData" style="padding-left:1em"&gt; Treatment&lt;/td&gt;</code></p><p><code>773</code><code>    &lt;/tr&gt;</code></p><p><code>774</code><code>                    &lt;tr&gt;</code></p><p><code>775</code><code>&lt;!--</code></p><p><code>776</code><code>      &lt;td headers="studyInfoColTitle" style="padding-top:2ex;"&gt;Official Title:&lt;/td&gt;</code></p><p><code>777</code><code>--&gt;</code></p><p><code>778</code><code>      &lt;td headers="studyInfoColTitle"&gt;Official Title:&lt;/td&gt;</code></p><p><code>779</code><code>      &lt;td headers="studyInfoColData" style="padding-left:1em;"&gt;A Phase 1a/1b Dose-Escalation and Expansion Trial of TTI-622 in Patients With Advanced Hematologic Malignancies, Including Lymphoma, Leukemia, and Multiple Myeloma&lt;/td&gt;</code></p><p><code>780</code><code>    &lt;/tr&gt;</code></p><p><code>781</code><code>    </code></p><p><code>782</code><code>            &lt;tr&gt;</code></p><p><code>783</code><code>        &lt;td headers="studyInfoColTitle"&gt;  Actual &lt;span style="display:inline;" class="term" data-term="Study Start Date" title="Show definition"&gt;Study Start Date &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Study Start Date" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; :&lt;/td&gt;</code></p><p><code>784</code><code>        &lt;td headers="studyInfoColData" style="padding-left:1em"&gt;June 7, 2018&lt;/td&gt;</code></p><p><code>785</code><code>      &lt;/tr&gt;</code></p><p><code>786</code><code>                  &lt;tr&gt;</code></p><p><code>787</code><code>        &lt;td headers="studyInfoColTitle"&gt;  Estimated &lt;span style="display:inline;" class="term" data-term="Primary Completion Date" title="Show definition"&gt;Primary Completion Date &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Primary Completion Date" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; :&lt;/td&gt;</code></p><p><code>788</code><code>        &lt;td headers="studyInfoColData" style="padding-left:1em"&gt;October 13, 2024&lt;/td&gt;</code></p><p><code>789</code><code>      &lt;/tr&gt;</code></p><p><code>790</code><code>                  &lt;tr&gt;</code></p><p><code>791</code><code>        &lt;td headers="studyInfoColTitle"&gt;  Estimated &lt;span style="display:inline;" class="term" data-term="Study Completion Date" title="Show definition"&gt;Study Completion Date &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Study Completion Date" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; :&lt;/td&gt;</code></p><p><code>792</code><code>        &lt;td headers="studyInfoColData" style="padding-left:1em"&gt;October 13, 2025&lt;/td&gt;</code></p><p><code>793</code><code>      &lt;/tr&gt;</code></p><p><code>794</code><code>            &lt;/tbody&gt;</code></p><p><code>795</code><code>    &lt;/table&gt;</code></p><p><code>796</code><code>          </code></p><p><code>797</code><code>    &lt;!-- NLM links --&gt;</code></p><p><code>798</code><code>&lt;p&gt;</code></p><p><code>799</code><code>&lt;div class="tr-indent2"&gt;</code></p><p><code>800</code><code>  &lt;div class="usa-alert usa-alert-warning nlm-info"&gt;</code></p><p><code>801</code><code>    &lt;strong&gt;Resource links provided by the National Library of Medicine&lt;/strong&gt;</code></p><p><code>802</code><code>    &lt;img src="/ct2/html/images/NIH_NLM_ABRV_BLK_4.png" style="width:5em; float:right;" alt=""/&gt;</code></p><p><code>803</code><code>    &lt;p&gt;</code></p><p><code>804</code><code>    &lt;p&gt;</code></p><p><code>805</code><code>          </code></p><p><code>806</code><code>    &lt;!-- ghr links --&gt;</code></p><p><code>807</code><code>  &lt;div style="margin-bottom:2ex"&gt;</code></p><p><code>808</code><code>    &lt;a class="tr-study-link" href="https://medlineplus.gov/genetics/" title="MedlinePlus Genetics" onclick="openNewWindow('https://medlineplus.gov/genetics/'); return false"&gt;MedlinePlus Genetics&lt;/a&gt; related topics:</code></p><p><code>809</code><code>    	    	    	&lt;a class="tr-study-link" style="margin-left:0.5em;" href="https://medlineplus.gov/genetics/condition/multiple-myeloma" title="Multiple&amp;#160;myeloma at Genetics Home Reference" onclick="openNewWindow('https://medlineplus.gov/genetics/condition/multiple-myeloma'); return false"&gt;Multiple&amp;#160;myeloma&lt;/a&gt;</code></p><p><code>810</code><code>	          &lt;/div&gt;</code></p><p><code>811</code><code>  </code></p><p><code>812</code><code>    &lt;!-- medline links --&gt;</code></p><p><code>813</code><code>  &lt;div style="margin-bottom:2ex;"&gt;</code></p><p><code>814</code><code>    &lt;a class="tr-study-link" href="https://medlineplus.gov/" title="MedlinePlus" onclick="openNewWindow('https://medlineplus.gov/'); return false"&gt;MedlinePlus&lt;/a&gt; related topics:</code></p><p><code>815</code><code>    	    	    	&lt;a class="tr-study-link" style="margin-left:0.5em;" href="https://medlineplus.gov/leukemia.html" title="Leukemia at MedlinePlus" onclick="openNewWindow('https://medlineplus.gov/leukemia.html'); return false"&gt;Leukemia&lt;/a&gt;</code></p><p><code>816</code><code>	        	    	    	&lt;a class="tr-study-link" style="margin-left:0.5em;" href="https://medlineplus.gov/lymphoma.html" title="Lymphoma at MedlinePlus" onclick="openNewWindow('https://medlineplus.gov/lymphoma.html'); return false"&gt;Lymphoma&lt;/a&gt;</code></p><p><code>817</code><code>	        	    	    	&lt;a class="tr-study-link" style="margin-left:0.5em;" href="https://medlineplus.gov/multiplemyeloma.html" title="Multiple&amp;#160;Myeloma at MedlinePlus" onclick="openNewWindow('https://medlineplus.gov/multiplemyeloma.html'); return false"&gt;Multiple&amp;#160;Myeloma&lt;/a&gt;</code></p><p><code>818</code><code>	          &lt;/div&gt;</code></p><p><code>819</code><code>  </code></p><p><code>820</code><code>  </code></p><p><code>821</code><code>    &lt;!-- ORD links --&gt;</code></p><p><code>822</code><code>  &lt;div style="margin-bottom:2ex;"&gt;</code></p><p><code>823</code><code>    &lt;a class="tr-study-link" href="https://rarediseases.info.nih.gov/gard" title="Genetic and Rare Diseases Information Center" onclick="openNewWindow('https://rarediseases.info.nih.gov/gard'); return false"&gt;Genetic and Rare Diseases Information Center&lt;/a&gt; resources:</code></p><p><code>824</code><code>    	    	    	&lt;a class="tr-study-link" style="margin-left:0.5em;" href="https://rarediseases.info.nih.gov/diseases/7108/multiple-myeloma" title="Multiple&amp;#160;Myeloma at Genetic and Rare Diseases Information Center" onclick="openNewWindow('https://rarediseases.info.nih.gov/diseases/7108/multiple-myeloma'); return false"&gt;Multiple&amp;#160;Myeloma&lt;/a&gt;</code></p><p><code>825</code><code>	        	    	    	&lt;a class="tr-study-link" style="margin-left:0.5em;" href="https://rarediseases.info.nih.gov/diseases/6946/lymphosarcoma" title="Lymphosarcoma at Genetic and Rare Diseases Information Center" onclick="openNewWindow('https://rarediseases.info.nih.gov/diseases/6946/lymphosarcoma'); return false"&gt;Lymphosarcoma&lt;/a&gt;</code></p><p><code>826</code><code>	        	    	    	&lt;a class="tr-study-link" style="margin-left:0.5em;" href="https://rarediseases.info.nih.gov/diseases/6544/acute-graft-versus-host-disease" title="Acute&amp;#160;Graft&amp;#160;Versus&amp;#160;Host&amp;#160;Disease at Genetic and Rare Diseases Information Center" onclick="openNewWindow('https://rarediseases.info.nih.gov/diseases/6544/acute-graft-versus-host-disease'); return false"&gt;Acute&amp;#160;Graft&amp;#160;Versus&amp;#160;Host&amp;#160;Disease&lt;/a&gt;</code></p><p><code>827</code><code>	        	    	    	&lt;a class="tr-study-link" style="margin-left:0.5em;" href="https://rarediseases.info.nih.gov/diseases/5877/b-cell-lymphoma" title="B-cell&amp;#160;Lymphoma at Genetic and Rare Diseases Information Center" onclick="openNewWindow('https://rarediseases.info.nih.gov/diseases/5877/b-cell-lymphoma'); return false"&gt;B-cell&amp;#160;Lymphoma&lt;/a&gt;</code></p><p><code>828</code><code>	        	    	    	&lt;a class="tr-study-link" style="margin-left:0.5em;" href="https://rarediseases.info.nih.gov/diseases/8226/myeloid-leukemia" title="Myeloid&amp;#160;Leukemia at Genetic and Rare Diseases Information Center" onclick="openNewWindow('https://rarediseases.info.nih.gov/diseases/8226/myeloid-leukemia'); return false"&gt;Myeloid&amp;#160;Leukemia&lt;/a&gt;</code></p><p><code>829</code><code>	        	    	    	&lt;a class="tr-study-link" style="margin-left:0.5em;" href="https://rarediseases.info.nih.gov/diseases/12757/acute-myeloid-leukemia" title="Acute&amp;#160;Myeloid&amp;#160;Leukemia at Genetic and Rare Diseases Information Center" onclick="openNewWindow('https://rarediseases.info.nih.gov/diseases/12757/acute-myeloid-leukemia'); return false"&gt;Acute&amp;#160;Myeloid&amp;#160;Leukemia&lt;/a&gt;</code></p><p><code>830</code><code>	        	    	    	&lt;a class="tr-study-link" style="margin-left:0.5em;" href="https://rarediseases.info.nih.gov/diseases/537/acute-non-lymphoblastic-leukemia" title="Acute&amp;#160;Non&amp;#160;Lymphoblastic&amp;#160;Leukemia at Genetic and Rare Diseases Information Center" onclick="openNewWindow('https://rarediseases.info.nih.gov/diseases/537/acute-non-lymphoblastic-leukemia'); return false"&gt;Acute&amp;#160;Non&amp;#160;Lymphoblastic&amp;#160;Leukemia&lt;/a&gt;</code></p><p><code>831</code><code>	        	    	    	&lt;a class="tr-study-link" style="margin-left:0.5em;" href="https://rarediseases.info.nih.gov/diseases/3178/diffuse-large-b-cell-lymphoma" title="Diffuse&amp;#160;Large&amp;#160;B-Cell&amp;#160;Lymphoma at Genetic and Rare Diseases Information Center" onclick="openNewWindow('https://rarediseases.info.nih.gov/diseases/3178/diffuse-large-b-cell-lymphoma'); return false"&gt;Diffuse&amp;#160;Large&amp;#160;B-Cell&amp;#160;Lymphoma&lt;/a&gt;</code></p><p><code>832</code><code>	          &lt;/div&gt;</code></p><p><code>833</code><code>  </code></p><p><code>834</code><code>  </code></p><p><code>835</code><code>  &lt;!-- Ropr Link --&gt;</code></p><p><code>836</code><code>&lt;!-- Commented out RoPR</code></p><p><code>837</code><code>  --&gt;</code></p><p><code>838</code><code>          </code></p><p><code>839</code><code>  &lt;div style="margin-bottom:2ex;"&gt;</code></p><p><code>840</code><code>  &lt;a class="tr-study-link" href="/ct2/info/fdalinks" title="Show FDA resources page" onclick="openNewWindow('/ct2/info/fdalinks'); return false"&gt;U.S. FDA Resources&lt;/a&gt;</code></p><p><code>841</code><code>  &lt;/div&gt;</code></p><p><code>842</code><code>          </code></p><p><code>843</code><code>  &lt;/div&gt;</code></p><p><code>844</code><code>&lt;/div&gt;</code></p><p><code>845</code><code>          </code></p><p><code>846</code><code>          </code></p><p><code>847</code><code>  </code></p><p><code>848</code><code>  &lt;br/&gt;</code></p><p><code>849</code><code>    &lt;/div&gt;</code></p><p><code>850</code><code>          </code></p><p><code>851</code><code>    &lt;!-- arms and groups table --&gt;</code></p><p><code>852</code><code>    		&lt;div class="tr-subsection"&gt;</code></p><p><code>853</code><code>		    		    	&lt;div class="ct-header2"&gt;&lt;a id="armgroup"&gt;&lt;/a&gt;Arms and Interventions&lt;/div&gt;</code></p><p><code>854</code><code>		    		    &lt;div class="tr-underline"&gt;&lt;/div&gt;</code></p><p><code>855</code><code>			&lt;div class="tr-dropdown" style="padding-right:10em"&gt;</code></p><p><code>856</code><code>Go&amp;nbsp;to&amp;nbsp;</code></p><p><code>857</code><code>&lt;button class="tr-dropbtn" style="font-weight:bold; font-size:14px"&gt;</code></p><p><code>858</code><code>&lt;img src="/ct2/html/images/pulldown.png" alt="sections"&gt;</code></p><p><code>859</code><code>&lt;/button&gt;</code></p><p><code>860</code><code>          </code></p><p><code>861</code><code>  &lt;div class="tr-dropdown-content"&gt;</code></p><p><code>862</code><code>	&lt;a href="#wrapper"&gt;Top of Page&lt;/a&gt;</code></p><p><code>863</code><code>    &lt;a href="#studydesc"&gt;Study Description&lt;/a&gt;</code></p><p><code>864</code><code>    &lt;a href="#studydesign"&gt;Study Design&lt;/a&gt;</code></p><p><code>865</code><code>          </code></p><p><code>866</code><code>    &lt;!-- arms and groups table --&gt;</code></p><p><code>867</code><code>        &lt;a href="#armgroup"&gt;Arms and Interventions&lt;/a&gt;</code></p><p><code>868</code><code>    </code></p><p><code>869</code><code>        &lt;a href="#outcomemeasures"&gt;Outcome Measures&lt;/a&gt;</code></p><p><code>870</code><code>        &lt;a href="#eligibility"&gt;Eligibility Criteria&lt;/a&gt;</code></p><p><code>871</code><code>    &lt;a href="#contactlocation"&gt;Contacts and Locations&lt;/a&gt;</code></p><p><code>872</code><code>    &lt;a href="#moreinfo"&gt;More Information&lt;/a&gt;</code></p><p><code>873</code><code>  &lt;/div&gt;</code></p><p><code>874</code><code>&lt;/div&gt;</code></p><p><code>875</code><code>		&lt;/div&gt;</code></p><p><code>876</code><code>	</code></p><p><code>877</code><code>    &lt;div style="padding-left:.8em; padding-right:1.2em;text-align:left;"&gt;</code></p><p><code>878</code><code>        &lt;p&gt;</code></p><p><code>879</code><code>    &lt;table class="ct-data_table tr-data_table" style="padding:5px;width:100%;border-width:1px;"&gt;</code></p><p><code>880</code><code>      &lt;thead&gt;</code></p><p><code>881</code><code>      &lt;tr style="text-align:left;"&gt;</code></p><p><code>882</code><code>        &lt;th class="ct-header3 tr-pale_banner_color" style="width:50%;"&gt;</code></p><p><code>883</code><code>            				&lt;span style="display:inline;" class="term" data-term="Arm" title="Show definition"&gt;Arm &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Arm" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; 			        &lt;/th&gt;</code></p><p><code>884</code><code>                &lt;th class="ct-header3 tr-pale_banner_color"&gt;</code></p><p><code>885</code><code>			&lt;span style="display:inline;" class="term" data-term="Intervention/treatment" title="Show definition"&gt;Intervention/treatment &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Intervention/treatment" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt;         &lt;/th&gt;</code></p><p><code>886</code><code>              &lt;/tr&gt;</code></p><p><code>887</code><code>      &lt;/thead&gt;</code></p><p><code>888</code><code>      &lt;tbody&gt;</code></p><p><code>889</code><code>            &lt;tr style="text-align:left;vertical-align:top;"&gt;</code></p><p><code>890</code><code>        &lt;td class="ct-body3"&gt;</code></p><p><code>891</code><code>          Experimental: maplirpacept (PF-07901801) Monotherapy</code></p><p><code>892</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;&lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;In the phase 1a dose- escalation part for single-agent maplirpacept (PF-07901801), participants with Relapsing or Refractory (R/R) lymphoma will be enrolled in sequential dose cohorts to receive maplirpacept (PF-07901801) QW to characterize safety, tolerability, and PK; to determine the Maximum Tolerated Dose (MTD) or P1b Starting Dose (a dose lower than or equal to the single-agent MTD), and to gain preliminary evidence of antitumor activity.&lt;/p&gt;</code></p><p><code>893</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;In addition, participants with R/R Lymphoma may also be enrolled in a cohort to receive maplirpacept (PF-07901801) Q2W and a cohort to receive maplirpacept (PF-07901801) Q3W to characterize safety, tolerability, and PK; to determine the MTD; and to gain preliminary evidence of antitumor activity.&lt;/p&gt;&lt;/div&gt;</code></p><p><code>894</code><code>        &lt;/td&gt;</code></p><p><code>895</code><code>                &lt;td class="ct-body3"&gt;</code></p><p><code>896</code><code>                      Drug: Maplirpacept (PF-07901801)</code></p><p><code>897</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;maplirpacept (PF-07901801) will be administered by intravenous infusion at ranging doses, as determined from sequential dosing cohorts.&lt;/div&gt;</code></p><p><code>898</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;Other Names:&lt;ul style="margin-top:0.5ex"&gt;</code></p><p><code>899</code><code>&lt;li&gt;SIRP&amp;#945;-IgG4 Fc&lt;/li&gt;</code></p><p><code>900</code><code>&lt;li&gt;TTI-622&lt;/li&gt;</code></p><p><code>901</code><code>&lt;/ul&gt;</code></p><p><code>902</code><code>&lt;/div&gt;&lt;br/&gt;</code></p><p><code>903</code><code>                  &lt;/td&gt;</code></p><p><code>904</code><code>              &lt;/tr&gt;</code></p><p><code>905</code><code>            &lt;tr style="text-align:left;vertical-align:top;"&gt;</code></p><p><code>906</code><code>        &lt;td class="ct-body3"&gt;</code></p><p><code>907</code><code>          Experimental: Cohort A: maplirpacept (PF-07901801) + Azacitidine</code></p><p><code>908</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;&lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Cohort A1: participants with newly diagnosed TP53-mutated Acute Myelocytic Leukemia (AML) will be treated with maplirpacept (PF-07901801) QW + azacitidine.&lt;/p&gt;</code></p><p><code>909</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Cohort A2: participants with newly diagnosed TP53-mutated AML will be treated with maplirpacept (PF-07901801) QW + azacitidine.&lt;/p&gt;&lt;/div&gt;</code></p><p><code>910</code><code>        &lt;/td&gt;</code></p><p><code>911</code><code>                &lt;td class="ct-body3"&gt;</code></p><p><code>912</code><code>                      Drug: Maplirpacept (PF-07901801)</code></p><p><code>913</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;maplirpacept (PF-07901801) will be administered by intravenous infusion at ranging doses, as determined from sequential dosing cohorts.&lt;/div&gt;</code></p><p><code>914</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;Other Names:&lt;ul style="margin-top:0.5ex"&gt;</code></p><p><code>915</code><code>&lt;li&gt;SIRP&amp;#945;-IgG4 Fc&lt;/li&gt;</code></p><p><code>916</code><code>&lt;li&gt;TTI-622&lt;/li&gt;</code></p><p><code>917</code><code>&lt;/ul&gt;</code></p><p><code>918</code><code>&lt;/div&gt;&lt;br/&gt;</code></p><p><code>919</code><code>                      Drug: Azacitidine</code></p><p><code>920</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;intravenous (IV) or subcutaneous (SC) daily for 7 days, repeated every 4 weeks&lt;/div&gt;</code></p><p><code>921</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;Other Name: VIDAZA&lt;/div&gt;&lt;br/&gt;</code></p><p><code>922</code><code>                  &lt;/td&gt;</code></p><p><code>923</code><code>              &lt;/tr&gt;</code></p><p><code>924</code><code>            &lt;tr style="text-align:left;vertical-align:top;"&gt;</code></p><p><code>925</code><code>        &lt;td class="ct-body3"&gt;</code></p><p><code>926</code><code>          Experimental: Cohort B: maplirpacept (PF-07901801) + Azacitidine and Venetoclax</code></p><p><code>927</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;&lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Cohort B1: elderly or unfit participants with newly diagnosed TP53-wildtype AML will be treated with maplirpacept (PF-07901801) QW + azacitidine and venetoclax&lt;/p&gt;</code></p><p><code>928</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Cohort B2: elderly or unfit participants with newly diagnosed TP53-wildtype AML will be treated with maplirpacept (PF-07901801) QW + azacitidine and venetoclax.&lt;/p&gt;&lt;/div&gt;</code></p><p><code>929</code><code>        &lt;/td&gt;</code></p><p><code>930</code><code>                &lt;td class="ct-body3"&gt;</code></p><p><code>931</code><code>                      Drug: Maplirpacept (PF-07901801)</code></p><p><code>932</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;maplirpacept (PF-07901801) will be administered by intravenous infusion at ranging doses, as determined from sequential dosing cohorts.&lt;/div&gt;</code></p><p><code>933</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;Other Names:&lt;ul style="margin-top:0.5ex"&gt;</code></p><p><code>934</code><code>&lt;li&gt;SIRP&amp;#945;-IgG4 Fc&lt;/li&gt;</code></p><p><code>935</code><code>&lt;li&gt;TTI-622&lt;/li&gt;</code></p><p><code>936</code><code>&lt;/ul&gt;</code></p><p><code>937</code><code>&lt;/div&gt;&lt;br/&gt;</code></p><p><code>938</code><code>                      Drug: Azacitidine</code></p><p><code>939</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;intravenous (IV) or subcutaneous (SC) daily for 7 days, repeated every 4 weeks&lt;/div&gt;</code></p><p><code>940</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;Other Name: VIDAZA&lt;/div&gt;&lt;br/&gt;</code></p><p><code>941</code><code>                      Drug: Venetoclax</code></p><p><code>942</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;orally daily for each day of each cycle (first 7 doses taken in clinic). The ramp-up and target dose of venetoclax will be adjusted per the package insert in subjects who are taking concomitant moderate or strong CYP3A4 inhibitors or posaconazole&lt;/div&gt;</code></p><p><code>943</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;Other Name: VENCLEXTA&lt;/div&gt;&lt;br/&gt;</code></p><p><code>944</code><code>                  &lt;/td&gt;</code></p><p><code>945</code><code>              &lt;/tr&gt;</code></p><p><code>946</code><code>            &lt;tr style="text-align:left;vertical-align:top;"&gt;</code></p><p><code>947</code><code>        &lt;td class="ct-body3"&gt;</code></p><p><code>948</code><code>          Experimental: Cohort D1 and D2: maplirpacept (PF-07901801) + an anti-CD20 targeting agent</code></p><p><code>949</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;&lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Cohort D1: participants with Relapsing or Recurrent (R/R) CD20+ Diffuse Large B Cell Lymphoma (DLBCL) will be treated with maplirpacept (PF-07901801) QW, then an increased dose Q3W + an anti-CD20 targeting agent.&lt;/p&gt;</code></p><p><code>950</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Cohort D2: participants with R/R CD20+ DLBCL will be treated with maplirpacept (PF-07901801) dosed QW for 4 weeks, then an increased dose Q3W + an anti-CD20 targeting agent.&lt;/p&gt;&lt;/div&gt;</code></p><p><code>951</code><code>        &lt;/td&gt;</code></p><p><code>952</code><code>                &lt;td class="ct-body3"&gt;</code></p><p><code>953</code><code>                      Drug: Maplirpacept (PF-07901801)</code></p><p><code>954</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;maplirpacept (PF-07901801) will be administered by intravenous infusion at ranging doses, as determined from sequential dosing cohorts.&lt;/div&gt;</code></p><p><code>955</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;Other Names:&lt;ul style="margin-top:0.5ex"&gt;</code></p><p><code>956</code><code>&lt;li&gt;SIRP&amp;#945;-IgG4 Fc&lt;/li&gt;</code></p><p><code>957</code><code>&lt;li&gt;TTI-622&lt;/li&gt;</code></p><p><code>958</code><code>&lt;/ul&gt;</code></p><p><code>959</code><code>&lt;/div&gt;&lt;br/&gt;</code></p><p><code>960</code><code>                      Drug: Anti-CD20 Targeting agent</code></p><p><code>961</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;Days 1,8,15, and 22 of the first 28-day cycle and then on Day 1 of subsequent 21-day cycles. The anti-CD20 targeting agent will be administered for a total of eight doses, and then Cohort F1, F2 and F3: TTI-622 + isatuximab, carfilzomib and dexamethasone Cohort C1, C2 and C3: TTI-622 + Carfilzomib and Dexamethasone will be continued as single-agent therapy.&lt;/div&gt;</code></p><p><code>962</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;Other Name: Ruxience or Rituxan&lt;/div&gt;&lt;br/&gt;</code></p><p><code>963</code><code>                  &lt;/td&gt;</code></p><p><code>964</code><code>              &lt;/tr&gt;</code></p><p><code>965</code><code>            &lt;tr style="text-align:left;vertical-align:top;"&gt;</code></p><p><code>966</code><code>        &lt;td class="ct-body3"&gt;</code></p><p><code>967</code><code>          Experimental: Cohort E1 and E2: single agent maplirpacept (PF-07901801)</code></p><p><code>968</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;&lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Cohort E1: participants with Relapsing or Recurrent (R/R) Multiple Myeloma (MM) will be treated with single agent maplirpacept (PF-07901801) QW.&lt;/p&gt;</code></p><p><code>969</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Cohort E2: participants with R/R MM will be treated with single agent maplirpacept (PF-07901801) increased dose QW.&lt;/p&gt;&lt;/div&gt;</code></p><p><code>970</code><code>        &lt;/td&gt;</code></p><p><code>971</code><code>                &lt;td class="ct-body3"&gt;</code></p><p><code>972</code><code>                      Drug: Maplirpacept (PF-07901801)</code></p><p><code>973</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;maplirpacept (PF-07901801) will be administered by intravenous infusion at ranging doses, as determined from sequential dosing cohorts.&lt;/div&gt;</code></p><p><code>974</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;Other Names:&lt;ul style="margin-top:0.5ex"&gt;</code></p><p><code>975</code><code>&lt;li&gt;SIRP&amp;#945;-IgG4 Fc&lt;/li&gt;</code></p><p><code>976</code><code>&lt;li&gt;TTI-622&lt;/li&gt;</code></p><p><code>977</code><code>&lt;/ul&gt;</code></p><p><code>978</code><code>&lt;/div&gt;&lt;br/&gt;</code></p><p><code>979</code><code>                  &lt;/td&gt;</code></p><p><code>980</code><code>              &lt;/tr&gt;</code></p><p><code>981</code><code>            &lt;tr style="text-align:left;vertical-align:top;"&gt;</code></p><p><code>982</code><code>        &lt;td class="ct-body3"&gt;</code></p><p><code>983</code><code>          Experimental: Cohort F1, F2 and F3: maplirpacept (PF-07901801) + isatuximab, carfilzomib and dexamethasone</code></p><p><code>984</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;&lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Cohort F1: participants with Relapsing or Recurrent (R/R) Multiple Myeloma (MM) will be treated with increasing doses of maplirpacept (PF-07901801) + isatuximab, carfilzomib and dexamethasone.&lt;/p&gt;</code></p><p><code>985</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Cohort F2: participants with R/R MM will be treated with maplirpacept (PF-07901801) QW + isatuximab, carfilzomib and dexamethasone.&lt;/p&gt;</code></p><p><code>986</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Cohort F3: participants with R/R MM will be treated with maplirpacept (PF-07901801) increased dose QW + isatuximab, carfilzomib and dexamethasone.&lt;/p&gt;&lt;/div&gt;</code></p><p><code>987</code><code>        &lt;/td&gt;</code></p><p><code>988</code><code>                &lt;td class="ct-body3"&gt;</code></p><p><code>989</code><code>                      Drug: Maplirpacept (PF-07901801)</code></p><p><code>990</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;maplirpacept (PF-07901801) will be administered by intravenous infusion at ranging doses, as determined from sequential dosing cohorts.&lt;/div&gt;</code></p><p><code>991</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;Other Names:&lt;ul style="margin-top:0.5ex"&gt;</code></p><p><code>992</code><code>&lt;li&gt;SIRP&amp;#945;-IgG4 Fc&lt;/li&gt;</code></p><p><code>993</code><code>&lt;li&gt;TTI-622&lt;/li&gt;</code></p><p><code>994</code><code>&lt;/ul&gt;</code></p><p><code>995</code><code>&lt;/div&gt;&lt;br/&gt;</code></p><p><code>996</code><code>                      Drug: Carfilzomib</code></p><p><code>997</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;Days 1, 8, and 15 of 28-day cycles; starting dose IV given on Cycle (C) 1 Day (D) 1, and if tolerated, then increased dose via IV given starting on C1D8 and subsequent doses thereafter.&lt;/div&gt;</code></p><p><code>998</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;Other Name: KYPROLIS&lt;/div&gt;&lt;br/&gt;</code></p><p><code>999</code><code>                      Drug: Dexamethasone</code></p><p><code>1000</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;starting dose via IV on Days 1, 8, 15, and increased dose via IV on 28-day cycles&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1001</code><code>                      Drug: Isatuximab</code></p><p><code>1002</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;&lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;F1: IV dose C0D1, C0D8, C0D15 and C0D22 (lead in phase);weekly during Cycle 1; Cycle 2 and beyond will be administered on Days 1 and 15 (Q2W).&lt;/p&gt;</code></p><p><code>1003</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;F2 and F3: IV dose C0D1 and C0D8 (lead in phase); C1D1, C1D8, C1D15 and C1D22; Cycle 2 and beyond will be administered on days 1 and 15 (Q2W). Carfilzomib: IV dose on days 1 and 2 of cycle 1; then increased IV dose on days 8, 9, 15, and 16 of cycle 1; cycle 2 and beyond: increased IV dose on days 1, 2, 8, 9, 15, and 16. Dexamethasone IV or PO on days 1, 2, 8, 9, 15, 16, 22, and 23 starting cycle 1.&lt;/p&gt;&lt;/div&gt;</code></p><p><code>1004</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;Other Name: Sarclisa&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1005</code><code>                  &lt;/td&gt;</code></p><p><code>1006</code><code>              &lt;/tr&gt;</code></p><p><code>1007</code><code>            &lt;tr style="text-align:left;vertical-align:top;"&gt;</code></p><p><code>1008</code><code>        &lt;td class="ct-body3"&gt;</code></p><p><code>1009</code><code>          Experimental: Cohort C1, C2 and C3: maplirpacept (PF-07901801) + Carfilzomib and Dexamethasone</code></p><p><code>1010</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;&lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Cohort C1: participants with Relapsing or Refractory (R/R) Multiple Myeloma (MM) will be treated with maplirpacept (PF-07901801) QW&lt;/p&gt;</code></p><p><code>1011</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;+ carfilzomib and dexamethasone.&lt;/p&gt;</code></p><p><code>1012</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Cohort C2: participants with R/R MM will be treated with maplirpacept (PF-07901801) QW + carfilzomib and dexamethasone.&lt;/p&gt;</code></p><p><code>1013</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Cohort C3: participants with R/R MM will be treated with maplirpacept (PF-07901801) Q2W + carfilzomib and dexamethasone.&lt;/p&gt;&lt;/div&gt;</code></p><p><code>1014</code><code>        &lt;/td&gt;</code></p><p><code>1015</code><code>                &lt;td class="ct-body3"&gt;</code></p><p><code>1016</code><code>                      Drug: Maplirpacept (PF-07901801)</code></p><p><code>1017</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;maplirpacept (PF-07901801) will be administered by intravenous infusion at ranging doses, as determined from sequential dosing cohorts.&lt;/div&gt;</code></p><p><code>1018</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;Other Names:&lt;ul style="margin-top:0.5ex"&gt;</code></p><p><code>1019</code><code>&lt;li&gt;SIRP&amp;#945;-IgG4 Fc&lt;/li&gt;</code></p><p><code>1020</code><code>&lt;li&gt;TTI-622&lt;/li&gt;</code></p><p><code>1021</code><code>&lt;/ul&gt;</code></p><p><code>1022</code><code>&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1023</code><code>                      Drug: Carfilzomib</code></p><p><code>1024</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;Days 1, 8, and 15 of 28-day cycles; starting dose IV given on Cycle (C) 1 Day (D) 1, and if tolerated, then increased dose via IV given starting on C1D8 and subsequent doses thereafter.&lt;/div&gt;</code></p><p><code>1025</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;Other Name: KYPROLIS&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1026</code><code>                      Drug: Dexamethasone</code></p><p><code>1027</code><code>&lt;div class="tr-indent2" style="margin-top:0.5ex"&gt;starting dose via IV on Days 1, 8, 15, and increased dose via IV on 28-day cycles&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1028</code><code>                  &lt;/td&gt;</code></p><p><code>1029</code><code>              &lt;/tr&gt;</code></p><p><code>1030</code><code>            &lt;/tbody&gt;</code></p><p><code>1031</code><code>    &lt;/table&gt;</code></p><p><code>1032</code><code>          &lt;/div&gt;</code></p><p><code>1033</code><code>    &lt;br/&gt;</code></p><p><code>1034</code><code>          </code></p><p><code>1035</code><code>    </code></p><p><code>1036</code><code>    &lt;!-- more details --&gt;</code></p><p><code>1037</code><code>  &lt;br/&gt;</code></p><p><code>1038</code><code>  &lt;div class="tr-subsection"&gt;</code></p><p><code>1039</code><code>	  &lt;div class="ct-header2"&gt;&lt;a id="outcomemeasures"&gt;&lt;/a&gt;Outcome Measures&lt;/div&gt;</code></p><p><code>1040</code><code>	  &lt;div class="tr-underline"&gt;&lt;/div&gt;</code></p><p><code>1041</code><code>	  &lt;div class="tr-dropdown" style="padding-right:10em"&gt;</code></p><p><code>1042</code><code>Go&amp;nbsp;to&amp;nbsp;</code></p><p><code>1043</code><code>&lt;button class="tr-dropbtn" style="font-weight:bold; font-size:14px"&gt;</code></p><p><code>1044</code><code>&lt;img src="/ct2/html/images/pulldown.png" alt="sections"&gt;</code></p><p><code>1045</code><code>&lt;/button&gt;</code></p><p><code>1046</code><code>          </code></p><p><code>1047</code><code>  &lt;div class="tr-dropdown-content"&gt;</code></p><p><code>1048</code><code>	&lt;a href="#wrapper"&gt;Top of Page&lt;/a&gt;</code></p><p><code>1049</code><code>    &lt;a href="#studydesc"&gt;Study Description&lt;/a&gt;</code></p><p><code>1050</code><code>    &lt;a href="#studydesign"&gt;Study Design&lt;/a&gt;</code></p><p><code>1051</code><code>          </code></p><p><code>1052</code><code>    &lt;!-- arms and groups table --&gt;</code></p><p><code>1053</code><code>        &lt;a href="#armgroup"&gt;Arms and Interventions&lt;/a&gt;</code></p><p><code>1054</code><code>    </code></p><p><code>1055</code><code>        &lt;a href="#outcomemeasures"&gt;Outcome Measures&lt;/a&gt;</code></p><p><code>1056</code><code>        &lt;a href="#eligibility"&gt;Eligibility Criteria&lt;/a&gt;</code></p><p><code>1057</code><code>    &lt;a href="#contactlocation"&gt;Contacts and Locations&lt;/a&gt;</code></p><p><code>1058</code><code>    &lt;a href="#moreinfo"&gt;More Information&lt;/a&gt;</code></p><p><code>1059</code><code>  &lt;/div&gt;</code></p><p><code>1060</code><code>&lt;/div&gt;</code></p><p><code>1061</code><code>  &lt;/div&gt;</code></p><p><code>1062</code><code>  &lt;br/&gt;</code></p><p><code>1063</code><code>  &lt;div class="tr-indent3" style="margin-right:1em;"&gt;</code></p><p><code>1064</code><code>          </code></p><p><code>1065</code><code>        &lt;!-- primary outcomes --&gt;</code></p><p><code>1066</code><code>    &lt;div class="ct-body3"&gt;</code></p><p><code>1067</code><code>&lt;span style="display:inline;" class="term" data-term="Primary Outcome Measure" title="Show definition"&gt;Primary Outcome Measures &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Primary Outcome Measure" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; :</code></p><p><code>1068</code><code>      &lt;ol style="margin-top:1ex; margin-bottom:1ex;"&gt;</code></p><p><code>1069</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;Phase 1a: Number of adverse events (AE) by severity [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Through study completion, up to 18 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To characterize the safety profile (incidence of AEs)&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1070</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;Phase 1a: Number of AEs by Frequency [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Through study completion, up to 18 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To characterize the safety profile (incidence of AEs) and&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1071</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;Phase 1a: Number of participants with Dose-Limiting Toxicities (DLT) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Up to 21-42 days&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To characterize the dose limiting toxicities (DLTs) of TTI-622.&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1072</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;Phase 1b: Number of adverse events (AE) by severity [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Through study completion, up to 30 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To characterize the safety profile (incidence of AEs) of TTI-622 given in combinations or as a single agent.&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1073</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;Phase 1b: Number of adverse events (AE) by frequency [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Through study completion, up to 30 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To characterize the safety profile (incidence of AEs) of TTI-622 given in combination or as a single agent.&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1074</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;Phase 1b: Number of participants with disease response [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Through study completion, up to 30 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To evaluate response rate of each combination treatment in the (7) combination cohorts (A1,A2, B1, B2, C1, C2, C3, D1, D2, F1, F2, F3) and for single agent treatment (Cohort E1 and E2). For AML, response = CR. For MM, response = CR+sCR+VGBR+PR. For DLBCL, OR=CR+PR&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1075</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;Phase 1a: Maximum Tolerated Dose (MTD) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Baseline (the start of each sequentially increased treatment dose), up to the 3rd evaluable patient completes DLT observation period of 21 or 42 days.&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To characterize the highest dose level for which no more than 1 participant in a dose cohort experienced DLTs.&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1076</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;Phase 1b: Recommended dose of TTI-622 in combination with selected anticancer treatments [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Through study completion, up to 30 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;&lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;To characterize the recommended dose of TTI-622 in combination with selected anticancer treatments in 5 patient populations:&lt;/p&gt;</code></p><p><code>1077</code><code>  &lt;ul style="margin-top:1ex; margin-bottom:1ex;"&gt;</code></p><p><code>1078</code><code>    &lt;li style="margin-top:0.7ex;"&gt;TTI-622 plus azacitidine in newly diagnosed TP53-mutated AML&lt;/li&gt;</code></p><p><code>1079</code><code>    &lt;li style="margin-top:0.7ex;"&gt;TTI-622 plus azacitidine and venetoclax in elderly (&amp;gt;/= 75 years old) or unfit, newly diagnosed TP53-wildtype AML&lt;/li&gt;</code></p><p><code>1080</code><code>    &lt;li style="margin-top:0.7ex;"&gt;TTI-622 plus Carfilzomib and dexamethasone in Carfilzomib-refractory, Relapsed/Refractory (R/R) multiple myeloma (MM) after 3 or more prior lines of therapy&lt;/li&gt;</code></p><p><code>1081</code><code>    &lt;li style="margin-top:0.7ex;"&gt;TTI-622 plus an anti-CD20 targeting agent (such as ruxience or rituxan) in R/R CD20+ DLBCL after 1 or more prior lines of therapy&lt;/li&gt;</code></p><p><code>1082</code><code>    &lt;li style="margin-top:0.7ex;"&gt;TTI-622 plus isatuximab, carfilzomib and dexamethasone in R/R MM after 1-3 prior lines of therapy&lt;/li&gt;</code></p><p><code>1083</code><code>  &lt;/ul&gt;&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1084</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;Phase 1b: Recommended dose of TTI-622 as a single agent [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Through study completion, up to 30 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To characterize the recommended dose of TTI-622 as a single agent in patients with R/R MM after 3 or more prior lines of therapy.&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1085</code><code>            	&lt;li style="margin-top:0.7ex;"&gt;Number of participants with response assessments that show preliminary efficacy [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Through study completion, up to 30 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To evaluate preliminary efficacy of each combination treatment in the selected patient populations and for single-agent treatment in R/R MM&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1086</code><code>            &lt;/ol&gt;</code></p><p><code>1087</code><code>    &lt;/div&gt;</code></p><p><code>1088</code><code>    &lt;br/&gt;</code></p><p><code>1089</code><code>    </code></p><p><code>1090</code><code>        &lt;!-- secondary outcomes --&gt;</code></p><p><code>1091</code><code>    &lt;div class="ct-body3"  style="margin-right:1em;"&gt;</code></p><p><code>1092</code><code>&lt;span style="display:inline;" class="term" data-term="Secondary Outcome Measure" title="Show definition"&gt;Secondary Outcome Measures &lt;i class="fa fa-info-circle term" aria-hidden="true" data-term="Secondary Outcome Measure" style="border-bottom-style:none;"&gt;&lt;/i&gt;&lt;/span&gt; :</code></p><p><code>1093</code><code>      &lt;ol style="margin-top:1ex; margin-bottom:1ex;"&gt;</code></p><p><code>1094</code><code>            &lt;li style="margin-top:0.7ex;"&gt;Phase 1a: TTI-622 PK parameter AUC0-t [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Through study completion, up to 18 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To characterize AUC0-t of TTI-622.&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1095</code><code>            &lt;li style="margin-top:0.7ex;"&gt;Phase 1a: TTI-622 PK parameter Cmax [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Through study completion, up to 18 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To characterize Cmax of TTI-622.&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1096</code><code>            &lt;li style="margin-top:0.7ex;"&gt;Phase 1a: Incidence of anti-drug antibodies (ADA) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Through study completion, up to 18 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To characterize the immunogenicity of TTI-622.&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1097</code><code>            &lt;li style="margin-top:0.7ex;"&gt;Phase 1a: Number of participants with overall response rate (ORR) for participants treated with TTI-622. [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Through study completion, up to 18 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To determine the disease response.&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1098</code><code>            &lt;li style="margin-top:0.7ex;"&gt;Phase 1a: Number of participants with disease control rate (DCR) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Through study completion, up to 18 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To determine the disease control rate (DCR) for participants treated with TTI-622.&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1099</code><code>            &lt;li style="margin-top:0.7ex;"&gt;Phase 1a: Time to response (TTR) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Through study completion, up to 18 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To determine the time to response (TTR) for participants treated with TTI-622.&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1100</code><code>            &lt;li style="margin-top:0.7ex;"&gt;Phase 1a: Duration of Response (DR) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Through study completion, up to 18 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To determine the duration of response (DR) for participants treated with TTI-622.&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1101</code><code>            &lt;li style="margin-top:0.7ex;"&gt;Phase 1a: Progression free survival (PFS) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Through study completion, up to 18 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To determine the progression free survival (PFS) time for participants treated with TTI-622.&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1102</code><code>            &lt;li style="margin-top:0.7ex;"&gt;Phase 1b: TTI-622 PK parameter Cmax when combined with selected anticancer treatments or as a single agent [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Through study completion, up to 30 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To characterize Cmax of TTI-622 when combined with selected anticancer treatments or as a single agent.&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1103</code><code>            &lt;li style="margin-top:0.7ex;"&gt;Phase 1b: incidence of anti-drug antibodies (ADA) Immunogenicity of TTI-622 when combined with selected anticancer treatments or as a single agent [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Through study completion, up to 30 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To characterize the immunogenicity of TTI-622 when combined with selected anticancer treatments or as a single agent&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1104</code><code>            &lt;li style="margin-top:0.7ex;"&gt;Phase 1b: Number of participants with disease control rate (DCR) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Through study completion, up to 30 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To determine the disease control rate (DCR) for participants treated with TTI-622 when combined with selected anticancer treatments or as a single agent.&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1105</code><code>            &lt;li style="margin-top:0.7ex;"&gt;Phase 1b: Time to response (TTR) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Through study completion, up to 30 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To determine the time to response (TTR) for participants treated with TTI-622 when combined with selected anticancer treatments or as a single agent.&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1106</code><code>            &lt;li style="margin-top:0.7ex;"&gt;Phase 1b: Event-free survival (EFS) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Through study completion, up to 30 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To determine event-free survival (EFS; for Cohorts A and B) time for participants treated with TTI-622 when combined with selected anticancer treatments or as a single agent.&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1107</code><code>            &lt;li style="margin-top:0.7ex;"&gt;Phase 1b: Duration of response (DR) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Through study completion, up to 30 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To determine the duration of response (DOR) for participants treated with TTI-622 when combined with selected anticancer treatments or as a single agent.&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1108</code><code>            &lt;li style="margin-top:0.7ex;"&gt;Phase 1b: Progression-free survival (PFS) [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Through study completion, up to 30 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To determine the progression-free survival (PFS) time for participants treated with TTI-622 when combined with selected anticancer treatments or as a single agent.&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1109</code><code>            &lt;li style="margin-top:0.7ex;"&gt;Phase 1b: Number of Participants With Minimal Residual Disease Burden (MRD) Positive, Negative and Not Evaluable (NE) Status [&amp;nbsp;Time&amp;nbsp;Frame:&amp;nbsp;Through study completion, up to 30 months&amp;nbsp;]&lt;div class="tr-indent2" style="margin-top:1ex;"&gt;To determine minimal residual disease (MRD; for Cohorts A, B, C , E and F) for participants treated with TTI-622 when combined with selected anticancer treatments or as a single agent.&lt;/div&gt;&lt;br/&gt;</code></p><p><code>1110</code><code>            &lt;/ol&gt;</code></p><p><code>1111</code><code>    &lt;/div&gt;</code></p><p><code>1112</code><code>    &lt;br/&gt;</code></p><p><code>1113</code><code>    </code></p><p><code>1114</code><code>    </code></p><p><code>1115</code><code>    </code></p><p><code>1116</code><code>  &lt;/div&gt;</code></p><p><code>1117</code><code>  </code></p><p><code>1118</code><code>			  </code></p><p><code>1119</code><code>&lt;!-- eligibility_section --&gt;</code></p><p><code>1120</code><code>&lt;div class="tr-indent1" style="margin-top:3ex; border:1px solid white"&gt;</code></p><p><code>1121</code><code>&lt;div class="tr-subsection"&gt;</code></p><p><code>1122</code><code>	&lt;div class="ct-header2"&gt;&lt;a id="eligibility"&gt;&lt;/a&gt;Eligibility Criteria&lt;/div&gt;</code></p><p><code>1123</code><code>	&lt;div class="tr-underline"&gt;&lt;/div&gt;</code></p><p><code>1124</code><code>	&lt;div class="tr-dropdown" style="padding-right:10em"&gt;</code></p><p><code>1125</code><code>Go&amp;nbsp;to&amp;nbsp;</code></p><p><code>1126</code><code>&lt;button class="tr-dropbtn" style="font-weight:bold; font-size:14px"&gt;</code></p><p><code>1127</code><code>&lt;img src="/ct2/html/images/pulldown.png" alt="sections"&gt;</code></p><p><code>1128</code><code>&lt;/button&gt;</code></p><p><code>1129</code><code>          </code></p><p><code>1130</code><code>  &lt;div class="tr-dropdown-content"&gt;</code></p><p><code>1131</code><code>	&lt;a href="#wrapper"&gt;Top of Page&lt;/a&gt;</code></p><p><code>1132</code><code>    &lt;a href="#studydesc"&gt;Study Description&lt;/a&gt;</code></p><p><code>1133</code><code>    &lt;a href="#studydesign"&gt;Study Design&lt;/a&gt;</code></p><p><code>1134</code><code>          </code></p><p><code>1135</code><code>    &lt;!-- arms and groups table --&gt;</code></p><p><code>1136</code><code>        &lt;a href="#armgroup"&gt;Arms and Interventions&lt;/a&gt;</code></p><p><code>1137</code><code>    </code></p><p><code>1138</code><code>        &lt;a href="#outcomemeasures"&gt;Outcome Measures&lt;/a&gt;</code></p><p><code>1139</code><code>        &lt;a href="#eligibility"&gt;Eligibility Criteria&lt;/a&gt;</code></p><p><code>1140</code><code>    &lt;a href="#contactlocation"&gt;Contacts and Locations&lt;/a&gt;</code></p><p><code>1141</code><code>    &lt;a href="#moreinfo"&gt;More Information&lt;/a&gt;</code></p><p><code>1142</code><code>  &lt;/div&gt;</code></p><p><code>1143</code><code>&lt;/div&gt;</code></p><p><code>1144</code><code>&lt;/div&gt;</code></p><p><code>1145</code><code>&lt;br/&gt;</code></p><p><code>1146</code><code>          </code></p><p><code>1147</code><code>&lt;p&gt;</code></p><p><code>1148</code><code>  &lt;div class="tr-indent2 usa-alert usa-alert-warning nlm-info"&gt;</code></p><p><code>1149</code><code>    &lt;strong&gt;Information from the National Library of Medicine&lt;/strong&gt;</code></p><p><code>1150</code><code>    &lt;img src="/ct2/html/images/NIH_NLM_ABRV_BLK_4.png" style="width:5em; float:right;" alt=""/&gt;</code></p><p><code>1151</code><code>    &lt;p&gt;</code></p><p><code>1152</code><code>    &lt;p&gt;</code></p><p><code>1153</code><code>    &lt;em&gt;Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, &lt;a href="/ct2/about-studies/learn" title="Learn About Clinical Studies"&gt;&lt;u&gt;Learn About Clinical Studies.&lt;/u&gt;&lt;/a&gt;</code></p><p><code>1154</code><code>    &lt;/em&gt;</code></p><p><code>1155</code><code>  &lt;/div&gt;</code></p><p><code>1156</code><code>          </code></p><p><code>1157</code><code>          </code></p><p><code>1158</code><code>  &lt;br/&gt;</code></p><p><code>1159</code><code>  &lt;div class="tr-indent2"&gt;</code></p><p><code>1160</code><code>    &lt;table class="ct-layout_table tr-tableStyle tr-studyInfo"&gt;</code></p><p><code>1161</code><code>      &lt;caption&gt;Layout table for eligibility information&lt;/caption&gt;</code></p><p><code>1162</code><code>      &lt;thead&gt;</code></p><p><code>1163</code><code>        &lt;tr&gt;</code></p><p><code>1164</code><code>          &lt;th id="elgType"&gt;&lt;/th&gt;</code></p><p><code>1165</code><code>          &lt;th id="elgData"&gt;&lt;/th&gt;</code></p><p><code>1166</code><code>        &lt;/tr&gt;</code></p><p><code>1167</code><code>      &lt;/thead&gt;</code></p><p><code>1168</code><code>      &lt;tbody&gt;</code></p><p><code>1169</code><code>            &lt;tr&gt;</code></p><p><code>1170</code><code>        &lt;td headers="elgType" class="ct-nowrap"&gt;Ages Eligible for Study: &amp;nbsp; &lt;/td&gt;</code></p><p><code>1171</code><code>        &lt;td headers="elgData" style="padding-left:1em"&gt;18 Years and older &amp;nbsp; (Adult, Older Adult)&lt;/td&gt;</code></p><p><code>1172</code><code>      &lt;/tr&gt;</code></p><p><code>1173</code><code>                  &lt;tr&gt;</code></p><p><code>1174</code><code>        &lt;td headers="elgType" class="ct-nowrap"&gt;Sexes Eligible for Study: &amp;nbsp; &lt;/td&gt;</code></p><p><code>1175</code><code>        &lt;td headers="elgData" style="padding-left:1em"&gt;All&lt;/td&gt;</code></p><p><code>1176</code><code>      &lt;/tr&gt;</code></p><p><code>1177</code><code>                              &lt;tr&gt;</code></p><p><code>1178</code><code>        &lt;td headers="elgType" class="ct-nowrap"&gt;Accepts Healthy Volunteers: &amp;nbsp; &lt;/td&gt;</code></p><p><code>1179</code><code>        &lt;td headers="elgData" style="padding-left:1em"&gt;No&lt;/td&gt;</code></p><p><code>1180</code><code>      &lt;/tr&gt;</code></p><p><code>1181</code><code>                  &lt;/tbody&gt;</code></p><p><code>1182</code><code>    &lt;/table&gt;</code></p><p><code>1183</code><code>          </code></p><p><code>1184</code><code>    </code></p><p><code>1185</code><code>        &lt;div class="ct-header3" style="margin-top:2ex"&gt;Criteria&lt;/div&gt;</code></p><p><code>1186</code><code>    &lt;div class="tr-indent2"&gt;&lt;p style="margin-top:1ex; margin-bottom:1ex;"&gt;Key Inclusion Criteria (Phase 1a and Phase 1b, all Cohorts):&lt;/p&gt;</code></p><p><code>1187</code><code>  &lt;ol style="margin-top:1ex; margin-bottom:1ex;"&gt;</code></p><p><code>1188</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Available fresh or archived tumor tissue.&lt;/li&gt;</code></p><p><code>1189</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Eastern Cooperative Oncology Group (ECOG) performance status score of 0, 1, or 2.&lt;/li&gt;</code></p><p><code>1190</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Adequate coagulation function.&lt;/li&gt;</code></p><p><code>1191</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Adequate hepatic function.&lt;/li&gt;</code></p><p><code>1192</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Adequate hematologic status.&lt;/li&gt;</code></p><p><code>1193</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Adequate renal function.&lt;/li&gt;</code></p><p><code>1194</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Recovery from non-hematopoietic toxicities of previous anticancer drugs or radiotherapy or previous surgeries to &amp;#8804;Grade 1 (or to baseline grade if condition was pre-existing).&lt;/li&gt;</code></p><p><code>1195</code><code>  &lt;/ol&gt;</code></p><p><code>1196</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Key Inclusion Criteria (Phase 1a): Histologically confirmed relapsed/refractory, transfusion- independent lymphoma (Hodgkin or non-Hodgkin) per the 2014 Lugano classification.&lt;/p&gt;</code></p><p><code>1197</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Key Inclusion Criteria (Phase 1b Cohort A1 and A2): Histologically confirmed, newly diagnosed TP53-mutated Acute Myeloid Leukemia (AML).&lt;/p&gt;</code></p><p><code>1198</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Key Inclusion Criteria (Phase 1b Cohort B1 and B2): Histologically confirmed, newly diagnosed TP53-wildtype AML, elderly or unfit for more aggressive treatment.&lt;/p&gt;</code></p><p><code>1199</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Key Inclusion Criteria (Phase 1b Cohorts C1, C2, C3 and E1, E2, F1, F2, F3): Histologically documented relapsed/refractory Multiple Myeloma (MM).&lt;/p&gt;</code></p><p><code>1200</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Key Inclusion Criteria (Phase 1b Cohort D1 and D2): Pathologically confirmed relapsed/refractory diffuse large B-cell lymphoma (DLBCL)&lt;/p&gt;</code></p><p><code>1201</code><code>  &lt;p style="margin-top:0ex; margin-bottom:1ex;"&gt;Key Exclusion Criteria (Phase 1a and Phase 1b, all Cohorts):&lt;/p&gt;</code></p><p><code>1202</code><code>  &lt;ol style="margin-top:1ex; margin-bottom:1ex;"&gt;</code></p><p><code>1203</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Known, current central nervous system disease involvement.&lt;/li&gt;</code></p><p><code>1204</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Use of any investigational agent or any anticancer drug within 14 days before planned start of study treatment (within 4 weeks for antibody-based therapies and within 8 weeks for cell-based therapies).&lt;/li&gt;</code></p><p><code>1205</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Subjects who have undergone radiation therapy within 14 days of study treatment administration.&lt;/li&gt;</code></p><p><code>1206</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Hematopoietic stem cell transplant within 90 days before the planned start of study treatment or subjects with active graft-vs-host disease, with the exception of Grade 1 skin involvement.&lt;/li&gt;</code></p><p><code>1207</code><code>    &lt;li style="margin-top:0.7ex;"&gt;Major surgery within 30 days before planned start of study treatment.&lt;/li&gt;</code></p><p><code>1208</code><code>  &lt;/ol&gt;&lt;/div&gt;</code></p><p><code>1209</code><code>    </code></p><p><code>1210</code><code>  &lt;/div&gt;</code></p><p><code>1211</code><code>          </code></p><p><code>1212</code><code>  &lt;/div&gt;</code></p><p><code>1213</code><code>          </code></p><p><code>1214</code><code>			  </code></p><p><code>1215</code><code>&lt;!-- location_section --&gt;</code></p><p><code>1216</code><code>&lt;a id="contacts"&gt;&lt;/a&gt;</code></p><p><code>1217</code><code>&lt;div class="tr-indent1" style="margin-top:3ex"&gt;</code></p><p><code>1218</code><code>&lt;div class="tr-subsection"&gt;</code></p><p><code>1219</code><code>	&lt;div class="ct-header2"&gt;&lt;a id="contactlocation"&gt;&lt;/a&gt;Contacts and Locations&lt;/div&gt;</code></p><p><code>1220</code><code>	&lt;div class="tr-underline"&gt;&lt;/div&gt;</code></p><p><code>1221</code><code>	&lt;div class="tr-dropdown" style="padding-right:10em"&gt;</code></p><p><code>1222</code><code>Go&amp;nbsp;to&amp;nbsp;</code></p><p><code>1223</code><code>&lt;button class="tr-dropbtn" style="font-weight:bold; font-size:14px"&gt;</code></p><p><code>1224</code><code>&lt;img src="/ct2/html/images/pulldown.png" alt="sections"&gt;</code></p><p><code>1225</code><code>&lt;/button&gt;</code></p><p><code>1226</code><code>          </code></p><p><code>1227</code><code>  &lt;div class="tr-dropdown-content"&gt;</code></p><p><code>1228</code><code>	&lt;a href="#wrapper"&gt;Top of Page&lt;/a&gt;</code></p><p><code>1229</code><code>    &lt;a href="#studydesc"&gt;Study Description&lt;/a&gt;</code></p><p><code>1230</code><code>    &lt;a href="#studydesign"&gt;Study Design&lt;/a&gt;</code></p><p><code>1231</code><code>          </code></p><p><code>1232</code><code>    &lt;!-- arms and groups table --&gt;</code></p><p><code>1233</code><code>        &lt;a href="#armgroup"&gt;Arms and Interventions&lt;/a&gt;</code></p><p><code>1234</code><code>    </code></p><p><code>1235</code><code>        &lt;a href="#outcomemeasures"&gt;Outcome Measures&lt;/a&gt;</code></p><p><code>1236</code><code>        &lt;a href="#eligibility"&gt;Eligibility Criteria&lt;/a&gt;</code></p><p><code>1237</code><code>    &lt;a href="#contactlocation"&gt;Contacts and Locations&lt;/a&gt;</code></p><p><code>1238</code><code>    &lt;a href="#moreinfo"&gt;More Information&lt;/a&gt;</code></p><p><code>1239</code><code>  &lt;/div&gt;</code></p><p><code>1240</code><code>&lt;/div&gt;</code></p><p><code>1241</code><code>&lt;/div&gt;</code></p><p><code>1242</code><code>&lt;br/&gt;</code></p><p><code>1243</code><code>          </code></p><p><code>1244</code><code>          </code></p><p><code>1245</code><code>&lt;div class="tr-indent2" style="margin-top:2ex"&gt;</code></p><p><code>1246</code><code>          </code></p><p><code>1247</code><code>&lt;!--</code></p><p><code>1248</code><code>Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. </code></p><p><code>1249</code><code>To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. </code></p><p><code>1250</code><code>For general information, see &lt;a href="/ct2/about-studies/learn" target="def_win" onClick="openNewWindow('/ct2/about-studies/learn'); return false;" title="Learn About Clinical Studies - opens new window"&gt;&lt;u&gt;Learn About Clinical Studies.&lt;/u&gt;&lt;/a&gt;</code></p><p><code>1251</code><code>&lt;br/&gt;</code></p><p><code>1252</code><code>--&gt;</code></p><p><code>1253</code><code>          </code></p><p><code>1254</code><code>  </code></p><p><code>1255</code><code>  &lt;div class="usa-alert usa-alert-warning nlm-info"&gt;</code></p><p><code>1256</code><code>    &lt;strong&gt;Information from the National Library of Medicine&lt;/strong&gt;</code></p><p><code>1257</code><code>    &lt;img src="/ct2/html/images/NIH_NLM_ABRV_BLK_4.png" style="width:5em; float:right;" alt=""/&gt;</code></p><p><code>1258</code><code>    &lt;p&gt;</code></p><p><code>1259</code><code>    &lt;p&gt;</code></p><p><code>1260</code><code>    &lt;em&gt;</code></p><p><code>1261</code><code>    To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.</code></p><p><code>1262</code><code>    &lt;/em&gt;</code></p><p><code>1263</code><code>    &lt;p&gt;</code></p><p><code>1264</code><code>    &lt;em&gt;</code></p><p><code>1265</code><code>    Please refer to this study by its ClinicalTrials.gov identifier (NCT number): &lt;strong&gt;NCT03530683&lt;/strong&gt;</code></p><p><code>1266</code><code>    &lt;/em&gt;</code></p><p><code>1267</code><code>  &lt;/div&gt;</code></p><p><code>1268</code><code>  &lt;br/&gt;</code></p><p><code>1269</code><code>          </code></p><p><code>1270</code><code>  &lt;!-- contacts --&gt;</code></p><p><code>1271</code><code>    &lt;div class="ct-header3" style="margin-top:2ex"&gt;Contacts&lt;/div&gt;</code></p><p><code>1272</code><code>  &lt;div class="tr-table_cover"&gt;</code></p><p><code>1273</code><code>    &lt;table class="ct-layout_table tr-indent2"&gt;</code></p><p><code>1274</code><code>      &lt;caption&gt;Layout table for location contacts&lt;/caption&gt;</code></p><p><code>1275</code><code>    &lt;thead&gt;</code></p><p><code>1276</code><code>    &lt;tr&gt;</code></p><p><code>1277</code><code>      &lt;th id="contactName" style="visibility:hidden"&gt;&lt;/th&gt;</code></p><p><code>1278</code><code>      &lt;th id="contactPhone" style="visibility:hidden"&gt;&lt;/th&gt;</code></p><p><code>1279</code><code>      &lt;th id="contactEmail" style="visibility:hidden"&gt;&lt;/th&gt;</code></p><p><code>1280</code><code>      &lt;th id="contactAddress" style="visibility:hidden"&gt;&lt;/th&gt;</code></p><p><code>1281</code><code>    &lt;/tr&gt;</code></p><p><code>1282</code><code>    &lt;/thead&gt;</code></p><p><code>1283</code><code>        &lt;tr&gt;</code></p><p><code>1284</code><code>      &lt;td headers="contactName"&gt;Contact: Pfizer CT.gov Pfizer CT.gov Call Center&lt;/td&gt;</code></p><p><code>1285</code><code>            &lt;td headers="contactPhone"&gt;1-800-718-1021&lt;/td&gt;</code></p><p><code>1286</code><code>                  &lt;td headers="contactEmail"&gt;&lt;a href="mailto:ClinicalTrials.gov_Inquiries%40pfizer.com?subject=NCT03530683, TTI-622-01, A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma"&gt;ClinicalTrials.gov_Inquiries@pfizer.com&lt;/a&gt;&lt;/td&gt;</code></p><p><code>1287</code><code>                  &lt;td headers="contactAddress"&gt;&lt;/td&gt;</code></p><p><code>1288</code><code>          &lt;/tr&gt;</code></p><p><code>1289</code><code>      &lt;/table&gt;</code></p><p><code>1290</code><code>  &lt;/div&gt;</code></p><p><code>1291</code><code>  &lt;br/&gt;</code></p><p><code>1292</code><code>  </code></p><p><code>1293</code><code>  &lt;!-- locations --&gt;</code></p><p><code>1294</code><code>   &lt;a id="locn"&gt;&lt;/a&gt;</code></p><p><code>1295</code><code>  &lt;div class="ct-header3" style="margin-top:2ex;margin-bottom:2ex;"&gt;Locations&lt;/div&gt;</code></p><p><code>1296</code><code>          </code></p><p><code>1297</code><code>      &lt;script type="text/javascript" async src="/ct2/html/js/ExpandCollapseScript.js"&gt;&lt;/script&gt;</code></p><p><code>1298</code><code>    </code></p><p><code>1299</code><code>    &lt;span id="EXPAND_CONTROL-Locations" class="EXPAND tr-showAndHide"       onclick="toggleSectionAndControls('-Locations');document.getElementById('locn').scrollIntoView({behavior: 'smooth', block: 'start'});" </code></p><p><code>1300</code><code>      title="Show 61 study locations"&gt;</code></p><p><code>1301</code><code>      &lt;img src="/ct2/html/images/expand.png" alt="Show"&gt;</code></p><p><code>1302</code><code>      &lt;span style="padding-bottom:3px"&gt; Show 61 study locations&lt;/span&gt;</code></p><p><code>1303</code><code>    &lt;/span&gt;</code></p><p><code>1304</code><code>    &lt;span  id="COLLAPSE_CONTROL-Locations" class="COLLAPSE tr-showAndHide" style="display:none"      onclick="toggleSectionAndControls('-Locations');" </code></p><p><code>1305</code><code>      title="Hide 61 study locations"&gt;</code></p><p><code>1306</code><code>      &lt;img src="/ct2/html/images/collapse.png"  alt="Hide"&gt;</code></p><p><code>1307</code><code>      &lt;span style="padding-bottom:3px"&gt; Hide 61 study locations&lt;/span&gt;</code></p><p><code>1308</code><code>    &lt;/span&gt;</code></p><p><code>1309</code><code>     </code></p><p><code>1310</code><code>  &lt;div id="COLLAPSE-Locations" class="COLLAPSE" style="display:none"&gt;</code></p><p><code>1311</code><code>        &lt;div class="tr-table_cover"&gt;</code></p><p><code>1312</code><code>      &lt;table class="ct-layout_table tr-indent2"&gt;</code></p><p><code>1313</code><code>        &lt;caption&gt;Layout table for location information&lt;/caption&gt;</code></p><p><code>1314</code><code>        &lt;thead&gt;</code></p><p><code>1315</code><code>          &lt;tr&gt;</code></p><p><code>1316</code><code>            &lt;th id="locName"&gt;&lt;/th&gt;</code></p><p><code>1317</code><code>            &lt;th id="locStatus"&gt;&lt;/th&gt;</code></p><p><code>1318</code><code>          &lt;/tr&gt;</code></p><p><code>1319</code><code>        &lt;/thead&gt;</code></p><p><code>1320</code><code>        &lt;tbody&gt;</code></p><p><code>1321</code><code>                                    &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, California&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1322</code><code>                                      &lt;tr&gt;</code></p><p><code>1323</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Keck Hospital of USC&lt;/td&gt;</code></p><p><code>1324</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1325</code><code>                          &lt;/tr&gt;</code></p><p><code>1326</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Los Angeles, California, United States, 90033  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1327</code><code>                                                          &lt;tr&gt;</code></p><p><code>1328</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;LAC+USC Medical Center&lt;/td&gt;</code></p><p><code>1329</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1330</code><code>                          &lt;/tr&gt;</code></p><p><code>1331</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Los Angeles, California, United States, 90033  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1332</code><code>                                                          &lt;tr&gt;</code></p><p><code>1333</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;USC/Norris Comprehensive Cancer Center&lt;/td&gt;</code></p><p><code>1334</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1335</code><code>                          &lt;/tr&gt;</code></p><p><code>1336</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Los Angeles, California, United States, 90033  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1337</code><code>                                                          &lt;tr&gt;</code></p><p><code>1338</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Keck Hospital of USC Pasadena&lt;/td&gt;</code></p><p><code>1339</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1340</code><code>                          &lt;/tr&gt;</code></p><p><code>1341</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Pasadena, California, United States, 91105  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1342</code><code>                                                            &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, Colorado&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1343</code><code>                                      &lt;tr&gt;</code></p><p><code>1344</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Colorado Blood Cancer Institute&lt;/td&gt;</code></p><p><code>1345</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1346</code><code>                          &lt;/tr&gt;</code></p><p><code>1347</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Denver, Colorado, United States, 80218  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1348</code><code>                                                          &lt;tr&gt;</code></p><p><code>1349</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;HealthONE Presbyterian/St. Luke's Medical Center&lt;/td&gt;</code></p><p><code>1350</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1351</code><code>                          &lt;/tr&gt;</code></p><p><code>1352</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Denver, Colorado, United States, 80218  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1353</code><code>                                                            &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, Delaware&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1354</code><code>                                      &lt;tr&gt;</code></p><p><code>1355</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Christiana Care Health Services&lt;/td&gt;</code></p><p><code>1356</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Not yet recruiting&lt;/td&gt;</code></p><p><code>1357</code><code>                          &lt;/tr&gt;</code></p><p><code>1358</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Newark, Delaware, United States, 19713  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1359</code><code>                                                          &lt;tr&gt;</code></p><p><code>1360</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Christiana Care Hematology Oncology - Helen F Graham Cancer Center&lt;/td&gt;</code></p><p><code>1361</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Not yet recruiting&lt;/td&gt;</code></p><p><code>1362</code><code>                          &lt;/tr&gt;</code></p><p><code>1363</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Newark, Delaware, United States, 19713  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1364</code><code>                                                          &lt;tr&gt;</code></p><p><code>1365</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Medical Oncology Hematology Consultants, PA, Helen F. Graham Cancer Center&lt;/td&gt;</code></p><p><code>1366</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Not yet recruiting&lt;/td&gt;</code></p><p><code>1367</code><code>                          &lt;/tr&gt;</code></p><p><code>1368</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Newark, Delaware, United States, 19713  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1369</code><code>                                                          &lt;tr&gt;</code></p><p><code>1370</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Christiana Care Health Services - Christiana Hospital&lt;/td&gt;</code></p><p><code>1371</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Not yet recruiting&lt;/td&gt;</code></p><p><code>1372</code><code>                          &lt;/tr&gt;</code></p><p><code>1373</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Newark, Delaware, United States, 19718  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1374</code><code>                                                            &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, District of Columbia&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1375</code><code>                                      &lt;tr&gt;</code></p><p><code>1376</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Georgetown University Medical Center&lt;/td&gt;</code></p><p><code>1377</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1378</code><code>                          &lt;/tr&gt;</code></p><p><code>1379</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Washington, District of Columbia, United States, 20007  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1380</code><code>                                                            &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, Florida&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1381</code><code>                                      &lt;tr&gt;</code></p><p><code>1382</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Tampa General Hospital Cancer Institute&lt;/td&gt;</code></p><p><code>1383</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1384</code><code>                          &lt;/tr&gt;</code></p><p><code>1385</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Tampa, Florida, United States, 33606  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1386</code><code>                                                          &lt;tr&gt;</code></p><p><code>1387</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Tampa General Hospital&lt;/td&gt;</code></p><p><code>1388</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1389</code><code>                          &lt;/tr&gt;</code></p><p><code>1390</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Tampa, Florida, United States, 33606  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1391</code><code>                                                            &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, Georgia&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1392</code><code>                                      &lt;tr&gt;</code></p><p><code>1393</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Blood and Marrow Transplant Group of Georgia&lt;/td&gt;</code></p><p><code>1394</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1395</code><code>                          &lt;/tr&gt;</code></p><p><code>1396</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Atlanta, Georgia, United States, 30342  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1397</code><code>                                                          &lt;tr&gt;</code></p><p><code>1398</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Northside Hospital&lt;/td&gt;</code></p><p><code>1399</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1400</code><code>                          &lt;/tr&gt;</code></p><p><code>1401</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Atlanta, Georgia, United States, 30342  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1402</code><code>                                                            &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, Indiana&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1403</code><code>                                      &lt;tr&gt;</code></p><p><code>1404</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Indiana Blood &amp;amp; Marrow Transplantation&lt;/td&gt;</code></p><p><code>1405</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Not yet recruiting&lt;/td&gt;</code></p><p><code>1406</code><code>                          &lt;/tr&gt;</code></p><p><code>1407</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Indianapolis, Indiana, United States, 46237  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1408</code><code>                                                          &lt;tr&gt;</code></p><p><code>1409</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Indiana Blood and Marrow Transplantation-Clinic&lt;/td&gt;</code></p><p><code>1410</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Not yet recruiting&lt;/td&gt;</code></p><p><code>1411</code><code>                          &lt;/tr&gt;</code></p><p><code>1412</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Indianapolis, Indiana, United States, 46237  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1413</code><code>                                                            &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, Kentucky&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1414</code><code>                                      &lt;tr&gt;</code></p><p><code>1415</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Norton Cancer Institute, St Matthews Campus&lt;/td&gt;</code></p><p><code>1416</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1417</code><code>                          &lt;/tr&gt;</code></p><p><code>1418</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Louisville, Kentucky, United States, 40207  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1419</code><code>                                                          &lt;tr&gt;</code></p><p><code>1420</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Norton Cancer Institute, St. Matthews Campus, Attn. Becky Champion, PharmD&lt;/td&gt;</code></p><p><code>1421</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1422</code><code>                          &lt;/tr&gt;</code></p><p><code>1423</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Louisville, Kentucky, United States, 40207  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1424</code><code>                                                          &lt;tr&gt;</code></p><p><code>1425</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Norton Diagnostic Center-Dupont (PET Scans)&lt;/td&gt;</code></p><p><code>1426</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1427</code><code>                          &lt;/tr&gt;</code></p><p><code>1428</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Louisville, Kentucky, United States, 40207  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1429</code><code>                                                          &lt;tr&gt;</code></p><p><code>1430</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Norton Women &amp;amp; Children's Hospital&lt;/td&gt;</code></p><p><code>1431</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1432</code><code>                          &lt;/tr&gt;</code></p><p><code>1433</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Louisville, Kentucky, United States, 40207  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1434</code><code>                                                            &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, Michigan&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1435</code><code>                                      &lt;tr&gt;</code></p><p><code>1436</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;University of Michigan Hospitals&lt;/td&gt;</code></p><p><code>1437</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1438</code><code>                          &lt;/tr&gt;</code></p><p><code>1439</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Ann Arbor, Michigan, United States, 48109  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1440</code><code>                                                          &lt;tr&gt;</code></p><p><code>1441</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;University of Michigan&lt;/td&gt;</code></p><p><code>1442</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1443</code><code>                          &lt;/tr&gt;</code></p><p><code>1444</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Ann Arbor, Michigan, United States, 48109  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1445</code><code>                                                          &lt;tr&gt;</code></p><p><code>1446</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Barbara Ann Karmanos Cancer Institute&lt;/td&gt;</code></p><p><code>1447</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1448</code><code>                          &lt;/tr&gt;</code></p><p><code>1449</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Detroit, Michigan, United States, 48201  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1450</code><code>                                                          &lt;tr&gt;</code></p><p><code>1451</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Karmanos Cancer Institute Weisberg Cancer Treatment Center&lt;/td&gt;</code></p><p><code>1452</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1453</code><code>                          &lt;/tr&gt;</code></p><p><code>1454</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Farmington Hills, Michigan, United States, 48334  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1455</code><code>                                                            &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, New Jersey&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1456</code><code>                                      &lt;tr&gt;</code></p><p><code>1457</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Memorial Sloan Kettering Cancer Center at Basking Ridge&lt;/td&gt;</code></p><p><code>1458</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1459</code><code>                          &lt;/tr&gt;</code></p><p><code>1460</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Basking Ridge, New Jersey, United States, 07920  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1461</code><code>                                                          &lt;tr&gt;</code></p><p><code>1462</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Summit Medical Group Cancer Center&lt;/td&gt;</code></p><p><code>1463</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Not yet recruiting&lt;/td&gt;</code></p><p><code>1464</code><code>                          &lt;/tr&gt;</code></p><p><code>1465</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Florham Park, New Jersey, United States, 07932  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1466</code><code>                                                          &lt;tr&gt;</code></p><p><code>1467</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Memorial Sloan Kettering Cancer Center at Monmouth&lt;/td&gt;</code></p><p><code>1468</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1469</code><code>                          &lt;/tr&gt;</code></p><p><code>1470</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Middletown, New Jersey, United States, 07748  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1471</code><code>                                                          &lt;tr&gt;</code></p><p><code>1472</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Memorial Sloan Kettering Bergen&lt;/td&gt;</code></p><p><code>1473</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1474</code><code>                          &lt;/tr&gt;</code></p><p><code>1475</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Montvale, New Jersey, United States, 07645  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1476</code><code>                                                          &lt;tr&gt;</code></p><p><code>1477</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Memorial Sloan Kettering Cancer Center at Montvale&lt;/td&gt;</code></p><p><code>1478</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1479</code><code>                          &lt;/tr&gt;</code></p><p><code>1480</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Montvale, New Jersey, United States, 07645  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1481</code><code>                                                            &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, New York&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1482</code><code>                                      &lt;tr&gt;</code></p><p><code>1483</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Montefiore Medical Center&lt;/td&gt;</code></p><p><code>1484</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1485</code><code>                          &lt;/tr&gt;</code></p><p><code>1486</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Bronx, New York, United States, 10467  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1487</code><code>                                                          &lt;tr&gt;</code></p><p><code>1488</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Roswell Park Cancer Institute&lt;/td&gt;</code></p><p><code>1489</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1490</code><code>                          &lt;/tr&gt;</code></p><p><code>1491</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Buffalo, New York, United States, 14263  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1492</code><code>                                                          &lt;tr&gt;</code></p><p><code>1493</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Memorial Sloan Kettering Cancer Center at Commack&lt;/td&gt;</code></p><p><code>1494</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1495</code><code>                          &lt;/tr&gt;</code></p><p><code>1496</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Commack, New York, United States, 11725  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1497</code><code>                                                          &lt;tr&gt;</code></p><p><code>1498</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Memorial Sloan Kettering Cancer Center at Westchester&lt;/td&gt;</code></p><p><code>1499</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1500</code><code>                          &lt;/tr&gt;</code></p><p><code>1501</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Harrison, New York, United States, 10604  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1502</code><code>                                                          &lt;tr&gt;</code></p><p><code>1503</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy&lt;/td&gt;</code></p><p><code>1504</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1505</code><code>                          &lt;/tr&gt;</code></p><p><code>1506</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Long Island City, New York, United States, 11101  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1507</code><code>                                                          &lt;tr&gt;</code></p><p><code>1508</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Memorial Sloan Kettering Cancer Center - David H. Koch Center&lt;/td&gt;</code></p><p><code>1509</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1510</code><code>                          &lt;/tr&gt;</code></p><p><code>1511</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;New York, New York, United States, 10021  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1512</code><code>                                                          &lt;tr&gt;</code></p><p><code>1513</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Memorial Sloan Kettering Cancer Center (Outpatient Center)&lt;/td&gt;</code></p><p><code>1514</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1515</code><code>                          &lt;/tr&gt;</code></p><p><code>1516</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;New York, New York, United States, 10065  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1517</code><code>                                                          &lt;tr&gt;</code></p><p><code>1518</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Memorial Sloan Kettering Cancer Center&lt;/td&gt;</code></p><p><code>1519</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1520</code><code>                          &lt;/tr&gt;</code></p><p><code>1521</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;New York, New York, United States, 10065  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1522</code><code>                                                          &lt;tr&gt;</code></p><p><code>1523</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Memorial Sloan Kettering Cancer Center at Nassau&lt;/td&gt;</code></p><p><code>1524</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1525</code><code>                          &lt;/tr&gt;</code></p><p><code>1526</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Uniondale, New York, United States, 11553  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1527</code><code>                                                            &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, North Carolina&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1528</code><code>                                      &lt;tr&gt;</code></p><p><code>1529</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Novant Health Cancer Institute - Research Office&lt;/td&gt;</code></p><p><code>1530</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Not yet recruiting&lt;/td&gt;</code></p><p><code>1531</code><code>                          &lt;/tr&gt;</code></p><p><code>1532</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Charlotte, North Carolina, United States, 28204  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1533</code><code>                                                          &lt;tr&gt;</code></p><p><code>1534</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Novant Health Cancer Institute Hematology - Charlotte&lt;/td&gt;</code></p><p><code>1535</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Not yet recruiting&lt;/td&gt;</code></p><p><code>1536</code><code>                          &lt;/tr&gt;</code></p><p><code>1537</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Charlotte, North Carolina, United States, 28204  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1538</code><code>                                                          &lt;tr&gt;</code></p><p><code>1539</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Novant Health Presbyterian Medical Center&lt;/td&gt;</code></p><p><code>1540</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Not yet recruiting&lt;/td&gt;</code></p><p><code>1541</code><code>                          &lt;/tr&gt;</code></p><p><code>1542</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Charlotte, North Carolina, United States, 28204  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1543</code><code>                                                          &lt;tr&gt;</code></p><p><code>1544</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Novant Health Cancer Institute - Research Office&lt;/td&gt;</code></p><p><code>1545</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Not yet recruiting&lt;/td&gt;</code></p><p><code>1546</code><code>                          &lt;/tr&gt;</code></p><p><code>1547</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Winston-Salem, North Carolina, United States, 27103  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1548</code><code>                                                          &lt;tr&gt;</code></p><p><code>1549</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Novant Health Cancer Institute Hematology - Forsyth&lt;/td&gt;</code></p><p><code>1550</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Not yet recruiting&lt;/td&gt;</code></p><p><code>1551</code><code>                          &lt;/tr&gt;</code></p><p><code>1552</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Winston-Salem, North Carolina, United States, 27103  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1553</code><code>                                                          &lt;tr&gt;</code></p><p><code>1554</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Novant Health Forsyth Medical Center&lt;/td&gt;</code></p><p><code>1555</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Not yet recruiting&lt;/td&gt;</code></p><p><code>1556</code><code>                          &lt;/tr&gt;</code></p><p><code>1557</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Winston-Salem, North Carolina, United States, 27103  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1558</code><code>                                                            &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, Ohio&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1559</code><code>                                      &lt;tr&gt;</code></p><p><code>1560</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Gabrail Cancer Center Research&lt;/td&gt;</code></p><p><code>1561</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Terminated&lt;/td&gt;</code></p><p><code>1562</code><code>                          &lt;/tr&gt;</code></p><p><code>1563</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Canton, Ohio, United States, 44718  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1564</code><code>                                                            &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, Pennsylvania&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1565</code><code>                                      &lt;tr&gt;</code></p><p><code>1566</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Sidney Kimmel Cancer Center, Clinical Trials Organization&lt;/td&gt;</code></p><p><code>1567</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1568</code><code>                          &lt;/tr&gt;</code></p><p><code>1569</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Philadelphia, Pennsylvania, United States, 19107  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1570</code><code>                                                          &lt;tr&gt;</code></p><p><code>1571</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Sidney Kimmel Cancer Center, Research Support Services&lt;/td&gt;</code></p><p><code>1572</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1573</code><code>                          &lt;/tr&gt;</code></p><p><code>1574</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Philadelphia, Pennsylvania, United States, 19107  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1575</code><code>                                                          &lt;tr&gt;</code></p><p><code>1576</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Thomas Jefferson University - Clinical Research Institute&lt;/td&gt;</code></p><p><code>1577</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Not yet recruiting&lt;/td&gt;</code></p><p><code>1578</code><code>                          &lt;/tr&gt;</code></p><p><code>1579</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Philadelphia, Pennsylvania, United States, 19107  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1580</code><code>                                                          &lt;tr&gt;</code></p><p><code>1581</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Thomas Jefferson University Investigational Drug Services&lt;/td&gt;</code></p><p><code>1582</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1583</code><code>                          &lt;/tr&gt;</code></p><p><code>1584</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Philadelphia, Pennsylvania, United States, 19107  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1585</code><code>                                                          &lt;tr&gt;</code></p><p><code>1586</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Thomas Jefferson University, Investigational Drug Service&lt;/td&gt;</code></p><p><code>1587</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1588</code><code>                          &lt;/tr&gt;</code></p><p><code>1589</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Philadelphia, Pennsylvania, United States, 19107  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1590</code><code>                                                          &lt;tr&gt;</code></p><p><code>1591</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Thomas Jefferson University, Medical Oncology&lt;/td&gt;</code></p><p><code>1592</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1593</code><code>                          &lt;/tr&gt;</code></p><p><code>1594</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Philadelphia, Pennsylvania, United States, 19107  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1595</code><code>                                                          &lt;tr&gt;</code></p><p><code>1596</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Thomas Jefferson University&lt;/td&gt;</code></p><p><code>1597</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1598</code><code>                          &lt;/tr&gt;</code></p><p><code>1599</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Philadelphia, Pennsylvania, United States, 19107  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1600</code><code>                                                          &lt;tr&gt;</code></p><p><code>1601</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;West Penn Hospital&lt;/td&gt;</code></p><p><code>1602</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1603</code><code>                          &lt;/tr&gt;</code></p><p><code>1604</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Pittsburgh, Pennsylvania, United States, 15224  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1605</code><code>                                                            &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, South Carolina&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1606</code><code>                                      &lt;tr&gt;</code></p><p><code>1607</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Prisma Health, Institute for Translational Oncology Research, Clinical Research Unit&lt;/td&gt;</code></p><p><code>1608</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Not yet recruiting&lt;/td&gt;</code></p><p><code>1609</code><code>                          &lt;/tr&gt;</code></p><p><code>1610</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Greenville, South Carolina, United States, 29605  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1611</code><code>                                                          &lt;tr&gt;</code></p><p><code>1612</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Prisma Health-Upstate Cancer Institute&lt;/td&gt;</code></p><p><code>1613</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Not yet recruiting&lt;/td&gt;</code></p><p><code>1614</code><code>                          &lt;/tr&gt;</code></p><p><code>1615</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Greenville, South Carolina, United States, 29605  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1616</code><code>                                                            &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, Tennessee&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1617</code><code>                                      &lt;tr&gt;</code></p><p><code>1618</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;University of TN Medical Center&lt;/td&gt;</code></p><p><code>1619</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1620</code><code>                          &lt;/tr&gt;</code></p><p><code>1621</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Knoxville, Tennessee, United States, 37920  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1622</code><code>                                                            &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, Texas&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1623</code><code>                                      &lt;tr&gt;</code></p><p><code>1624</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Oncology Consultants P.A.&lt;/td&gt;</code></p><p><code>1625</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Not yet recruiting&lt;/td&gt;</code></p><p><code>1626</code><code>                          &lt;/tr&gt;</code></p><p><code>1627</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Houston, Texas, United States, 77030  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1628</code><code>                                                          &lt;tr&gt;</code></p><p><code>1629</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;The University of Texas MD Anderson Cancer Center&lt;/td&gt;</code></p><p><code>1630</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1631</code><code>                          &lt;/tr&gt;</code></p><p><code>1632</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Houston, Texas, United States, 77030  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1633</code><code>                                                            &lt;tr&gt;&lt;td colspan="2" class="ct-header3" style="padding-top:2ex;"&gt;United States, Washington&lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1634</code><code>                                      &lt;tr&gt;</code></p><p><code>1635</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Swedish Cancer Institute&lt;/td&gt;</code></p><p><code>1636</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1637</code><code>                          &lt;/tr&gt;</code></p><p><code>1638</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Seattle, Washington, United States, 98104  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1639</code><code>                                                          &lt;tr&gt;</code></p><p><code>1640</code><code>                            &lt;td headers="locName" style="padding-left:2em;"&gt;Swedish Medical Center&lt;/td&gt;</code></p><p><code>1641</code><code>                                          &lt;td headers="locStatus" class="ct-header3" style="padding:1ex 0px 0px 2em;"&gt;Recruiting&lt;/td&gt;</code></p><p><code>1642</code><code>                          &lt;/tr&gt;</code></p><p><code>1643</code><code>                          &lt;tr&gt;&lt;td colspan="2" style="padding:0;padding-left:4em;"&gt;Seattle, Washington, United States, 98122  &lt;/td&gt;&lt;/tr&gt;</code></p><p><code>1644</code><code>                                          &lt;/tbody&gt;</code></p><p><code>1645</code><code>      &lt;/table&gt;</code></p><p><code>1646</code><code>    &lt;/div&gt;</code></p><p><code>1647</code><code>  &lt;/div&gt;   </code></p><p><code>1648</code><code>  </code></p><p><code>1649</code><code>  &lt;!-- sponsors --&gt;</code></p><p><code>1650</code><code>      &lt;div class="ct-header3" style="margin-top:2ex"&gt;Sponsors and Collaborators&lt;/div&gt;</code></p><p><code>1651</code><code>              &lt;div class="tr-indent2" style="margin-top:1ex"&gt;Pfizer&lt;/div&gt;</code></p><p><code>1652</code><code>        </code></p><p><code>1653</code><code>  &lt;!-- overall officials --&gt;</code></p><p><code>1654</code><code>    &lt;div class="ct-header3" style="margin-top:2ex"&gt;Investigators&lt;/div&gt;</code></p><p><code>1655</code><code>  &lt;div class="tr-table_cover"&gt;</code></p><p><code>1656</code><code>  &lt;table class="ct-layout_table tr-indent2"&gt;</code></p><p><code>1657</code><code>    &lt;caption&gt;Layout table for investigator information&lt;/caption&gt;</code></p><p><code>1658</code><code>    &lt;thead&gt;</code></p><p><code>1659</code><code>    &lt;tr&gt;</code></p><p><code>1660</code><code>      &lt;th id="role" style="visibility:hidden"&gt;&lt;/th&gt;</code></p><p><code>1661</code><code>      &lt;th id="name" style="visibility:hidden"&gt;&lt;/th&gt;</code></p><p><code>1662</code><code>      &lt;th id="affiliation" style="visibility:hidden"&gt;&lt;/th&gt;</code></p><p><code>1663</code><code>      &lt;th id="address" style="visibility:hidden"&gt;&lt;/th&gt;</code></p><p><code>1664</code><code>    &lt;/tr&gt;</code></p><p><code>1665</code><code>    &lt;/thead&gt;</code></p><p><code>1666</code><code>        &lt;tr&gt;</code></p><p><code>1667</code><code>      &lt;td headers="role"&gt;Study Director:&lt;/td&gt;</code></p><p><code>1668</code><code>      &lt;td headers="name"&gt;Pfizer CT.gov Call Center&lt;/td&gt;</code></p><p><code>1669</code><code>            &lt;td headers="affiliation"&gt;Pfizer&lt;/td&gt;</code></p><p><code>1670</code><code>            &lt;td headers="address"&gt;&lt;/td&gt;</code></p><p><code>1671</code><code>    &lt;/tr&gt;</code></p><p><code>1672</code><code>      &lt;/table&gt;</code></p><p><code>1673</code><code>  &lt;/div&gt;</code></p><p><code>1674</code><code>  </code></p><p><code>1675</code><code>          </code></p><p><code>1676</code><code>&lt;/div&gt;</code></p><p><code>1677</code><code>&lt;/div&gt;</code></p><p><code>1678</code><code>						</code></p><p><code>1679</code><code>&lt;!-- more_info_section --&gt;</code></p><p><code>1680</code><code>          </code></p><p><code>1681</code><code>&lt;!-- Large docs section --&gt;</code></p><p><code>1682</code><code>          </code></p><p><code>1683</code><code>    </code></p><p><code>1684</code><code>          </code></p><p><code>1685</code><code>&lt;!-- More info section --&gt;</code></p><p><code>1686</code><code>  &lt;div class="tr-indent1" style="margin-top:3ex; border:1px solid white"&gt;</code></p><p><code>1687</code><code>  &lt;div class="tr-subsection"&gt;</code></p><p><code>1688</code><code>  	&lt;div class="ct-header2"&gt;&lt;a id="moreinfo"&gt;&lt;/a&gt;More Information&lt;/div&gt;</code></p><p><code>1689</code><code>  	&lt;div class="tr-underline"&gt;&lt;/div&gt;</code></p><p><code>1690</code><code>  	&lt;div class="tr-dropdown" style="padding-right:10em"&gt;</code></p><p><code>1691</code><code>Go&amp;nbsp;to&amp;nbsp;</code></p><p><code>1692</code><code>&lt;button class="tr-dropbtn" style="font-weight:bold; font-size:14px"&gt;</code></p><p><code>1693</code><code>&lt;img src="/ct2/html/images/pulldown.png" alt="sections"&gt;</code></p><p><code>1694</code><code>&lt;/button&gt;</code></p><p><code>1695</code><code>          </code></p><p><code>1696</code><code>  &lt;div class="tr-dropdown-content"&gt;</code></p><p><code>1697</code><code>	&lt;a href="#wrapper"&gt;Top of Page&lt;/a&gt;</code></p><p><code>1698</code><code>    &lt;a href="#studydesc"&gt;Study Description&lt;/a&gt;</code></p><p><code>1699</code><code>    &lt;a href="#studydesign"&gt;Study Design&lt;/a&gt;</code></p><p><code>1700</code><code>          </code></p><p><code>1701</code><code>    &lt;!-- arms and groups table --&gt;</code></p><p><code>1702</code><code>        &lt;a href="#armgroup"&gt;Arms and Interventions&lt;/a&gt;</code></p><p><code>1703</code><code>    </code></p><p><code>1704</code><code>        &lt;a href="#outcomemeasures"&gt;Outcome Measures&lt;/a&gt;</code></p><p><code>1705</code><code>        &lt;a href="#eligibility"&gt;Eligibility Criteria&lt;/a&gt;</code></p><p><code>1706</code><code>    &lt;a href="#contactlocation"&gt;Contacts and Locations&lt;/a&gt;</code></p><p><code>1707</code><code>    &lt;a href="#moreinfo"&gt;More Information&lt;/a&gt;</code></p><p><code>1708</code><code>  &lt;/div&gt;</code></p><p><code>1709</code><code>&lt;/div&gt;</code></p><p><code>1710</code><code>  &lt;/div&gt;</code></p><p><code>1711</code><code>  </code></p><p><code>1712</code><code>  &lt;div class="tr-indent2" style="margin-top:1em;"&gt;</code></p><p><code>1713</code><code>          </code></p><p><code>1714</code><code>          </code></p><p><code>1715</code><code>    &lt;!-- Additional Information --&gt;</code></p><p><code>1716</code><code>        &lt;span class="ct-header3"&gt;Additional Information:&lt;/span&gt;</code></p><p><code>1717</code><code>    &lt;div class="tr-indent2"&gt;  </code></p><p><code>1718</code><code>      &lt;!-- See Also Links --&gt;</code></p><p><code>1719</code><code>                        &lt;div style="margin-top:2ex;"&gt;</code></p><p><code>1720</code><code>	          	            &lt;a class="tr-study-link" href="/ct2/bye/YQoPWwoRrXS9Ed7zNd-ymXNgZdD90dhzuQ7gkdYLWwNzkdYLedN6ZX1yzw1Hzw-VA8-PL6ozyP4L8Hj5mg0nSXCta/hHhqJdcyWB7zunhgZdUPkB-VJQ7xNd-ymB1PedcOJ6N9SnhjJw-PL6o5JBcHuihHSnhxzB1nJT79LXY30dhz0QS3l61yzXJ" title="To obtain contact information for a study center near you, click here." onclick="openNewWindow('/ct2/bye/YQoPWwoRrXS9Ed7zNd-ymXNgZdD90dhzuQ7gkdYLWwNzkdYLedN6ZX1yzw1Hzw-VA8-PL6ozyP4L8Hj5mg0nSXCta/hHhqJdcyWB7zunhgZdUPkB-VJQ7xNd-ymB1PedcOJ6N9SnhjJw-PL6o5JBcHuihHSnhxzB1nJT79LXY30dhz0QS3l61yzXJ'); return false"&gt;To obtain contact information for a study center near you, click here.&lt;/a&gt;&amp;nbsp;</code></p><p><code>1721</code><code>	            &lt;img src="/ct2/html/images/frame/exit.bmp" alt="This link exits the ClinicalTrials.gov site"/&gt;</code></p><p><code>1722</code><code>	          	      &lt;/div&gt;</code></p><p><code>1723</code><code>                  &lt;/div&gt;</code></p><p><code>1724</code><code>    &lt;br/&gt;</code></p><p><code>1725</code><code>    </code></p><p><code>1726</code><code>          </code></p><p><code>1727</code><code>    &lt;!-- Available Study Data/Document --&gt;</code></p><p><code>1728</code><code>    </code></p><p><code>1729</code><code>          </code></p><p><code>1730</code><code>  &lt;!-- References --&gt;</code></p><p><code>1731</code><code>    </code></p><p><code>1732</code><code>    </code></p><p><code>1733</code><code>  &lt;!-- Derived References --&gt;</code></p><p><code>1734</code><code>    </code></p><p><code>1735</code><code>   </code></p><p><code>1736</code><code>  &lt;table class="ct-layout_table tr-tableStyle tr-moreInfo" style="margin-top:1ex;"&gt;</code></p><p><code>1737</code><code>    &lt;caption&gt;Layout table for additonal information&lt;/caption&gt;</code></p><p><code>1738</code><code>    &lt;thead&gt;</code></p><p><code>1739</code><code>    &lt;tr&gt;</code></p><p><code>1740</code><code>      &lt;th id="colTitle1"&gt;&lt;/th&gt;</code></p><p><code>1741</code><code>      &lt;th id="colData1"&gt;&lt;/th&gt;</code></p><p><code>1742</code><code>    &lt;/tr&gt;</code></p><p><code>1743</code><code>    &lt;/thead&gt;</code></p><p><code>1744</code><code>    &lt;tbody&gt;</code></p><p><code>1745</code><code>        &lt;tr&gt;</code></p><p><code>1746</code><code>      &lt;td headers="colTitle1" class="ct-nowrap"&gt;Responsible Party:&lt;/td&gt;</code></p><p><code>1747</code><code>      &lt;td headers="colData1" style="padding-left:1em"&gt;Pfizer&lt;/td&gt;</code></p><p><code>1748</code><code>    &lt;/tr&gt;</code></p><p><code>1749</code><code>        &lt;tr&gt;</code></p><p><code>1750</code><code>      &lt;td headers="colTitle1" class="ct-nowrap"&gt;ClinicalTrials.gov Identifier:&lt;/td&gt;</code></p><p><code>1751</code><code>      &lt;td headers="colData1" style="padding-left:1em"&gt;</code></p><p><code>1752</code><code>        &lt;a class="tr-study-link" title="Current version of study NCT03530683 on ClinicalTrials.gov" href="https://classic.clinicaltrials.gov/show/NCT03530683"&gt;NCT03530683&lt;/a&gt; &amp;nbsp; &amp;nbsp;</code></p><p><code>1753</code><code>        </code></p><p><code>1754</code><code>  &lt;script type="text/javascript"&gt;</code></p><p><code>1755</code><code>    &lt;!--</code></p><p><code>1756</code><code>    // Scramble access to archive site -</code></p><p><code>1757</code><code>    // don't want crawlers directing users to outdated versions of the study</code></p><p><code>1758</code><code>    // this should be opaque to crawlers that don't execute javascript</code></p><p><code>1759</code><code>    var yyy=new Array(</code></p><p><code>1760</code><code>      ['&lt;','a clas','s="tr-study','-link c', 't-now','rap" t','itle="Hist','orical vers','ions of '],</code></p><p><code>1761</code><code>      ['study ','NCT03530683',' on Clin','icalTrials.','go'],</code></p><p><code>1762</code><code>      ['v Ar','chive',' Sit','e" ','onc','lick="','openN','ewWin', 'dow(','\'/ct2/', 'history/'],</code></p><p><code>1763</code><code>      ['NCT03530683','\'); return', ' false;" '],</code></p><p><code>1764</code><code>      ['href','="/ct2/','history/','NCT03530683"','&gt;'],</code></p><p><code>1765</code><code>      ['Histo','ry of C','hange','s&lt;','/','a&gt;']);</code></p><p><code>1766</code><code>    var i=0;</code></p><p><code>1767</code><code>    var j=0;</code></p><p><code>1768</code><code>    var xxx='';</code></p><p><code>1769</code><code>    for (i=0; i&lt;yyy.length; i++)</code></p><p><code>1770</code><code>      for (j=0; j&lt;yyy[i].length; j++)</code></p><p><code>1771</code><code>        xxx+=yyy[i][j];</code></p><p><code>1772</code><code>    document.write(xxx)</code></p><p><code>1773</code><code>    --&gt;</code></p><p><code>1774</code><code>  &lt;/script&gt;</code></p><p><code>1775</code><code>          </code></p><p><code>1776</code><code>      &lt;/td&gt;</code></p><p><code>1777</code><code>    &lt;/tr&gt;</code></p><p><code>1778</code><code>            &lt;tr&gt;</code></p><p><code>1779</code><code>      &lt;td headers="colTitle1" class="ct-nowrap"&gt;Other Study ID Numbers:&lt;/td&gt;</code></p><p><code>1780</code><code>      &lt;td headers="colData1" style="padding-left:1em"&gt;</code></p><p><code>1781</code><code>                                    TTI-622-01 &lt;br/&gt;</code></p><p><code>1782</code><code>                                                C4971001 ( Other Identifier: Alias Study Number )&lt;br/&gt;</code></p><p><code>1783</code><code>                            &lt;/td&gt;</code></p><p><code>1784</code><code>    &lt;/tr&gt;</code></p><p><code>1785</code><code>            &lt;tr&gt;</code></p><p><code>1786</code><code>      &lt;td headers="colTitle1" class="ct-nowrap"&gt;First Posted:&lt;/td&gt;</code></p><p><code>1787</code><code>      &lt;td headers="colData1" style="padding-left:1em"&gt;May 21, 2018</code></p><p><code>1788</code><code>          &amp;nbsp;&amp;nbsp;</code></p><p><code>1789</code><code>          &lt;a class="tr-study-link ct-nowrap" href="/ct2/keydates/NCT03530683"</code></p><p><code>1790</code><code>                title="View key record dates for NCT03530683"</code></p><p><code>1791</code><code>                onclick="openNewWindow('/ct2/keydates/NCT03530683'); return false;"&gt;Key Record Dates&lt;/a&gt;</code></p><p><code>1792</code><code>      &lt;/td&gt;</code></p><p><code>1793</code><code>    &lt;/tr&gt;</code></p><p><code>1794</code><code>            &lt;tr&gt;</code></p><p><code>1795</code><code>      &lt;td headers="colTitle1" class="ct-nowrap"&gt;Last Update Posted:&lt;/td&gt;</code></p><p><code>1796</code><code>      &lt;td headers="colData1" style="padding-left:1em"&gt;September 1, 2023</code></p><p><code>1797</code><code>      &lt;/td&gt;</code></p><p><code>1798</code><code>    &lt;/tr&gt;</code></p><p><code>1799</code><code>        &lt;tr&gt;</code></p><p><code>1800</code><code>      &lt;td headers="colTitle1" class="ct-nowrap"&gt;Last Verified:&lt;/td&gt;</code></p><p><code>1801</code><code>      &lt;td headers="colData1" style="padding-left:1em"&gt;August 2023</code></p><p><code>1802</code><code>      &lt;/td&gt;</code></p><p><code>1803</code><code>    &lt;/tr&gt;</code></p><p><code>1804</code><code>           </code></p><p><code>1805</code><code>    &lt;!-- Plan to Share Data --&gt;</code></p><p><code>1806</code><code>          &lt;tr&gt;</code></p><p><code>1807</code><code>        &lt;td headers="colTitle1" class="ct-nowrap" colspan="2" style="padding-top:3ex;"&gt;Individual Participant Data (IPD) Sharing Statement:&lt;/td&gt;</code></p><p><code>1808</code><code>      &lt;/tr&gt;</code></p><p><code>1809</code><code>      &lt;tr&gt;</code></p><p><code>1810</code><code>        &lt;td headers="colTitle1" class="ct-nowrap" style="padding-left:1em;"&gt;Plan to Share IPD:&lt;/td&gt;</code></p><p><code>1811</code><code>        &lt;td headers="colData1" style="padding-left:1em"&gt;No&lt;/td&gt;</code></p><p><code>1812</code><code>      &lt;/tr&gt;</code></p><p><code>1813</code><code>            &lt;tr&gt;</code></p><p><code>1814</code><code>        &lt;td headers="colTitle1" class="ct-nowrap" style="padding-left:1em;"&gt;Plan Description:&lt;/td&gt;</code></p><p><code>1815</code><code>        &lt;td headers="colData1" style="padding-left:1em"&gt;Pfizer will provide access to individual de-identified participant data and related study documents (e.g. protocol, Statistical Analysis Plan (SAP), Clinical Study Report (CSR)) upon request from qualified researchers, and subject to certain criteria, conditions, and exceptions. Further details on Pfizer's data sharing criteria and process for requesting access can be found at: https://www.pfizer.com/science/clinical_trials/trial_data_and_results/data_requests.&lt;/td&gt;</code></p><p><code>1816</code><code>      &lt;/tr&gt;</code></p><p><code>1817</code><code>                                      &lt;/tbody&gt;</code></p><p><code>1818</code><code>  &lt;/table&gt;</code></p><p><code>1819</code><code>          </code></p><p><code>1820</code><code>    &lt;br/&gt;</code></p><p><code>1821</code><code>  &lt;table class="ct-layout_table tr-tableStyle tr-moreInfo" style="margin-top:1ex"&gt;</code></p><p><code>1822</code><code>    &lt;caption&gt;Layout table for additional information&lt;/caption&gt;</code></p><p><code>1823</code><code>    &lt;thead&gt;</code></p><p><code>1824</code><code>    &lt;tr&gt;</code></p><p><code>1825</code><code>      &lt;th id="colTitle2"&gt;&lt;/th&gt;</code></p><p><code>1826</code><code>      &lt;th id="colData2"&gt;&lt;/th&gt;</code></p><p><code>1827</code><code>    &lt;/tr&gt;</code></p><p><code>1828</code><code>    &lt;/thead&gt;</code></p><p><code>1829</code><code>    &lt;tbody&gt;       </code></p><p><code>1830</code><code>        &lt;tr&gt;</code></p><p><code>1831</code><code>      &lt;td headers="colTitle2" class="ct-nowrap"&gt;Studies a U.S. FDA-regulated Drug Product:&lt;/td&gt;</code></p><p><code>1832</code><code>      &lt;td headers="colData2" style="padding-left:1em"&gt;Yes&lt;/td&gt;</code></p><p><code>1833</code><code>    &lt;/tr&gt;</code></p><p><code>1834</code><code>            &lt;tr&gt;</code></p><p><code>1835</code><code>      &lt;td headers="colTitle2" class="ct-nowrap"&gt;Studies a U.S. FDA-regulated Device Product:&lt;/td&gt;</code></p><p><code>1836</code><code>      &lt;td headers="colData2" style="padding-left:1em"&gt;No&lt;/td&gt;</code></p><p><code>1837</code><code>    &lt;/tr&gt;</code></p><p><code>1838</code><code>                    &lt;/tbody&gt;</code></p><p><code>1839</code><code>  &lt;/table&gt;</code></p><p><code>1840</code><code>  </code></p><p><code>1841</code><code>  </code></p><p><code>1842</code><code>    &lt;!-- keywords --&gt;</code></p><p><code>1843</code><code>        	</code></p><p><code>1844</code><code>    	    	  	&lt;div class="tr-tableLabel"&gt;Keywords provided by Pfizer:&lt;/div&gt;</code></p><p><code>1845</code><code>    	    	&lt;div class="tr-indent3"&gt;</code></p><p><code>1846</code><code>          &lt;table class="ct-layout_table tr-moreInfo" style="width:100%;"&gt;</code></p><p><code>1847</code><code>    	      &lt;thead&gt;</code></p><p><code>1848</code><code>    	      &lt;tr&gt;</code></p><p><code>1849</code><code>    	        &lt;th id="keywordCol1" style="width:50%;"&gt;&lt;/th&gt;</code></p><p><code>1850</code><code>    	        &lt;th id="keywordCol2" style="width:50%;"&gt;&lt;/th&gt;</code></p><p><code>1851</code><code>    	      &lt;/tr&gt;</code></p><p><code>1852</code><code>    	      &lt;/thead&gt;</code></p><p><code>1853</code><code>    	      &lt;tr&gt;</code></p><p><code>1854</code><code>    	        &lt;td headers="keywordCol1" style="padding-left:1em;"&gt;</code></p><p><code>1855</code><code>    	              	          Neoplasms&lt;br/&gt;</code></p><p><code>1856</code><code>    	              	          Lymphoma&lt;br/&gt;</code></p><p><code>1857</code><code>    	              	          Myeloma&lt;br/&gt;</code></p><p><code>1858</code><code>    	              	          Leukemia&lt;br/&gt;</code></p><p><code>1859</code><code>    	              	        &lt;/td&gt;</code></p><p><code>1860</code><code>    	            	        &lt;td&gt;&lt;/td&gt;</code></p><p><code>1861</code><code>    	            	      &lt;/tr&gt;</code></p><p><code>1862</code><code>    	    &lt;/table&gt;</code></p><p><code>1863</code><code>    	&lt;/div&gt;</code></p><p><code>1864</code><code>    </code></p><p><code>1865</code><code>    &lt;!-- mesh terms --&gt;</code></p><p><code>1866</code><code>          &lt;div class="tr-tableLabel"&gt;Additional relevant MeSH terms:&lt;/div&gt;</code></p><p><code>1867</code><code>      &lt;div class="tr-indent3"&gt;</code></p><p><code>1868</code><code>        &lt;table class="ct-layout_table tr-meshTerms" style="width:100%;"&gt;</code></p><p><code>1869</code><code>          &lt;caption&gt;Layout table for MeSH terms&lt;/caption&gt;</code></p><p><code>1870</code><code>          &lt;thead&gt;</code></p><p><code>1871</code><code>          &lt;tr&gt;</code></p><p><code>1872</code><code>            &lt;th id="meshTermCol1" style="width:50%;"&gt;&lt;/th&gt;</code></p><p><code>1873</code><code>            &lt;th id="meshTermCol2"&gt;&lt;/th&gt;</code></p><p><code>1874</code><code>          &lt;/tr&gt;</code></p><p><code>1875</code><code>          &lt;/thead&gt;</code></p><p><code>1876</code><code>          &lt;tr&gt;</code></p><p><code>1877</code><code>            &lt;td headers="meshTermCol1" style="padding-left:1em;"&gt;</code></p><p><code>1878</code><code>                            Lymphoma&lt;br/&gt;</code></p><p><code>1879</code><code>                            Leukemia&lt;br/&gt;</code></p><p><code>1880</code><code>                            Multiple Myeloma&lt;br/&gt;</code></p><p><code>1881</code><code>                            Neoplasms, Plasma Cell&lt;br/&gt;</code></p><p><code>1882</code><code>                            Lymphoma, Large B-Cell, Diffuse&lt;br/&gt;</code></p><p><code>1883</code><code>                            Neoplasms by Histologic Type&lt;br/&gt;</code></p><p><code>1884</code><code>                            Neoplasms&lt;br/&gt;</code></p><p><code>1885</code><code>                            Lymphoproliferative Disorders&lt;br/&gt;</code></p><p><code>1886</code><code>                            Lymphatic Diseases&lt;br/&gt;</code></p><p><code>1887</code><code>                            Immunoproliferative Disorders&lt;br/&gt;</code></p><p><code>1888</code><code>                            Immune System Diseases&lt;br/&gt;</code></p><p><code>1889</code><code>                            Hemostatic Disorders&lt;br/&gt;</code></p><p><code>1890</code><code>                            Vascular Diseases&lt;br/&gt;</code></p><p><code>1891</code><code>                            Cardiovascular Diseases&lt;br/&gt;</code></p><p><code>1892</code><code>                            Paraproteinemias&lt;br/&gt;</code></p><p><code>1893</code><code>                          &lt;/td&gt;</code></p><p><code>1894</code><code>                        &lt;td headers="meshTermCol1" style="padding-left:1em;"&gt;</code></p><p><code>1895</code><code>                            Blood Protein Disorders&lt;br/&gt;</code></p><p><code>1896</code><code>                            Hematologic Diseases&lt;br/&gt;</code></p><p><code>1897</code><code>                            Hemorrhagic Disorders&lt;br/&gt;</code></p><p><code>1898</code><code>                            Lymphoma, B-Cell&lt;br/&gt;</code></p><p><code>1899</code><code>                            Lymphoma, Non-Hodgkin&lt;br/&gt;</code></p><p><code>1900</code><code>                            Dexamethasone&lt;br/&gt;</code></p><p><code>1901</code><code>                            Azacitidine&lt;br/&gt;</code></p><p><code>1902</code><code>                            Venetoclax&lt;br/&gt;</code></p><p><code>1903</code><code>                            Anti-Inflammatory Agents&lt;br/&gt;</code></p><p><code>1904</code><code>                            Antiemetics&lt;br/&gt;</code></p><p><code>1905</code><code>                            Autonomic Agents&lt;br/&gt;</code></p><p><code>1906</code><code>                            Peripheral Nervous System Agents&lt;br/&gt;</code></p><p><code>1907</code><code>                            Physiological Effects of Drugs&lt;br/&gt;</code></p><p><code>1908</code><code>                            Gastrointestinal Agents&lt;br/&gt;</code></p><p><code>1909</code><code>                            Glucocorticoids&lt;br/&gt;</code></p><p><code>1910</code><code>                          &lt;/td&gt;</code></p><p><code>1911</code><code>                      &lt;/tr&gt;</code></p><p><code>1912</code><code>        &lt;/table&gt;</code></p><p><code>1913</code><code>      &lt;/div&gt;</code></p><p><code>1914</code><code>    </code></p><p><code>1915</code><code>  &lt;br/&gt;</code></p><p><code>1916</code><code>          </code></p><p><code>1917</code><code>  &lt;!--</code></p><p><code>1918</code><code>        &lt;span class="ct-body3"&gt;ClinicalTrials.gov processed this record on September 26, 2023&lt;/span&gt;&lt;br/&gt;</code></p><p><code>1919</code><code>      --&gt;</code></p><p><code>1920</code><code>    &lt;br/&gt;  </code></p><p><code>1921</code><code>  &lt;/div&gt;</code></p><p><code>1922</code><code>   &lt;/div&gt;</code></p><p><code>1923</code><code>						</code></p><p><code>1924</code><code>			&lt;div id="to-top"&gt;&lt;a href="#wrapper"&gt;To Top&lt;/a&gt;&lt;/div&gt;</code></p><p><code>1925</code><code>			</code></p><p><code>1926</code><code>			&lt;div style="clear:both;"&gt;&lt;/div&gt;</code></p><p><code>1927</code><code>		&lt;/div&gt;</code></p><p><code>1928</code><code>	&lt;/div&gt;</code></p><p><code>1929</code><code>&lt;/div&gt;  </code></p><p><code>1930</code><code>&lt;div&gt;       &lt;div id="for-footer"&gt;</code></p><p><code>1931</code><code>        &lt;ul class="ct-horz-list"&gt;</code></p><p><code>1932</code><code>            &lt;li style="border-left:0;"&gt;&lt;a    href="/ct2/help/for-patient"&gt;For Patients and Families&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1933</code><code>            &lt;li&gt;&lt;a href="/ct2/help/for-researcher"&gt;For Researchers&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1934</code><code>            &lt;li&gt;&lt;a     href="/ct2/help/for-manager"&gt;For Study Record Managers&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1935</code><code>        &lt;/ul&gt;</code></p><p><code>1936</code><code>    &lt;/div&gt;</code></p><p><code>1937</code><code>	</code></p><p><code>1938</code><code>&lt;/div&gt;  </code></p><p><code>1939</code><code>&lt;div id="footer-menu" class="horz-line-above-menu"&gt;</code></p><p><code>1940</code><code>    &lt;ul class="ct-horz-list"&gt;</code></p><p><code>1941</code><code>		&lt;li&gt;&lt;a     href="/ct2/home"&gt;Home&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1942</code><code>		&lt;li&gt;&lt;a     href="/ct2/resources/rss"&gt;RSS Feeds&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1943</code><code>		&lt;li&gt;&lt;a     href="/ct2/sitemap"&gt;Site Map&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1944</code><code>		&lt;li&gt;&lt;a     href="/ct2/about-site/terms-conditions"&gt;Terms and Conditions&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1945</code><code>		&lt;li&gt;&lt;a     href="/ct2/about-site/disclaimer"&gt;Disclaimer&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1946</code><code>		&lt;li&gt;&lt;a     href="https://support.nlm.nih.gov/knowledgebase/category/?id=CAT-01242&amp;amp;category=clinicaltrials.gov&amp;amp;hd_url=http%3A%2F%2Fclassic.clinicaltrials.gov%2Fct2%2Fshow%2FNCT03530683%3Fterm%3DNCT03530683%26draw%3D2%26rank%3D1" onclick="openNewWindow('https://support.nlm.nih.gov/knowledgebase/category/?id=CAT-01242&amp;amp;category=clinicaltrials.gov&amp;amp;hd_url=http%3A%2F%2Fclassic.clinicaltrials.gov%2Fct2%2Fshow%2FNCT03530683%3Fterm%3DNCT03530683%26draw%3D2%26rank%3D1'); return false"&gt;Customer Support&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1947</code><code>	&lt;/ul&gt;</code></p><p><code>1948</code><code>&lt;/div&gt;</code></p><p><code>1949</code><code>          </code></p><p><code>1950</code><code>&lt;/div&gt;  </code></p><p><code>1951</code><code>&lt;div id="fine-print"&gt;</code></p><p><code>1952</code><code>	&lt;ul class="ct-horz-list"&gt;</code></p><p><code>1953</code><code>		&lt;li &gt;&lt;a title="NLM copyright information - opens new window"  href="https://www.nlm.nih.gov/copyright.html" onclick="openNewWindow('https://www.nlm.nih.gov/copyright.html'); return false"</code></p><p><code>1954</code><code>&gt;Copyright&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1955</code><code>		&lt;li &gt;&lt;a title="NLM privacy policy - opens new window"  href="https://www.nlm.nih.gov/privacy.html" onclick="openNewWindow('https://www.nlm.nih.gov/privacy.html'); return false"</code></p><p><code>1956</code><code>&gt;Privacy&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1957</code><code>		&lt;li &gt;&lt;a href="/ct2/accessibility" title="NLM Accessibility"&gt;Accessibility&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1958</code><code>		&lt;li &gt;&lt;a title="NLM viewers and players - opens new window"  href="https://www.nlm.nih.gov/plugins.html" onclick="openNewWindow('https://www.nlm.nih.gov/plugins.html'); return false"</code></p><p><code>1959</code><code>&gt;Viewers and Players&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1960</code><code>		&lt;li &gt;&lt;a title="NIH Freedom of Information Act office - opens new window"  href="https://www.nih.gov/icd/od/foia/index.htm" onclick="openNewWindow('https://www.nih.gov/icd/od/foia/index.htm'); return false"</code></p><p><code>1961</code><code>&gt;Freedom of Information Act&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1962</code><code>		&lt;li &gt;&lt;a title="USA.gov - opens new window"  href="https://www.usa.gov/" onclick="openNewWindow('https://www.usa.gov/'); return false"</code></p><p><code>1963</code><code>&gt;USA.gov&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1964</code><code>		&lt;!--li &gt;&lt;a id="vdp" title="HHS Vulnerability Disclosure - opens new window"  href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" onclick="openNewWindow('https://www.hhs.gov/vulnerability-disclosure-policy/index.html'); return false"</code></p><p><code>1965</code><code>&gt;HHS Vulnerability Disclosure&lt;/a&gt;&lt;/li--&gt;</code></p><p><code>1966</code><code>		&lt;li&gt;</code></p><p><code>1967</code><code>			&lt;a id="vdp" </code></p><p><code>1968</code><code>				href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" </code></p><p><code>1969</code><code>				title="HHS Vulnerability Disclosure" </code></p><p><code>1970</code><code>				target="_blank"&gt;</code></p><p><code>1971</code><code>				HHS Vulnerability Disclosure</code></p><p><code>1972</code><code>			&lt;/a&gt;</code></p><p><code>1973</code><code>		&lt;/li&gt;</code></p><p><code>1974</code><code>	&lt;/ul&gt;</code></p><p><code>1975</code><code>    &lt;ul class="ct-horz-list"&gt;</code></p><p><code>1976</code><code>       &lt;li&gt;&lt;a title="U.S. National Library of Medicine - opens new window"  href="https://www.nlm.nih.gov/" onclick="openNewWindow('https://www.nlm.nih.gov/'); return false"</code></p><p><code>1977</code><code>&gt;U.S. National Library of Medicine&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1978</code><code>       &lt;li&gt;&lt;a title="U.S. National Institutes of Health - opens new window"  href="https://www.nih.gov/" onclick="openNewWindow('https://www.nih.gov/'); return false"</code></p><p><code>1979</code><code>&gt;U.S. National Institutes of Health&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1980</code><code>       &lt;li&gt;&lt;a title="U.S. Department of Health and Human Services - opens new window"  href="https://www.hhs.gov/" onclick="openNewWindow('https://www.hhs.gov/'); return false"</code></p><p><code>1981</code><code>&gt;</code></p><p><code>1982</code><code>            U.S. Department of Health and Human Services&lt;/a&gt;&lt;/li&gt;</code></p><p><code>1983</code><code>    &lt;/ul&gt;</code></p><p><code>1984</code><code>&lt;/div&gt;</code></p><p><code>1985</code><code>          </code></p><p><code>1986</code><code>&lt;script type="text/javascript"&gt;__ncbi_sg_gaMode="clinicaltrials"&lt;/script&gt;</code></p><p><code>1987</code><code>&lt;script type="text/javascript" src="/ct2/html/js/pinger.js?v=2"&gt;&lt;/script&gt;&lt;noscript&gt;&lt;/noscript&gt;</code></p><p><code>1988</code><code>&lt;script type="text/javascript" src="/ct2/html/js/main-glossary.js?v=48"&gt;&lt;/script&gt;&lt;noscript&gt;&lt;/noscript&gt;</code></p><p><code>1989</code><code>&lt;script type="text/javascript"&gt;</code></p><p><code>1990</code><code>//OnSubmit routine - copy over some useful data and submit</code></p><p><code>1991</code><code>function sendSearchPing() {</code></p><p><code>1992</code><code>// Get pinger values</code></p><p><code>1993</code><code>var cVals = ncbi.sg.getInstance()._cachedVals;</code></p><p><code>1994</code><code>var app = cVals['ncbi_app'];</code></p><p><code>1995</code><code>var db = cVals['ncbi_db'];</code></p><p><code>1996</code><code>var pdid = cVals['ncbi_pdid'];</code></p><p><code>1997</code><code>var pcid = cVals['ncbi_pcid'];</code></p><p><code>1998</code><code>// Populate search details</code></p><p><code>1999</code><code>var searchDetails = {};</code></p><p><code>2000</code><code>searchDetails['jsevent'] = 'search';</code></p><p><code>2001</code><code>searchDetails['searchtext'] = jQuery('#header-search-query').val();</code></p><p><code>2002</code><code>if (app!=null) searchDetails['ncbi_app'] = app.value;</code></p><p><code>2003</code><code>if (db!=null) searchDetails['ncbi_db'] = db.value;</code></p><p><code>2004</code><code>if (pdid!=null) searchDetails['ncbi_pdid'] = pdid.value;</code></p><p><code>2005</code><code>if (pcid!=null) searchDetails['ncbi_pcid'] = pcid.value;</code></p><p><code>2006</code><code>// Send ping msg</code></p><p><code>2007</code><code>ncbi.sg.ping(searchDetails);</code></p><p><code>2008</code><code>};</code></p><p><code>2009</code><code>&lt;/script&gt;</code></p><p><code>2010</code><code>          </code></p><p><code>2011</code><code>          </code></p><p><code>2012</code><code>&lt;/body&gt;</code></p><p><code>2013</code><code>&lt;/html&gt;</code></p><div></div></main><iframe hidden="hidden" title="Hidden frame for spell checking" src="about:blank" id="iframeSpelling"></iframe></body></html>